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Abstract 
The reduction of phosphine oxides with silanes occurs with high specificity and fidelity and 
represents one of the most useful methods for synthesis of phosphines. The chemoselectivity of 
this process also allows for in situ recycling of phosphine oxide by-products to afford catalytic 
versions of the Wittig, Staudinger, and Mitsunobu reactions, among others. However, silane-
mediated reduction of phosphine oxides generally requires both elevated temperatures (80–120 
°C) and additives, substantially limiting substrate scope.  
Abnormal patterns in the reduction rates of phosphetane oxides by phenylsilane were noted, 
causing initiation of a comprehensive investigation of silane-mediated phosphine oxide reduction 
which revealed widespread misunderstandings of the reduction process. This led to 
characterization of a required pre-activation step for all commercially available silane reductants 
as well as a key 6-membered transition state that explains reactivity trends. Such insight fueled 
rational reagent design, furnishing 1,3-diphenyldisiloxane (DPDS), a superior disiloxane reducing 
agent. DPDS allowed for development of room temperature phosphine recycling Wittig, 
Staudinger, and Appel methodologies and is broadly applicable in phosphine synthesis, reducing 
acyclic phosphine oxides either additive-free at 110 °C or in combination with an additive under 
ambient conditions. 
Mechanism-based inhibitors (MBIs) are widely employed in chemistry, biology, and 
medicine due to their exquisite specificity and sustained duration of inhibition. The global kinetic 
parameters kinact and KI have been used to characterize MBIs, but derivation reveals they provide 
far less information than is commonly assumed. A more rigorous approach is determination of the 
individual microscopic rate constants of inactivation, which is demonstrated in the optimization 
of MBI 1.  
  iv 
1 inactivates tubercular BioA through a four-step mechanism, and kinetic analysis revealed 
the rate-limiting step is the removal of the α-proton of 1. This knowledge was subsequently 
applied to rationally design dihydro-4-pyranone 42, dihydro-4-pyridone 43 and dihydro-4-
thiopyranone 51. A unified synthetic strategy was employed for heterocycle construction 
featuring α-amino ynone generation followed by 6-endo-dig cyclization. However, competitive 5-
exo-dig cyclization, β-elimination of the ynone, and dimerization of the resultant α-amino 
carbonyls had to be overcome through Teoc and Boc-MOM protection amino groups. Dihydro-4-
pyridone 3 possessed an improved kinact value against BioA, validating the pKa–based design 
strategy. 
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Chapter 1 
 
 
How Phosphine Reduction by Silanes Actually Works and Applications to 
Phosphine Recycling and Phosphine Synthesis 
 
Adapted with permission from: 
 
Eiden, C. G.; Buonomo, J. A.; Aldrich, C. C. Phosphine Reduction Mechanism Paper. J. 
Am. Chem. Soc. 2017, unknown, unknown 
 
And 
 
Buonomo, J. A.; Eiden, C. G.; Aldrich, C. C. Phosphine Synthesis Paper. J. Am. Chem. 
Soc. 2017, unknown, unknown 
 
And 
 
Buonomo, J. A.; Eiden, C. G.; Aldrich, C. C. Scalable Synthesis of Disiloxanes from 
Silanes: A One-Pot Preparation of 1,3-Diphenyl-Disiloxane from Phenylsilane. Synthesis 
2017, unknown, unknown 
 
This work was done in collaboration with Joseph A. Buonomo and Dr. Courtney C. 
Aldrich. Credit is due as follows: 
 
J.A.B designed and synthesized the phosphine precatalysts. He also performed the initial 
Mitsunobu silane and phosphine screen, the initial NMR studies with TMPPO (Section 
1.3.3, 1.3.4), the functional group compatibility studies with DPDS, the ball-milling 
synthesis of disiloxanes, the phosphine recycling reactions, and the non-NMR based 
reductions of acyclic phosphines with DPDS. 
 
C.G.E designed and synthesized the silane reductants. He also designed and coded 
MassNMRProcessing. He performed all of the rest of the NMR studies, the kinetic 
analysis of the progress curves, the mathematical proofs, the reaction modeling, and the 
failed room temperature catalytic Mitsunobu reactions with DPDS (Section 1.10.1). 
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1.1 Introduction 
Phosphorous(III) compounds are nearly ubiquitous throughout the synthetic organic 
literature, serving as ligands in transition metal-catalyzed transformations and as essential 
reagents in classical reactions such as the Wittig1, Mitsunobu2, Staudinger3 (ligation and 
reduction), and Appel4. The reduction of phosphorous(V) oxides is a high-value process, as the 
final step of phosphine synthesis is commonly reduction of the corresponding phosphine oxide,5 
and each of the aforementioned venerable reactions generate a stoichiometric equivalent of 
phosphine oxide. Whether used for phosphine recycling or construction, a simple, 
chemoselective, and facile method for the reduction of phosphine oxides is necessary, and many 
investigations have aimed at the development of such conditions.  
Speaking specifically towards phosphine recycling, there are multiple strategies one could 
pursue. The most straightforward and “brute-force” method involves regeneration of the 
phosphine in an additional step following purification and isolation of the phosphine oxide from 
the initial reaction. An alternative, and many would suggest superior, option involves using only a 
catalytic amount of phosphine and reducing its oxide continually in situ. The first method uses 
stoichiometric amounts of the phosphine, requires multiple purifications (including purification of 
a phosphine oxide, which can be extremely difficult) and a subsequent reaction. This would lead 
to the loss of substantial amounts of phosphine materials as well as being far less atom-
economical than the second option, which uses catalytic amounts of phosphine and only requires 
a single, much simpler (phosphines are much easier to separate) purification. There is a third 
approach, the use of redox neutral catalysis, but it appears to have very limited reaction breadth as 
well as substrate scope.6 So far, the most generalizable7 method necessitates the in situ generation 
of chlorophosphonium species, requiring harsh reagents,8910 and there is no clear path to facilitate 
redox neutral versions of many phosphine-dependent reactions.  
  3 
For both phosphine synthesis and in situ phosphine recycling, extreme levels of 
chemoselectivity and stability of the reducing agent to alternative functional groups is necessary. 
The ideal catalytic-in-phosphine Wittig, Mitsunobu, Staudinger, or Appel reaction would have the 
substrate scope of the non-catalytic versions, and novel phosphines often contain reducible or 
reactive groups to tune the reactivity of the transition metals effectively. The remaining portion of 
the introduction describes the development of methods for phosphine oxide reduction, their 
application to both phosphine construction and in situ recycling, and the proposed mechanisms of 
such processes.  
The first example of reducing of a phosphine oxide to a phosphine was described by Hein and 
coworkers, utilizing lithium aluminum hydride and calcium aluminum hydride in 1,4-dioxane to 
reduce phosphine oxides.11 Lithium aluminum hydride was found to be the superior reagent, 
producing yields of trialkylphosphines in the 70% range, while calcium aluminum hydride 
produced yields around 40%.  However, when triphenylphosphine oxide (TPPO) was added to 
LiAlH4, they found that only about 20% of the desired product was formed, while the byproduct 
diphenylphosphoric acid was formed in about a 30% yield.12 This diphenylphosphoric acid was 
suggested to be formed following reduction of TPPO to diphenylphosphine, which then oxidized 
upon contact with atmospheric oxygen. Subsequent investigations by Issleib and Grams about the 
choice of solvent revealed that this side reactivity was substantial in both THF and dioxane, but 
was greatly hampered in non-cyclic ethers, as diethyl-, dipropyl-, and dibutyl-ether all furnished 
only trace amounts of diphenylphosphoric acid.13 The problem of phosphorous-carbon bond 
breakage was thus alleviated, but substantial problems remained for application of this reduction 
to phosphorous recycling.   
These problems revolve around the complete lack of chemoselectivity of this reduction 
system. Campbell and Way found that 6-7 hours of heating to 80 °C with LiAlH4 in di-n-butyl 
ether was necessary to complete reduction of a phosphine oxide,14 which is subjecting the 
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phosphine oxide to extremely harsh conditions for an extended period of time. As is well known, 
LiAlH4 rapidly reduces aldehydes, carboxylic acids, esters, and amides in a relatively short 
amount of time at 0 °C, so the conditions necessary for phosphine oxide reduction have no 
functional group tolerance. In fact, heating to 80 °C with LiAlH4 for multiple hours is harsh 
enough that the attempted regeneration of triphenylphosphine (TPP) immobilized on a polymeric 
surface using such conditions is believed to result in degradation of the polymer. 
Multiple groups have also developed non-chemoselective reductions of phosphine oxides.15 
The reduction of TPPO using hydrogen gas proceeds smoothly using high pressure and high 
temperature (98 bar, 160 °C) or with heterogeneous metal catalysts at extreme temperature (500 
°C).16 Electrochemical methods have also been used in combination with a silylating agent 
(TMSCl, TMSOTf) or alkylating agent (MeOTf).17 Additionally, metal hydrides other than 
LiAlH4 also demonstrated proficiency, including boranes at 120 °C18, sodium borohydride with or 
without alkylating agents, DIBAL, and Aluminum hydride. Clearly, each of these reactions suffer 
from very low functional group tolerance, and as such none will be sufficient for general 
reduction of phosphine oxides. 
Currently, the best reagents for phosphine oxide reduction are silanes, displaying moderate 
reductive potential in combination with moderate to high functional group tolerance depending on 
the system used. The first silane-mediated reduction of phosphine oxides was reported by 
Fritszche and coworkers in 1964, using Polymethylhydrosiloxane (PMHS), phenylsilane, 
diphenylsilane, and triphenylsilane to reduce a variety of both acyclic phosphine oxides and 
phospholane oxides.19 The same group followed this up with an additional manuscript that 
described the use of trichlorosilane in place of the other silanes.20 Most of the reduction 
conditions were solvent-free, though they did report highly concentrated reactions with 
trichlorosilane in benzene.  
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Fritzsche and coworkers determined conditions for the reduction of TPPO in under three 
hours, and successfully obtained good yields (80–95%) with all silanes in this time frame. The 
real test for the effectiveness of each of the different silanes was the degree of heating required to 
achieve the reported conversion, which drastically differed between the silanes. Phenylsilane and 
diphenylsilane were far most facile reductants of TPPO than PMHS and triphenylsilane, as only 
120 °C was necessary for the former compared to 280 °C and 300 °C for PMHS and 
triphenylsilane, respectively.21 Trichlorosilane was the most powerful of them all, achieving 
reduction at only 80 °C.22 Of the silanes used, PMHS is the most desirable from a sustainability 
standpoint, as it is an inexpensive industrial byproduct, but the intense heat necessary has limited 
its usefulness. Trichlorosilane was the most potent reductant; however, it is unpleasant to work 
with in a laboratory setting due to its corrosive nature, high flammability, and boiling point of 31 
°C, necessitating pressurized vessels. It also displays limited functional group tolerance. 
Phenylsilane and diphenylsilane have thus been widely perceived as the best reducing agents for 
generalized phosphine oxide reduction.  
One final discovery that Fritzsche and coworkers made was that the nature of the phosphine 
greatly influenced its ease of reduction. Multiple dihydrophospholes were reduced to the 
corresponding phosphines by heating phenylsilane to only 80 °C for 2 hours. A decade later, 
Marsi thoroughly investigated the use of phenylsilane for the reduction of 5-membered 
phosphorous heterocycles and found that phospholanes could also be reduced by phenylsilane at 
80 °C. It appeared that most 5-membered phosphorous heterocycles were reduced in a more facile 
manner than their acyclic coutnerparts, which was a key finding for the development of in situ 
phosphine oxide reduction. 
The first silane-mediated catalytic-in-phosphine reaction was reported by O’Brien and 
coworkers as they developed the first catalytic Wittig reaction.23 Instead of initializing the 
reaction with the addition of a phosphine, O’Brien and coworkers used phosphine oxide 
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precatalysts to take advantage of the latter’s significantly greater stability. They chose 3-methyl-
1-phenylphospholane-1-oxide (M1PPO), one of the phosphine oxides reported by Marsi that gets 
reduced at a lower temperature, as their precatalyst and used diphenylsilane as the preferred 
reductant. With a model system of benzaldehyde, methyl bromoacetate, sodium carbonate, and 
precatalyst at 100 °C for 24 hours, they tested phenylsilane, trimethoxysilane, and triphenylsilane, 
and found that the first two furnished lower yields of product than diphenylsilane, while 
triphenylsilane afforded no product at all. These trends in silane reactivity are consistent with the 
aforementioned results of Fritzsche and coworkers.24 
O’Brien and coworkers also reported varying the temperature of the reaction to empirically 
determine its effect.25 They found lowering the temperature from 100 to 80 °C did not 
compromise the reaction yield, but any additional decrease, to 70 °C or 60 °C, was detrimental to 
turnover.  However, reducing the temperature to 80 °C reduced the E/Z ratio from >95:5 to 67:33, 
which suggested the enhanced stereoselectivity was due to post-olefination isomerization of the Z 
alkene to the more stable E isomer. Consequently, the preferred temperature was 100 °C. 
Evaluating the substrate scope, they found their methodology produced E–olefins from a wide 
range of aldehydes. The success of para-nitrobenzaldehyde and 4-cyanobenzaldehyde with labile 
cyano and nitro groups demonstrated the high chemoselectivity of diphenylsilane.  O’Brien and 
coworkers also employed both bromo and chloro compounds as ylide precursors. This pioneering 
work by O’Brien and coworkers showed that phosphine recycling is feasible with impressive 
chemoselectivity with the proper selection of phosphine and silane reagents. This seminal finding 
inspired others to further advance this recycling methodology in other phosphine-dependent 
reactions. 
 Two years later, van Delft and coworkers reported the development of a catalytic Appel 
reaction that used similar methods to implement phosphine recycling.26 Recognizing the large gap 
in reducibility with different phosphines, they synthesized many potential phosphine oxide 
  7 
precatalysts and investigated the effect of ring-strain and electronics on reduction rate. Through 
GC and NMR studies, they monitored the reaction rate of 5-membered, 6-membered, and 7-
membered phosphorous heterocycles when combined with diphenylsilane at 100 °C in 1,4-
dioxane. They found that that ring size is extremely important in determining the potential for 
precatalyst reduction by diphenylsilane. The 5-membered phospholanes are reduced much more 
quickly than the 6-membered phosphine oxides, and the 7-membered phosphepanes are barely 
reduced at all. They also showed that removal of the methyl group on M1PPO did not impact 
reactivity. 
With the trend in ring size established, they next explored replacing the aliphatic 5-membered 
phosphine oxides with aromatic dibenzophospholes. Phospholes have additional ring strain when 
compared to phospholanes, which O’Brien and coworkers proposed was the reason for the ease of 
reduction of M1PPO in comparison to acyclic phosphine oxides. Phospholes also have the 
additional benefit of being easily tuned to have different electronic properties through 
incorporation of substituents on the dibenzophosphole core. However, when testing the aromatic 
phospholes, they found that diphenylsilane reduced the entire class of compounds slower, with 
the best compound reacting at approximately one-seventh the rate of the phenylphospholanes 
under otherwise identical conditions. When tuning the electronics of the dibenzophosphole, they 
found that adding electron withdrawing trifluoromethyl substituents provided a two-fold decrease 
in the rate of reduction, while electron donating methoxy substituents caused only a small 
increase in rate. Dibenzophospholes are much more electron deficient than phospholanes, which 
in combination with the diminished reduction rate observed with trifluoromethyl substituents, 
suggests electronic factors heavily influence the ease of reduction. On the other hand, clearly 
some ring strain is necessary, but whether or not additional ring strain helps the rate of reduction 
was inconclusive. 
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In terms of the actual development of the catalytic Appel reaction, van Delft and coworkers 
first tested for the stability of the phospholanes and dibenzophospholes with (2-
bromoethyl)benzene.27 They found that 3-methyl-1-phenylphospholane (M1PP) reacted with the 
bromo compound, while no alkylation occurred in the presence of the dibenzophosphole. 
Therefore, despite the substantially slower reduction of dibenzophospholes when compared to 
phospholanes, they selected phenyldibenzophosphole as their catalyst of choice for further 
optimization. Another major concern was finding a bromonium donor stable to diphenylsilane at 
100 °C. They thus tested tetrabromomethane, N-bromosaccarine, bromine, N-bromosuccinimide, 
N-bromoacetamide, 2,4,4,6-tetrabromocyclohexa-2,5-dienone, and diethyl bromomalonate 
(DEBM) for their reactivity with diphenylsilane, and found that DEBM was the most stable. Van 
Delft and coworkers then tested the reaction of 2-phenylethanol with DEBM, diphenylsilane, and 
a catalytic amount of phenyldibenzophosphole in multiple solvents, finding that the reaction to 
form 2-bromoethylbenzene proceeded best in MeCN. Switching silanes to either 
trimethoxylsilane or triethylsilane gave yields under 10%, while a switch of the phosphine 
catalyst to a substituted dibenzophosphole had no effect. However, this methodology was 
extremely limited when it came to both substrate scope and yield. For the synthesis of primary 
bromides, the highest yield determined by GC was only 80%, and isolated yields hovered 
between 50 and 75%. For secondary bromides, they were able to achieve good yields with a 
specialized cholesterol, but simple bromocyclohexane was produced from the corresponding 
alcohol in only 20% yield, and other secondary alcohols were unreactive towards the reported 
conditions. They were also unable to obtain similar results with a chloronium donor. Overall, this 
methodology is very important in terms of the careful study of the dependence of the rate of 
reduction on the identity of the precatalyst as well as demonstrating that alkyl bromides and 
alcohols are rather stable towards silanes at 80 °C, but not particularly useful for generalized 
Appel reactions. 
  9 
In 2012, an unrelated publication by Beller and coworkers reported that using the esoteric 
silane diethoxymethylsilane with bis-phenolic phosphoric acid additives allows reduction of 
acyclic phosphine oxides at 110 °C.28 This system also worked with phenylsilane replacing 
diethoxymethylsilane, though they did not choose to further explore phenylsilane. A screen of 
bis-phenolic phosphoric acids was performed and found that the addition of electron withdrawing 
groups on the phenols increased reductive activity, while replacing the phenyls with benzyl or 
alkyl groups had the opposite effect. Electron withdrawing groups decrease the pKa of the 
phosphoric acid proton, while benzyl and alkyl groups would increase it, making the pKa of this 
proton likely responsible for the changes in rate, though this concept is not elaborated on. Their 
best additive from the screen, bis-(4-nitrophenyl)-phosphoric acid (BNPA), facilitated the 
reduction of a wide variety of acyclic phosphines in 48 hours at 110 °C using 4 equivalents of 
silane. Therefore, if a given phosphine-dependent reaction can handle high temperature with a 
strong phosphoric acid, using BNPA, diethoxymethylsilane, and relatively cheap TPPO could be 
an alternative to the use of non-commercially available cyclic phosphines, even if the usage of 4 
equivalents is certainly not atom-economical. 
Beller’s system was indeed put to use in multiple publications. Mecinovic and coworkers 
reported a triphenylphosphine and carbon tetrachloride mediated amide bond formation that they 
successfully made catalytic in phosphine through the addition of bis-(4-nitrophenyl)-phosphoric 
acid and diethoxymethylsilane at 110 °C.29 They successfully applied this methodology to both 
primary and secondary amines. Fourmy and Voituriez also reported making the cyclization of 
diazodicarboxylates with α-ketoesters catalytic in phosphine using bis-(4-nitrophenyl)-phosphoric 
acid, phenylsilane, and phenyl dibenzophosphole at 90 °C.30 The use of TPPO as the phosphine 
catalyst did furnish product, but they found that switching to a cyclic phosphine facilitated much 
more turnover, likely due to a reduction of the temperature from 110 °C in Beller’s original 
conditions to 90 °C. These reactions demonstrate the effectiveness of the 
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diethoxymethylsilane/BNPA system in promoting catalytic-in-phosphine reactions with the 
inexpensive reagent TPPO, but requiring such a high temperature is certainly not ideal and 
hampers substrate scope. 
Beller’s system using catalytic BNPA is the first organo-catalyzed reduction of phosphine 
oxides by silanes, but metallic additives were also previously explored. Seeking to utilize cheaper 
but less reactive silanes such as PMHS or 1,1,3,3-tetramethyldisiloxane (TMDSO), Lemaire and 
coworkers reported a Ti(OiPr)4 catalyzed system that reduced phosphine oxides while heating to 
100 °C.31 Using TMDSO with 7.5-15% Ti(OiPr)4 facilitated 100% conversion of acyclic 
phosphines including TPPO within 10 hours. They also reported the use of PMHS with the 
titanium additive, but conversion to TPP from TPPO was lessened. They were able to reduce 
both alkyl and aryl phosphines, but included very few functional groups as ethers, ketones, esters, 
amides, and many other functional groups are known to not be stable to such conditions.32 In 
another report by Beller’s group, they obtained 96% conversion of TPPO to TPP with 10 mol% 
copper(II) triflate and three equivalents of TMDSO at 100 °C.33 They also demonstrate that at 
least among copper salts, copper(II) triflate is uniquely active, as it facilitated at least 3x more 
phosphine reduction than copper(II) fluoride, chloride, or bromide, and copper(I) iodide 
demonstrated no activity at all. The copper triflate/TMDSO system was then used to reduce a 
range of acyclic phosphine oxides to the corresponding phosphines in reasonable yields. Based on 
the scope of substrates compared to Beller’s organocatalytic system, it is safe to say that Cu(II) 
triflate/TMDSO is likely much less chemoselective.  
The first and only room temperature silane-mediated catalytic-in-phosphine reaction was 
reported by O’Brien and coworkers in 2013.34 They studied the isolated reduction of 1-
phenylphospholane-1-oxide (1PPO) in the presence of 14 equivalents of silane and DIPEA as 
well as a single equivalent of benzoic acid. These conditions were very similar to their previous 
Wittig reaction conditions but with a small amount of benzoic acid added. They found that with 
  11 
diphenylsilane, they were able to correlate the yield of phosphine with the pKa of the benzoic acid 
additive, where substituents were added to the benzoic acid to adjust the pKa. The addition of 
electron withdrawing groups to lower the pKa furnished higher yields of phosphine, while 
electron donating groups had the opposite effect. The key result, however, was that switching the 
silane to phenylsilane while keeping the rest of the system the same caused a huge spike in the 
rate of reduction, reaching upwards of 70% conversion in just two minutes at room temperature. 
O’Brien and coworkers also decided to change the non-cyclic substituent on the phosphine 
for the first time, replacing the phenyl with a butyl to make 1-butylphospholane-1-oxide (1BPO). 
The increased electron density on the phosphine of 1BPO as opposed to 1PPO likely contributed 
to its increased rate of reduction, as 85% conversion was achieved in just 2 minutes.35 Satisfied, 
they explored a range of aprotic solvents and found that the system worked quite well in THF as 
well as the more environmentally friendly EtOAc and cyclopentylmethyl ether (CPME). Using 
EtOAc as the solvent, they explored adding their 1BPO recycling system with the 4-nitrobenzoic 
acid additive to a range of aldehydes and primary or secondary bromides and successfully formed 
the Wittig products with most yields between 60 and 80%. These results validated this approach 
to room temperature recycling in the Wittig reaction, the first of its kind. 
O’Brien and coworkers also explored applying the DIPEA/phenylsilane/4-nitrobenzoic acid 
to acyclic phosphine oxides.36 By increasing the temperature to 100 °C with toluene as the 
solvent, they were able to achieve competent reduction with tri-n-octylphosphine oxide (TOPO), 
and successfully synthesized a range of Wittig products from the corresponding aldehydes and 
alkyl bromides. Naturally, they were interested in using the inexpensive phosphine oxide TPPO 
as well, but they found that their yields decreased unless para-trifluoromethylphenylsilane was 
used in place of phenylsilane, indicating that this electron-deficient silane reduced TPPO more 
rapidly. They did successfully synthesize a few alkenes using TPPO and p-
trifluoromethylphenylsilane in the presence of 4-nitrobenzoic acid at 100 °C. Through the use of 
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phenylsilane and addition of p-nitrobenzoic acid to the previous catalytic Wittig conditions, 
O’Brien and coworkers created the most ideal reduction system to date. 
Unfortunately, this system could not be applied to other common phosphine-dependent 
reactions as benzoic acids act as nucleophiles in the Mitsunobu, Appel, and Staudinger reactions. 
It also is not able to be applied universally to Wittig reactions, as O’Brien and coworkers reported 
a catalytic Wittig reaction that uses a masked strong base and a phosphine specifically designed 
to lower the pKa of its ylides.37 This report does not include the use of the room temperature 
recycling system with a benzoic acid, presumably because the addition of an acid to a reaction 
mixture that needs to be strongly basic interferes with the basicity. Therefore, while O’Brien’s 
room temperature recycling conditions were indeed an important stepping stone towards 
generalized room temperature catalytic-in-phosphine reactions, their scope is limited both across 
the class of phosphine-dependent reactions as well as within Wittig reactions themselves. 
The application of in situ phosphine recycling to other reactions continued with the 
development of a “traceless” catalytic Staudinger ligation by Ashfeld and coworkers.38 They 
mixed benzyl azide, a benzoic acid, TPP, and phenylsilane in a single pot at 60 °C to make benzyl 
benzoyl amides in high yields. Some notable features of this system include the fact that 1.2 
equivalents of azide is necessary for optimal yields, and increasing the phenylsilane equivalents 
to 1.5 drastically decreases the amount of product obtained. Additionally, diphenylsilane 
furnished product, though in much lower yield, but other silanes such as trichlorosilane, 
diethoxymethylsilane, and trimethoxysilane did not. This methodology is highly effective with 
benzyl azide and benzoic acids, but yields dip into the 60–80% range when benzyl azide is 
replaced with alkyl or allylic azides, or when the benzoic acid is replaced by an alkyl carboxylic 
acid. 
A year later, Van Delft and coworkers reported a Staudinger/aza-Wittig sequence using esters 
of 2-azidophenol, 10 mol% phenyldibenzophosphole, and diphenylsilane.39 The phosphine reacts 
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with the azide to form a phosphine imine, which is primed for an aza-Wittg reaction with the 
ester. This aza-Wittig reaction produces a benzoxazole and a molecule of phosphine oxide, which 
is then be recycled by the diphenylsilane. They were concerned with the competing reaction 
where the intermediate phosphine imine is reduced to form an amine while regenerating the 
phosphine, so they tested both phenylsilane and diphenylsilane in their initial benzoxazole 
forming reaction, and found that much higher yields were obtained with the less potent reducing 
agent diphenylsilane. Using the 2-azidophenolic esters primed for benzoxazole formation, they 
were able run this reaction successfully with a variety of esters at 101 °C in dioxane. The 
reactions also succeeded with azidophenol analogues, but yields dropped to the 55–65% range. 
They also synthesized azido esters that could form benzodiazepinones through the 
Staudinger/aza-Wittig sequence, and were able to form select products successfully with 
reduction of the phosphine imine predominating in the other cases. Ashfeld’s and van Delft’s 
reports clearly demonstrate that silane-based recycling of phosphine reagents is a successful 
strategy in Staudinger-like processes, though it is interesting that Ashfeld was able to use TPP at 
only 60 °C, while van Delft used a dibenzophosphole and had to increase the temperature to 101 
°C. Room temperature Staudinger processes remain elusive. 
A catalytic-in-phosphine methodology for the Mitsunobu reaction was reported by Buonomo 
and Aldrich in 2015, completing the set of classical phosphine-dependent reactions.40  They 
reported good yields on a Mitsunobu reaction at 80 °C using phenylsilane, 1PPO, 
diisopropylazodicarboxylate (DIAD), benzyl alcohol, and 4-nitrobenzoic acid as their 
pronucleophile. Originally phenyldibenzophosphole was used as the precatalyst, but they found 
that 1PPO gave superior yields, presumably due to the increased rate of reduction.  
Diphenylsilane was also tried, but was less effective. The benzyl alcohol could be replaced with 
aliphatic alcohols with no decrease in yield, indicating a wide substrate scope for the alcohol, but 
replacing 4-nitrobenzoic acid with phenols and aliphatic esters was more problematic, reducing 
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the yields to 50–65%. This system demonstrated that phenylsilane was compatible with DIAD at 
elevated temperature, providing a further illustration of the chemoselectivity of phenylsilane. It is 
interesting as well to note that high temperatures were required for turnover of the catalyst, as 
benzoic acid, which facilitated room temperature recycling of 1PPO in the catalytic Wittig 
reaction, is present in the Mitsunobu reaction. Other components combined with the benzoic acid 
must be what renders that reduction facile at room temperature.  
We want to note at this point that the previously discussed reports are certainly not a 
comprehensive list; other manuscripts describe the use of silanes to make phosphine-dependent 
reactions catalytic, but these have narrow utility and do not include developments in reduction 
conditions.41,42,43,44,45 Consequently, we have elected not to highlight them. 
We have quite thoroughly discussed the state-of-the-art reduction conditions as well as the 
drawbacks inherent in each system. In order to provide further improvements, it is vital to fully 
understand how phosphine oxides are reduced via silanes, with or without additives. Several 
mechanistic suggestions have been made, beginning with Fritzche and coworkers in their seminal 
work on the reduction of phosphine oxides with trichlorosilane.46 They proposed the bimolecular 
reaction of phosphine oxide with trichlorosilane to form a reduced phosphine and trichlorosilanol 
(Scheme 1.1). They propose that trichlorosilanol condenses into silyl-oxy polymers, releasing 
HCl, which then reacts with another molecule of trichlorosilane to form hydrogen and silicon 
tetrachloride (Scheme 1.1). The suggested steps that took place post-phosphine oxide reduction 
steps were made based on the observation that without additives, two equivalents of 
trichlorosilane were necessary to reduce a single equivalent of phosphine oxide to completion, but 
if a full equivalent of amine base was added, only one equivalent of trichlorosilane was 
necessary.  
Horner and Balzer added to this proposal by suggesting that the phosphine oxide and 
trichlorosilane react via 4-membered transition state to form a phosphonium silanolate ion pair 
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(Figure 1.1), ultimately producing the reduced phosphine and trichlorosilanol.47 The 
phosphonium-silanolate ion pair is predicted to be transient, and following the generation of 
trichlorosilanol, they propose it condenses into silyl-oxy polymers. 4-Membered transition states, 
while certainly not unheard of, are not particularly common in organic chemistry. It is likely that 
Horner and Balzer put for such a suggestion due to the fact that the transition state for the Wittig 
reaction, which contains a phosphorous center, is predicted to be 4-membered.48 
 
 
Scheme 1.1. Proposed Mechanisms for Additive-free Reduction of Phosphine Oxides by 
Phenylsilane and Trichlorosilane 
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A decade later, Marsi proposed the first mechanism of reduction of phosphine oxides by 
phenylsilane.49 Drawing from the mechanistic proposals with trichlorosilane, Marsi also 
suggested a phosphine oxide and phenylsilane come together in a 4-membered transition state and 
dissociate to from a transient ion pair. A proton is exchanged to form the phosphine and a silanol, 
after which Marsi proposes two additional reactions to account for the observed formation of 
hydrogen gas and water. The first is a reaction of the silanol with another silyl-hydride to form a 
disiloxane bond and hydrogen gas, and the second is a combination of two silanols to form a 
disiloxane and water. Interestingly, without explicitly discussing the potential differences 
between phenylsilane, phenylsilanol, and phenylsilanediol, Marsi suggests that phenylsilanol 
and/or phenylsilanediol are also active reductants. This is due to a previous observation by 
Fritzsche and coworkers that full conversion to the phosphine was achievable with only 0.7 
equivalents of phenylsilane.  
Horner and Marsi’s 4-membered transition state for additive-free silane-mediate reduction of 
phosphine oxides appears to be widely accepted as multiple groups refer to it. Computational 
studies have much more recently been performed on the mechanisms of phosphine oxide 
reduction by both trichlorosilane50 and phenylsilane51, seeking to ascertain the theoretical energy 
barriers towards transition state formation. Using quantum mechanical calculations with the SCS-
MP2 method, Krenske reports that trichlorosilane and trimethylphosphine oxide would need 27.1 
kcal/mol to undergo the 4-membered transition state towards reduction. Phenylsilane, when 
reacting with the admittedly more sterically hindered tri-n-butylphosphine oxide, is reported to 
need a shocking 43-45 kcal/mol to enter the transition state. This is using B3LYP calculations of 
the silane and phosphine oxide in solution, so the results for trichlorosilane and phenylsilane are 
not directly comparable. Both results, but particularly the ones with phenylsilane, suggest a very 
high activation barrier towards reduction, so much so if the calculations are accurate, the 
observed rates of reduction should be much slower. 
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Lemaire and coworkers propose a much different mechanism for their reduction of phosphine 
oxides using TMDSO and Ti(OiPr)4. They suggest the mechanism shown in Scheme 1.2 based on 
observation of the reduction with EPR and 29Si NMR.52 The EPR revealed the presence of Ti(III) 
and small amounts of an Si-Si species, so they propose that the Ti(IV) abstracts an electron from 
TMDSO to form a Ti(III) species and a silicon radical. This silicon radical can either go through 
an unproductive dimerization to form the Si-Si species, or it can react with the double bond of a 
phosphine oxide to produce a phosphorous-centered radical with a single bond between the 
phosphorous and oxygen. This then breaks apart to form reduced phosphine and a silyl-oxy 
radical, which they propose oxidizes the TI(III) back to Ti(IV). Lemaire and coworkers thus 
proposed that phosphine oxides are reduced in their system via single-electron transfer, a unique 
and interesting mechanistic proposal.  
 
Scheme 1.2. Proposed Mechanism for the Reduction of Phosphine Oxides by 
TMDSO/Ti(OiPr)4. Entries in red are intermediates observed by either EPR or 29Si NMR 
studies. 
Substantial progress has clearly been made in developing catalytic methodologies for 
phosphine dependent redox reactions, with phenylsilane and diphenylsilane appearing to be 
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excellent chemoselective reagents for the recycling of cyclic phosphines at 80-100 °C.53,54,55 With 
reactions and substrates that are compatible with the Bronsted acid BNPA at 110 °C, one can 
even use commercially available and cheap TPPO as the precatalyst, though four equivalents of 
the silane are required.56 The catalytic Wittig reaction can even be run at room temperature with 
the addition of a catalytic amount of benzoic acid to the reaction mixture, as long as the 
conditions require only a low degree of basicity.57 However, there are clearly multiple areas that 
these methodologies could be improved. An ideal system would be completely chemoselective 
for phosphine oxides and reduce them at room temperature in the absence of non-silane additives. 
This would greatly aid both phosphine recycling and phosphine ligand synthesis. Finally, it would 
also be ideal to have a better understanding of why additives such as PNBA or BNPA can affect 
the reaction rate so drastically. The remainder of this chapter describes our attempts and progress 
towards these goals, with the initial intention of improving the catalytic Mitsunobu described by 
Buonomo and Aldrich.58  
1.2 Towards a Room Temperature Catalytic Mitsunobu: Phosphine and Silane 
Screen 
1.2.1 The Design and Synthesis of Phosphine Precatalysts 
As mentioned previously, the Mitsunobu reaction is a widely used reaction in organic 
synthesis today, as its combination of broad applicability and substrate scope with exquisite 
stereocontrol are extremely attractive features to chemists.59 Stoichiometric Mitsunobu reactions 
are regularly run at room temperature, but when Buonomo and Aldrich developed the catalytic-
in-phosphine Mitsunobu reaction, they required heating to 80 °C in THF.60 This temperature is 
above the boiling point of THF, necessitating a sealed pressure vessel to accommodate those 
conditions, which is certainly not ideal. As expected, the rate-limiting step in the catalytic 
Mitsunobu was found to be reduction of the phosphine oxide back to the phosphine, with the 
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increased temperature required to obtain a reasonable rate of phosphine generation. 
Unfortunately, they reported multiple undesired side reactions that were likely caused by the 
addition of heat, and such temperatures provide general limitations to the substrate scope of this 
catalytic modification to the Mitsunobu reaction. We thus began an investigation to obtain facile 
room temperature reduction of phosphine oxides, preferably additive-free, but at least in such a 
way that the conditions would be compatible with a catalytic-in-phosphine Mitsunobu reaction. 
We first sought to redesign the phosphine precatalyst, attempting to achieve room 
temperature reduction in combination with either phenylsilane or diphenylsilane. To find 
inspiration, we first noted that O’Brien and Chass61 suggest that the reason cyclic phospholane 
oxides are reduced at much lower temperatures than acyclic phosphine oxides is the relief of ring 
strain that is granted in the 5-coordinate trigonal bipyramidal state immediately following transfer 
of the hydride. Van Delft attempted to increase the ring strain through the design of 
phenyldibenzophospholes, but these were found to have less reductive potential when paired with 
silanes.62 The reason for this was not thoroughly examined, but van Delft and coworkers varied 
the electronics on their dibenzophospholes and found that increasing electron density on the 
phenyl rings correlated with faster reduction. We hypothesized that the differences in reactivity 
between the dibenzophosphole and phospholane scaffolds were due to electronics, as the 
dibenzophosphole scaffold certainly has less electron density on the phosphine oxide than an 
alkyl phospholane oxide due to the more electron withdrawing nature of an sp2 carbon compared 
to sp3. Also, when O’Brien and coworkers replaced the phenyl ring on 1PPO with a less electron 
withdrawing butyl substituent (1BPO), they found that 1BPO had a superior rate of reduction.63 
From these reports, there appears to be a consistent pattern where increased electron density on 
the phosphine oxide increases the reductive potential of the precatalyst. It is less clear exactly 
what role ring strain plays in reductive potential, as van Delft and coworkers demonstrated that 5-
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membered cyclic phosphine oxides are superior to larger ring sizes, but were unable to fully 
characterize effects of ring strain on reactivity.64  
As no evidence appeared to contradict such an assumption, we hypothesized that increasing 
the ring strain through the use of 4-membered cyclic phosphetanesn would lead to faster 
reduction. Substituted 2,2,3-trimethylphosphetane oxides, 2,2,3,3-tetramethylphosphetane oxides, 
and 2,2,3,4,4-pentamethylphosphetane oxides can easily be synthesized65 from the corresponding 
phosphinic dichlorides via McBride synthesis.66 Radosevich and coworkers have used the 
trimethyl and pentamethyl variants in catalytic-in-phosphine reactions with phenylsilane as the 
reductant,67 demonstrating the efficacy of both scaffolds. We chose to use the 2,2,3-
trimethylphosphetane scaffold due to its presumed lower level of steric bulk around the P=O 
bond when compared to the tetramethyl or pentamethyl variants. Utilizing a phenyl substituent on 
the phosphorous atom would provide a direct comparison to 1PPO, potentially allowing for the 
isolation of ring strain effects, but more electron donating substituents were likely to increase the 
rate of reduction further. We chose to make P-butyl and P-pyrrolidinyl phosphetanes, with butyl 
being a safe option;68 it is less electron withdrawing than phenyl and should therefore increase the 
electron density on both the phosphorous and oxygen atoms of the precatalyst. On the other hand, 
a pyrrolidinyl substituent should decrease the electron density on the phosphorous atom due to the 
increased electronegativity of nitrogen, but it should substantially increase the electron density on 
the oxygen atom of the precatalyst through resonance. Based on the mechanism proposed by 
Marsi,69 where phosphine oxide and silane are predicted to come together with an attack of the 
oxygen atom on the silicon center, it appeared much more likely that increased electron density 
on the oxygen atom, not the phosphorous atom, is what facilitates faster reduction. Phosphinic 
amides had previously been synthesized but never evaluated for their isolated rate of reduction, so 
we chose to be the first to test one. Our belief was that the use of a highly-strained phosphetane 
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with an electron donating P-substituent would increase the rate of reduction enough to facilitate a 
room temperature catalytic Mitsunobu reaction.  
2,2,3-trimethyl-1-phenylphosphetane oxide (TMPPO) was synthesized in quite poor yield 
from the combination of phenylphosphonous dichloride and 3,3-dimethyl-1-butene (Scheme 
1.3).70 Beginning with the known compound 2,2,3-trimethyl-1-chlorophosphetane oxide,71 the 
addition of  butyl magnesium bromide afforded 2,2,3-trimethyl-1-butylphosphetane oxide 
(TMBPO) as a white crystalline solid. Similarly, submitting the chlorophosphetane precursor to a 
mixture of pyrrolidine and triethylamine at 60 °C produced 2,2,3-trimethyl-1-
pyrrolidinylphosphetane oxide (TMPyrPO) in good yield. For stability purposes, all three 
phosphine oxide precatalysts were stored at -20 °C under the exclusion of light. 
 
Scheme 1.3. Synthesis of Phosphetane Precatalysts TMPPO, TMBPO, and TMPyrPO 
1.2.2 Phosphine and Silane Screen 
With the precatalysts in hand, we performed an empirical screen of their effectiveness by 
testing each of them in the catalytic Mitsunobu reaction at 80 °C (Table 1.1) using the previously 
optimized conditions by Buonomo and Aldrich for 1PPO.72 While doing this, we noted that 
O’Brien and coworkers had evaluated a few silyl hydrides as potential reductants,73 but a more 
thorough list was necessary to determine whether any previously unreported silanes had reductive 
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activity. We thus selected a list of silanes, and evaluated each one with each of our precatalysts. 
Using a very basic Mitsunobu reaction with benzyl alcohol and p-nitrobenzoic acid (PNBA) 
combining to form benzyl p-nitrobenzoate, we examined each combination of precatalyst and 
silane. The results are shown in Table 1.1  
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Table 1.1. Screening Phosphine Precatalysts and Silanes for Effectiveness in the 
Catalytic Mitsunobu Reaction 
 
Entry R3P=O Silane Yield (%) 
1 1PPO PhSiH3 7774 
2 TMPPO PhSiH3 65 
3 TMBPO PhSiH3 44 
4 TMPyrPO PhSiH3 0 
5 1PPO Ph2SiH2 4275 
6 TMPPO Ph2SiH2 42 
7 TMBPO Ph2SiH2 15 
8 TMPyrPO Ph2SiH2 0 
9 1PPO Ph3SiH 0 
10 TMPPO Ph3SiH 0 
11 TMBPO Ph3SiH 0 
12 TMPyrPO Ph3SiH 0 
13 1PPO PMHS 0 
14 TMPPO PMHS 0 
15 TMBPO PMHS 0 
16 TMPyrPO PMHS 0 
17 1PPO TMDSO 0 
18 TMPPO TMDSO 0 
19 TMBPO TMDSO 0 
20 TMPyrPO TMDSO 0 
21 1PPO Et3SiH 0 
22 TMPPO Et3SiH 0 
23 TMBPO Et3SiH 0 
24 TMPyrPO Et3SiH 0 
25 1PPO iPr3SiH 0 
26 TMPPO iPr3SiH 0 
27 TMBPO iPr3SiH 0 
28 TMPyrPO iPr3SiH 0 
29 1PPO (TMS)3SiH 28 
30 TMPPO (TMS)3SiH 26 
31 TMBPO (TMS)3SiH <5 
32 TMPyrPO (TMS)3SiH 0 
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These results were discouraging, as the silane screen revealed that the conditions used by 
Buonomo and Aldrich in terms of phosphine and silane identity were still the highest yielding set 
discovered. Looking exclusively at the silanes, most resulted in the formation of no product, and 
TLC analysis allowed us to infer this was due to zero precatalyst reduction. Diphenylsilane and 
tris-TMSsilane were the only silanes besides phenylsilane to furnish product. Based on previous 
results, phenylsilane performed as expected, it afforded product, but less than phenylsilane. On 
the other hand, tris-TMSsilane being successful was more surprising, though TLCs of each of the 
reaction mixtures revealed quite a smattering of UV-active products, suggesting that many side 
reactions are also occurring. This can be explained by the fact that tris-TMSsilane is often used as 
a radical initiator due to the ease of homolytic fragmentation of its Si-H bond. Therefore, the side 
reactions are likely radical-mediated, which is certainly undesirable, and caused us to remove this 
silane from further consideration with any precatalyst. 
As for trends with the phosphines, 1PPO>TMPPO>TMBPO>TMPyrPO, with the 
phosphinic amide affording no product with any silane. As the system was optimized with 1PPO, 
it was likely that adjusting the conditions would allow us to obtain similar yields with TMPPO, 
which is okay, but does not move the project forward. The yields with TMBPO were consistently 
and significantly below the P-phenyl phosphines. Taken together, we observed the exact opposite 
trend that we hypothesized during the design process, though this was only an empirical screen. 
We decided to investigate each of the phosphetane precatalysts further, choosing to perform 
isolated reduction studies with each of TMPPO, TMBPO, and TMPyrPO with phenylsilane. 
1.3 Isolated Reductions of Precatalysts 
1.3.1 Reduction of TMPyrPO 
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To begin, we chose to investigate TMPyrPO, attempting to see if we could uncover the 
reason that it produced zero product in the catalytic Mitsunobu reaction. Isolated reduction 
studies were performed by adding TMPyrPO, PhSiH3, and solvent to a sealed NMR tube, 
heating it for a predetermined amount of time, cooling, and evaluating the percentage reduction 
by obtaining a 31P NMR spectrum of the resulting mixture (integrating 31P NMR peaks accurately 
reveals relative species amounts). This method produces a time course of the percentages of 
reduced and unreduced precatalyst that can be displayed as a reaction progress curve. Our 
isolated reduction studies were also performed using a large excess of silane so that the reduction 
proceeded under pseudo-first order conditions with respect to phosphine oxide. Pseudo-first order 
conditions allow for easy calculation of the rate constant of reduction, which can be used to 
directly compare catalysts as well as provide a quantitative number for the activation energy 
through Arrhenius analysis. However, when we mixed TMPyrPO and PhSiH3 in THF and heated 
the mixture to 80 °C for only 5 minutes, the subsequent 31P NMR revealed no peaks. This result 
demonstrated that TMPyrPO degrades in THF when reacted with PhSiH3 and heat, which would 
explain the lack of product formed in the catalytic Mitsunobu reaction. Radosevich and 
coworkers had previously used 2,2,3,4,4-pentamethyl-1-pyrrolidinyl-phosphetane oxide in a 
phosphine redox reaction with phenylsilane in CH2Cl2, suggesting that the choice of solvent could 
be important when using TMPyrPO. 
To explore this possibility, we reacted TMPyrPO with PhSiH3 under pseudo-first order 
conditions in CH2Cl2, toluene, and 25% THF in CH2Cl2. 25% THF in CH2Cl2 was chosen because 
PNBA, BnOH, and DIAD were all soluble in this mixture, meaning if this solvent allowed for 
reduction without degradation of TMPyrPO, a catalytic Mitsunobu using the phosphinic amide 
was still a possibility. Unfortunately this was not the case, as no 31P peaks were visible after 30 
minutes, meaning the degradation was slowed, but still far too fast to be competent in reactions. 
The other solvent choices were substantially more successful. TMPyrPO was found to be fully 
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reduced within 90 minutes in both CH2Cl2 and toluene, with 31P product peaks visible in both 
cases.  
Further investigation of this reduction, however, revealed that a lot more was going on than 
removal of the P=O bond. According to the spectra provided by Radosevich and coworkers, the 
reduced phosphinic amide should have a chemical shift around 100-120 ppm.76 We did observe 
the presence of such peaks, however, they were short-lived. Most of the final reduction product 
had a chemical shift around 10 ppm. Due to the intense degradation observed, we proposed that 
TMPyrPO was reduced all the way to the secondary phosphetane, which are known to be 
unstable. With such results, it was extremely unlikely that TMPyrPO could serve as an effective 
catalyst with PhSiH3 as the reductant, though possible if a reduced temperature blocked over-
reduction to the secondary phosphetane. 
1.3.2 Reduction of TMBPO 
Isolated reduction studies with TMBPO revealed a different problem, as before any silane 
was added, multiple 31P NMR peaks were visible regardless of the solvent used. The catalyst was 
thus unstable and had undergone substantial degradation despite being stored in the freezer under 
exclusion of light. Upon addition of phenylsilane, TMBPO reduced quite quickly, finishing in a 
90 minute period, but additional degradation peaks were observed. Even though the degradation 
peaks only accounted for ~15% of the total post-reduction phosphine peaks when beginning with 
a purified sample, we believed that the observed degradation was the reason for TMBPO halving 
the yield of the catalytic Mitsunobu. Any of the unidentified phosphorous species could cause 
side reactions within the Mitsunobu, and the catalyst must undergo multiple redox cycles over an 
18 hour period, which would undoubtedly prompt further degradation. This degradation was also 
visible regardless of whether the solvent was THF, CH2Cl2, or toluene. TMBPO was thus 
unlikely to be a successful precatalyst in a redox recycling phosphine depedent reaction. 
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1.3.3 Reduction of TMPPO 
TMPPO was the most successful of the three phosphetane precatalysts synthesized in the 
catalytic Mitsunobu reaction, so we did not expect to observe any obvious issues in isolated 
reduction studies. This was indeed the case, as TMPPO reductions proceeded smoothly with 
phenylsilane with minimal or no appearance of other phosphorous containing by-products. 
Reduction of TMPPO by phenylsilane also was successful in THF, CH2Cl2, and toluene, with 
each solvent producing slight but insignificant differences in the reduction rate. To directly 
compare the reductive potential of TMPPO and 1PPO, we decided to do Arrhenius analysis on 
the reduction of TMPPO by phenylsilane in THF (1PPO has already been reported77), which 
revealed two interesting features about this reaction. 
Both diasteromers of TMPPO have the same 31P NMR signal in THF, but the peaks for the 
corresponding reduced phosphine diasteromers are separated by several ppm. Close examination 
revealed the presence of a fourth 31P peak that appears after only 5 minutes of heating. It accounts 
for about 10% of the total phosphorous in this time point, and then decreases over time. We were 
very excited about this, as we thought the fourth peak could potentially represent an intermediate 
in the reduction of TMPPO by phenylsilane. A similar peak was not observed with either 1PPO 
or TMBPO. However, further investigation revealed that this peak was in equilibrium with the 
main TMPPO peak, as heating TMPPO in THF without phenylsilane for 5 minutes caused the 
fourth peak to appear, again accounting for about 10% of the total 31P NMR signal. Further 
heating did not increase this percentage, indicating that it was not the product of an irreversible 
reaction. Additionally, careful monitoring of the reduction time courses revealed that the fourth 
peak was always about 10% of the size of the main TMPPO peak. We thus discarded this peak as 
meaningful, and still are not certain what it represents. 
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Our other observation proved much more important. Figure 1.1 shows a reaction progress 
curve for the reduction of TMPPO by PhSiH3. As you can see, the reduction appears to start off 
more slowly, then speed up between the 30 and 45 minute mark. The reason that the observation 
is important is that such behavior is contrary to both our expectation and the presumed 
mechanism presented by Marsi. That mechanism would predict the concentration of phosphine 
oxide would decay in a single-exponential fashion as occurs with single-step mechanisms. 
Instead, Figure 1.1 strongly suggests that we are observing some kind of a multi-step process, 
which was very exciting, as no one has ever suggested that the reduction of phosphine oxides by 
phenylsilane occurs via a multi-step process.  
 
Figure 1.1. Reaction Progress Curve for the Reduction of TMPPO by Phenylsilane. 
[PhSiH3] = 0.4 M & [TMPPO] = 0.04 M 
1.3.4 Evaluating Potential Kinetic Mechanisms 
We sought to determine what was the cause of the multi-step behavior of the curve in Figure 
1.1, and thus listed every potential cause that we considered feasible for the reduction process 
occurring. The four ideas that we settled on were that the reduction process itself could be multi-
step, the silane could be undergoing pre-activation, the phosphine could be undergoing pre-
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activation, and phenylsilanol and/or phenylsilanediol could be substantially more rapid reductants 
than phenylsilane (Figure 1.2). It could also be due to any combination of these, but we designed 
experiments to evaluate each one of these potential causes individually. 
 
Figure 1.2. Potential Kinetic Mechanisms that Would Cause an Increase in the Rate of 
Reactivity Following Initiaition of the Reaction. PO = Phosphine Oxide. P = Reduced 
Phosphine. Si = A silyl hydride species. SiOH = Si with a hydride replaced by a hydroxyl. 
The * symbol denotes a potential unknown intermediate. 
We decided to begin by testing whether pre-activation of silane or phosphine was occurring 
during the reduction process. We did not consider phosphine pre-activation likely to yield any 
results, as there are no obvious pre-activation pathways, but due to the ease of testing it was still 
deemed worth doing. Pre-activation of the silane appeared much more plausible, as phenylsilane 
could react with water to form phenylsilanol, which is almost certain to have some reductive 
potential (This theory is a combination of the silane pre-activation/differential reactivity rates 
mechanisms). Alternatively, phenylsilane could homocouple to form a silylsilane that could also 
theoretically reduce phosphine oxides faster than itself. To perform the actual tests, we heated 
TMPPO and phenylsilane separately in THF at 80 °C for one hour before addition of the other 
component. Figure 1.3 shows the resulting time courses following initiation of the reaction, as 
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well as their comparison to a no preincubation control. The phosphine preincubation curve 
appears to have a slightly less sigmoidal trajectory when compared to the control, but this could 
be just experimental error, and the difference between the two curves in terms of rate of reduction 
is likely insignificant. Fitting the phosphine preincubation curve to a single exponential still fits 
quite poorly (Figure 1.4), making it unlikely that there is an important phosphine oxide pre-
activation preceding reduction. Silane preincubation, on the other hand, appears to cause a 
slightly faster reduction, but the curve still fits very poorly to a single exponential (Figure 1.5).  
The data was thus inconclusive, as silane preincubation does not appear to remove the multi-step 
nature of the reaction, but did appear to improve the rate of the reaction. 
 
Figure 1.3. Comparison of Reduction Rates when TMPPO or PhSiH3 is Pre-incubated in 
Heated THF. [PhSiH3] = 0.2 M & [TMPPO] = 0.04 M 
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Figure 1.4. Fitting the Phosphine Pre-incubation Curve to a Single Exponential. [PhSiH3] 
= 0.2 M & [TMPPO] = 0.04 M 
 
 
Figure 1.5. Fitting the Silane Pre-incubation Curve to a Single Exponential. [PhSiH3] = 
0.2 M & [TMPPO] = 0.04 M 
We were able to obtain strong evidence that the reduction of TMPPO by phenylsilane is not 
a multi-step process. A multi-step process of reduction should involve one or more intermediates, 
which would have distinct 31P NMR signatures. With such a substantial increase observed in the 
rates of reduction at earlier time points compared to what single-exponential decay would 
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provide, a significant buildup of the intermediate should be seen. Even when increasing the 
concentration of TMPPO to 0.10 M to obtain a greater signal-to-noise ratio, we observed no 
peaks that could credibly be intermediates in the reduction process (there was still that 4th peak 
mentioned earlier). We thus ruled out a multi-step reduction process contributing in any 
significant way to the sigmoidal nature of the reduction curves. 
One more interesting result was obtained from varying the concentration of TMPPO (as 
previously mentioned) or silane while holding the other constant and maintaining pseudo-first 
order conditions with respect to the phosphine oxide. Increasing concentrations of silane 
correlated with increases in the rate of reduction, which was unsurprising (Compare Figure 1.4 to 
Figure 1.3). Higher concentrations of silane also appeared to decrease the sigmoidal nature of the 
curves, though they still fit to a single exponential somewhat poorly. On the other hand, 
increasing the concentration of phosphine oxide appeared to cause a corresponding increase in the 
rate of reduction when measured by the percentage of total phosphine (Figure 1.6). Unfortunately, 
the data was again inconclusive, as reduction with the concentration of TMPPO being 0.10 M 
was slower than with 0.07 M, but still faster than 0.04 M. This result was important because if the 
initial concentration of phosphine influences the percentage rate of reduction of phosphine oxide 
even with a large excess of silane, we are not actually succeeding in making the reaction first-
order with respect to phosphine. (See section 1.14). 
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Figure 1.6. The Effect of the Concentration of TMPPO on the Reduction Rate. [PhSiH3] 
= 0.75 M 
Throughout this process, we became frustrated that our reaction progress curves contained so 
much error, especially in the silane preincubation and phosphine concentration dependence 
studies. With more accurate results, we could have conclusively ruled out explanations for why 
an increase in the rate of reduction of TMPPO with phenylsilane is observed after initiation. 
Even with running each of our reactions in triplicate (while removing curves that strayed too far 
from the norm), we were unable to obtain data that was sufficient for our purposes. With these 
frustrations in mind, we decided to pursue using variable temperature (VT) NMR. The idea was 
that by starting the reaction (in an NMR tube) and then submitting it to the NMR, we could 
continually obtain FID files at intervals of our choosing as the tube would be heated to the desired 
temperature, which would accomplish what we had been doing with an oil bath. This method 
would reduce sources of error such as the time between when a timer signaled that an NMR was 
to be taken and the actual cooling of the NMR tube, as well as the time spent waiting in the NMR 
queue or the NMR itself at room temperature, during which the reaction is likely proceeding at a 
slower rate. We were particularly interested in obtaining multiple FIDs in the initial portion of the 
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reduction for accuracy in assessing the increase in the rate of reduction during that time. This 
would require the time of collection for each FID to be quite short, resulting in numerous FIDs. 
Standard processing of each FID is time consuming, so we decided to write a program that 
automates processing of our FIDs. 
1.4 MassNMRProcessing 
1.4.1 Introduction and Outlining 
In order to write the program, which we termed MassNMRProcessing, we first had to outline 
exactly what we expected it to accomplish, included proposing inputs and outputs. The basic idea 
for this program was that a set of NMR data and instructions on which peaks should be integrated 
will be submitted to MassNMRProcessing, which will then sort, process, and integrate the 
spectra, ultimately providing the numbers obtained from integration. With such a framework, the 
main output should be a list of the integrated values for each peak in table format, with each 
column a peak and each row an individual FID, with the rows sorted by the order in which the 
experiments were performed. As an additional output, we wanted to display up to twelve of the 
integrated spectra. This would provide quality control for the program to make sure the spectra 
were being processed and phased correctly, as well as quality control for the experiment to see if 
anything unexpected happened. 
Concerning the inputs, one has to be the ppm of each peak that is to be integrated. Another 
should be the ppm of a peak that will serve as the standard to orient the spectra, much like the 
residual solvent peak is used in typical 1H or 13C NMR. To allow for different substances to serve 
as the standard, it is easiest to just have the chemical shift of the chosen standard submitted to 
MassNMRProcessing. The final input would need to tell the program where to obtain the 
experimental data. In order to ascertain how this should be input, we had to choose how we were 
going to set up our NMR time courses. We eventually settled on submitting several experiments 
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in a single queue as opposed to using an arrayed experiment. The reason for this is that arrayed 
experiments generate a single file containing all of the individual spectra, and there was no 
information available on how to successfully extract each of the spectra from this file, likely for 
proprietary reasons. An ideal final input would thus be the location and name of the overarching 
folder containing all of the data-filled folders generated from each experiment. The program 
should be able to take this input and extract the raw data. 
1.4.2 Processing Spectra 
With these basic inputs and outputs established, we began working on writing functional 
NMR processing code. We decided to write this program in Matlab, as though the use of such a 
high level language may decrease the speed of our program, there are several presets relating to 
mathematical functions and input/output that we would be able to use and not have to write/find 
ourselves. As we had easy access to both Varian and Bruker instruments, we also decided that we 
wanted MassNMRProcessing to be able to input both Varian and Bruker data.  
Moving on to actual coding, there are several parts involved in processing a FID, as it is often 
apodized, zerofilled, fourier transformed, and phased before integration occurs. Apodization is 
the process of multiplying the FID by a decaying function, usually a Lorentzian or Gaussian 
function. The choice of apodization function can either improve the signal to noise ratio or the 
resolution of the NMR spectra, which are each useful under differing circumstances. Zerofilling 
is the process of adding zeros to the end of the FID, which increases the apparent digital 
resolution of the spectrum. This improves the cosmetic appearance of the spectrum without 
actually generating any new data, which would be useful when visualizing the output spectra 
through MassNMRProcessing. Taking the Fourier Transform of the FID is what actually 
generates the NMR spectrum that all organic chemists know and love, and phasing the spectrum 
is essential, as otherwise the peaks cannot be accurately integrated due to poor peak shapes. We 
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decided that we wanted our program to implement user-friendly controls for changeable 
parameters for all of these features. 
The first task was to input the data from an FID. This is easily accomplished with a Matlab 
preset function, and the data was placed in a Matlab array. From there, it was again trivial to 
multiply this array with an apodization function and perform zerofilling. Doing a Fast Fourier 
Transform is another preset function in Matlab, which resulted in a spectrum 2X the width of a 
typical spectrum with the left half being a mirror image of the right half. Removal of the left half 
brought about an unphased NMR spectrum. Unfortunately, phasing proved quite difficult, for two 
reasons. The first is that we were finding it difficult to write an area minimization function for the 
spectrum that would properly phase it (likely due to our inexperience, not the difficulty of the 
task).78 The second was specific to Bruker data, as we discovered that Bruker includes a digital 
filter at the beginning of the FID which must be placed at the end of the spectrum after 
apodization and zerofilling. Leaving the filter data at the beginning results in extremely “wiggly” 
NMR spectrum79 that are completely unusable. Therefore, it must be removed and appended to 
the end of the spectrum, though this requires knowing the precise number of time points at the 
beginning of the FID in order to have a spectrum with an accurate baseline. Even with the correct 
number of points moved, certain apodization and zerofilling procedures result in a spectrum with 
baseline artifacts that either increase (smiles) or decrease (frowns) at each end of the spectrum.80 
Avoiding smiles and frowns is even more difficult, with the information and algorithms necessary 
to do so not easily obtained. 
After several attempts to bypass these issues, we decided to take a different approach to 
writing MassNMRProcessing. Instead of coding de novo, we would attempt to build our program 
out of NMR processing programs already written in Matlab. We found two programs, 
MatlabNMR and MatNMR 3.9, that uploaded their code to the internet and licensced it for open 
use/modification. When testing them, we found that MatlabNMR no longer ran due to the 
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changes in Matlab syntax over the last few years. MatNMR, however, was a fully functional 
NMR processing program, similar to ACDlabs or the default Varian or Bruker NMR workup 
packages. Because MatNMR was functional, we chose to use its code as our starting point for 
MassNMRProcessing.  Through performing several processes on FIDs loaded into MatNMR, we 
discovered MatNMR created an object that contained most the information about the FID that we 
would need, including the FID, the folder it was stored in, whether the data was Bruker or Varian, 
and many other important variables. It also contained much more information that was mostly 
related to how the spectrum was supposed to be visualized, which was not useful as we were not 
interested in using the MatNMR visual interface, but rather in creating automated code behind the 
scenes. Following creation of the main spectrum-containing object, that were separate functions 
that MatNMR used to perform modifications to it. Again, most of these concerned the visual 
appearance/orientation of the spectrum, and thus were not useful. However, we found that the 
functions “apodize1d”, “regelsize1d”, “four1d”, and “setphase1d” apodized, zerofilled, fourier 
transformed, and autophased the actual FID/spectrum, respectively. These functions served as our 
main initial development tools. 
MatNMR used the function matNMRReadBinaryFID to bring the FID and related acquisition 
parameters into the main spectrum-containing object. It needed to be fed both the file name of the 
FID (including the directory) and whether the spectra was obtained on a Bruker or Varian 
instrument, so we would have to write code that provided those inputs to the function later. With 
placeholders pointing to a spectrum we were using for testing, we were able to use this input 
function by removing all of the code that had to do with initialization or adjustment of the 
matNMR visual interface, as these lines caused bugs since the interface was non-existent. We 
envisioned writing a for loop over all of the spectra intended to be processed each time 
MassNMRProcessing was run. Following removal of any lines of code adjusting the visual 
interface in apodize1d and regelsize1d, we successfully were able to apodize and zerofill the FID. 
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However, this was by again using placeholders for the inputs. apodize1d needed to be fed three 
inputs: the type of function used, and one or more parameters defining that function. regelsize1d 
only needed a single one, the desired size of the spectrum in number of data points. To provide 
control to the user of MassNMRProcessing, we would want to obtain the inputs for these 
functions as inputs when the program is initialized. For the sake of user-friendliness, we decided 
to modify regelsize1d further, changing its input instead to a number that would define the 
number of zeros to be added as a multiplier of the original size of the spectrum. Using “1” would 
leave the spectrum as is, “2” would double the size of the spectrum through the addition of the 
same number of zeros as the length of the spectrum, “4” would quadruple the size of the 
spectrum, and so on. This made it so when the user input this number, he or she would not need 
to know the typical number of points in an FID, which can change depending on the instrument. 
Before performing the Fourier Transform, we had to remove the dreaded Bruker digital filter 
for Bruker spectra. The function regelBrukerdig (with the typical modifications) did an admirable 
job of this, which we found out after performing the Fourier Transform with four1d. There were 
very few to no “smiles” or “frowns” on our tested spectra, which was excellent. setphase1d (with 
the typical modifications) successfully phased our spectra as well once we discovered we had to 
set a flag to allow for autophasing, providing us with spectra that were visually indistinguishable 
from one processed using a conventional NMR processor.  
The next step was to create the x-axis for the spectra, as previously the pseudo-x-axis went 
from 0 to the post-zerofilling number of points in the FID. This had to be performed differently 
for Varian and Bruker data, as each company records the important parameters in different files: 
procpar for Varian and acqus for Bruker. Justin Gardner at Stanford University developed a 
Matlab file called readprocpar that reads the information from the procpar file into a Matlab 
object. After a couple of trials, we were able to pinpoint the procpar parameters from this file that 
described the starting frequency, the reference frequency, and the acquisition frequency width, 
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allowing for reconstruction of the axis. For Bruker files, MatlabNMR contained a function that 
created an array of every data point from the original axis.  Through extraction of the original 
start and end points, we could build a new axis that contained the appropriate number of points 
according to the degree of zerofilling. 
With the axis completed, now all we had to do was perform an automated shift based on the 
ppm of whatever compound was used as the standard, which is from an input value. Since the 
standard peak should be near the ppm input, we told our function to test a symmetrical range of 
data points on each side of the inputted ppm for the maximum value, which would correspond to 
the top of the reference peak. In determining the size of the range of data points, we wanted this 
value to be in terms of ppm, not raw data points, so that zerofilling does not affect the ppm 
distance searched. We settled on searching within 2 ppm for 19F and 31P spectra, and 0.2 ppm for 
1H spectra. This distinction between nuclei seemed quite important, though this did necessitate 
one more input on what atom type was being magnetized. Following determination of the top of 
the peak, the x-axis would shift accordingly. 
With the spectra being evaluated by MassNMRProcessing now phased and referenced, it was 
time to integrate. Integration was performed by creating a “bin” for each range specified by the 
inputs that contained all of the data points within that range of ppm values. To perform 
integration in the most simplistic way possible, the y-values of each data point within an 
individual “bin” were summed. The summed values for an individual “bin” were then divided by 
the sum total from all “bins” and multiplied by 100 to provide normalized integration values. 
These were then placed in a matrix, with the value from each bin in a different column, which 
completed the goal of taking in a raw set of data and producing integrated values based on 
provided ranges. This completed the processing and integration phase, and looping over the 
process for multiple spectra would provide all of the information that we wanted. 
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1.4.3 Inputs 
The central portion of the program was thus complete (Figure 1.11), with inputting and the 
final QC check remaining. Through development of the middle of the program, we had identified 
all of the inputs that we would need. One of the Matlab preset functions that would be ideal for 
inputting information was inputdlg, which automatically opened a window with a specified 
number of fields for data entry, sized the window appropriately, and allowed for the addition of 
text in the title of the window and above each entry field. We decided that we would first prompt 
the user for the desired ranges for integration. This is done through the window shown in Figure 
1.7. 
 
Figure 1.7. The First Input Window for MassNMRProcessing. This window asks the user 
for the desired ranges of integration. 
Clicking the OK button at the bottom sends the data to MassNMRProcessing. We then have 
the program bring a second prompt (Figure 1.8) which contains all of the extra inputs we learned 
  41 
we needed when writing the main loop of the program, including the identity of the nuclei, the 
ppm of the standard, the zerofilling multiplier, and the apodization information. 
 
Figure 1.8. The Second Input Window for MassNMRProcessing. This window asks the 
user for parameters regarding spectrum processing. 
Most of these inputs are fairly straightforward and unlikely to cause bugs/problems, with the 
lone exception being the zerofilling multiplier, as large numbers would drastically decrease the 
performance of MassNMRProcessing and all numbers below 1 would cause it to crash. 
Therefore, we added a failsafe that states if 1, 2, 4, 8, or 16 is not entered, the program will set the 
zerofilling value to 2. The only remaining input that was necessary was the identity and location 
of the overarching folder. Matlab contains an extremely convenient prompt for this purpose, 
uigetdir, which opens a window that allows the user to select a folder and input its path into the 
program. The selection window is shown in Figure 1.9. 
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Figure 1.9. The Third Input Window for MassNMRProcessing. This window asks the 
user for the folder containing the NMR data. 
Once the path of the desired overarching folder was obtained by the program, we needed to 
use it to acquire the path of the folder that directly contained the fid and the procpar or acqus 
parameter file. Since both Bruker and Varian name the filter directly containing the data by the 
title of the experiment, we decided that we would require these titles to contain an underscore. 
The program would then search the contents of the overarching folder to find those folders that 
had an underscore and sort them according to name. This was necessary to avoid the inclusion of 
hidden folders/files that appear to be present in every Windows folder but have nothing to do with 
our experiments.  Then, the program checks to see if the first folder (from the above sorting) has 
“.fid” in its name. If it does, MassNMRProcessing recognizes that this is Varian data, and sets a 
flag accordingly. If not, it sets the flag to tell the program the current session is processing Bruker 
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data. This completed the input section, as MassNMRProcessing now had all of the required 
information to facilitate the processing of spectra. 
1.4.4 Outputs and QC 
The only remaining unwritten piece of the program was the QC part. We wanted to ensure 
that the spectra were being processed correctly, with the main concerns being correct 
identification of the standard and phasing of the spectrum. At the end the loop, the data for the 
spectrum that had just been processed was added to a structure for future use. Once the program 
had looped over every data-containing folder, we had MassNMRProcessing display the spectra in 
a window using the standard Matlab “plot” function (Figure 1.10). 
 
Figure 1.10. A sample set of QC data from MassNMRProcessing. 
Zoom is possible for each of these spectra for evaluation of the phasing and the correct 
positioning of the x-axis. For jobs submitted to MassNMRProcessing that included less than 12 
spectra, we had the program display all of them. They are displayed in a 1x1 format for a single 
spectrum, in a 1x2 if the job contains 2 spectra, in a 2x2 for 3 or 4, up to a 3x4 format for 10, 11, 
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or 12 spectra. If the job contains more than 12 spectra, MassNMRProcessing displays the first 
spectrum and 11 more representative examples evenly spaced throughout the list that was 
submitted to it. That way, one can view how the spectra look while the reaction proceeds. 
With the implementation of the final output, we completed this program. A flowchart of 
MassNMRProcessing is shown in Figure 1.11, showing the inputs, outputs, and the loop in the 
middle where the processing takes place. With this layout, the program could process a spectrum 
every 3-4 seconds on our personal lab computer. The only parameter that dramatically changed 
the processing speed was degree of zerofilling. 8x zerofilling caused a dramatic increase in 
processing time, increasing it to around 15 seconds per spectrum. We were able to trace this to a 
substantial slowing of phasing, which was already the most time intensive aspect of 
MassNMRProcessing, taking nearly two seconds per spectra with no zerofilling. Regardless, we 
were satisfied with the speed of processing, as it would greatly improve productivity since all the 
user had to do was enter the correct inputs. 
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Figure 1.11. Flowchart Describing the Actions of MassNMRProcessing. 
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1.4.5 Improving the Phasing Algorithm 
Unfortunately, continued testing of MassNMRProcessing with a variety of NMR spectra 
revealed that the algorithm from MatNMR only phased the spectrum correctly about two-thirds of 
the time, far below our desired threshold of 95%. We thus investigated other phasing algorithms, 
specifically looking for ones that were already written or simple to implement, and selected one 
described by Liu and coworkers as a two-step method for NMR phasing, beginning with “coarse 
tuning” and finishing with “fine tuning”.81 Their “coarse tuning” method is based on baseline 
recognition and minimization of the height difference at the edges of peaks, while “fine tuning” 
proceeds via minimization of negative area. They specifically note the excellent performance of 
their algorithm in phasing spectra with a very low signal-to-noise (S/N) ratio, which was essential 
for our usage of 31P NMR with low concentrations of the phosphorous containing compound. 
Finally, they published their algorithm online using Matlab code, which was wonderful. 
Through the usual changing of various names and addition or removal of flags, we were able 
to replace the old phasing algorithm with this new two-step one. Initial testing of the Liu 
algorithm was not promising, but this was expected, as they intended for the method to be able to 
phase DEPT spectra and others that had intentionally negative peaks. Following the “coarse 
tuning” process, their algorithm classifies peaks as either positive, negative, or distorted. The 
second round of tuning attempts to minimize negative area within a positive peak, positive area 
within a negative peak, and ignores distorted peaks. Through removal of the ability for the 
algorithm to classify peaks as negative or distorted, we achieved an excellent rate of success in 
properly phasing spectra. We tested MassNMRProcessor with over 100 spectra from different 
sources and deemed (subjectively) that greater than 90% were excellently phased and the rest 
were merely satisfactory. The switch in algorithms did come at a processing speed cost, as the 
phasing time increased about 4 seconds to 6-7 per spectrum, but this was still an acceptable speed 
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since the only user input required was at the beginning. Basically, through modification of the 
algorithm reported by Liu and coworkers and implementation in MassNMRProcessing, we 
removed the last barrier to large-scale processing of NMR spectra, and could proceed in our 
original desire to study detailed reaction time courses. 
1.4.6 Future Directions for MassNMRProcessing 
As will be demonstrated in following sections of this chapter, MassNMRProcessing is a 
useful and functional NMR processing and integrating program. There are certain aspects, 
however, that could be modified to improve both the process and scope of its usage. The main 
reason that we developed MassNMRProcessor was to allow us to perform other experiments 
while our NMRs were processing, saving valuable time that would otherwise be spent manually 
processing the spectra. With that in mind, we were satisfied with a processing speed of 10 
seconds per spectrum. For time courses that included many spectra, this could take up to half an 
hour, or much longer if large amounts of zerofilling was necessary. As mentioned previously, we 
deemed this acceptable, but less time would certainly be preferred. We are certain that the time 
for processing each spectrum could be reduced by complete removal of all lines of code that 
performed unimportant processes in every function, particularly the functions that were originally 
from MatNMR, as these were meant to be used in a much different manner. This would be time 
consuming, but not difficult, and we did not choose to undertake it. It is also likely that the 
algorithms we obtained from the internet were not properly optimized for performance. With our 
level of programming expertise, it would be very difficult to upgrade these algorithms to improve 
performance, but another could probably develop improved code. 
While trying to make a program that needed as little input as possible, we realized early on 
that the input structure necessitated substantial prior knowledge of the system being investigated. 
In order to know what ranges to input, one needed to know how the peaks drifted over time, and 
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how broad the peaks were. This knowledge could usually be obtained by observing the first 
spectrum and one near the end of the time course in a conventional NMR processor. We observed 
that the first peak often contained the broadest peaks, and peak drift was usually in a single 
direction, so looking at just two spectra provided all of the necessary information. However, it 
would be preferred if this was not necessary, if this information could be obtained by 
MassNMRProcessing without user inputs. We thus propose two changes/additions that would 
assist the program and the user during this process. These could be used either in combination or 
alone. 
The first change that we could make would require minimal changes to the input and no 
change to the overall structure of the program, and as such would be easiest to implement. 
Currently, following creation of the x-axis, MassNMRProcessing takes the ranges that are 
submitted in the first input window and divides the spectrum that is being processed at that 
moment into bins for integration purposes. This could be changed so that the inputs were ppm 
values that stated a location near where each peak should be found, rather than describing the 
lower and upper bounds of the bins to be created. The program would then have a preset value 
that showed how far to look on each side of the inputs for a peak maximum. The highest point 
would be declared the top of the peak, and MassNMRProcessing would divide the spectrum into 
bins again with the center point of the bin the location of peak maximum. The width of the bin 
would also be preset in MassNMRProcessing, but in one of the input boxes the user would be 
allowed to change this value. This would eliminate needing to look at each reaction time course, 
and would probably be slightly more accurate as the bins could be smaller. With a knowledge of 
where the peaks generally are, the program would find the peak and then create a symmetrical bin 
around it for integration. We believe that this would result in significant improvement to the 
program without being hard to implement. 
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Another change that could really increase the applicability of MassNMRProcessing would be 
to reorder the structure of the program so as to let the user see the phased spectra first and then 
submit either ranges for integration or a ppm value to tell the program where to search for the 
peak. This would remove the need to use another NMR processing program to observe the 
location of the peaks, which is currently one of the largest drawbacks of using 
MassNMRProcessing. This could be accomplished by letting the user submit the second window 
of inputs (Figure 1.8) and the overarching folder (Figure 1.9) first. The structure of the program 
would then be changed so that MassNMRProcessing would process and store the data but not 
integrate it. The program would then pause and display the phased spectra just like it does right 
now as the second output (Figure 1.10). After the user perused through the spectra and recorded 
both peak location as well as whether the peaks drift, a second set of inputs would be required. 
Here this could be combined with the first change, as these inputs could be the ppm values of the 
peaks or the edges of the to-be-formed integration bins, whichever is preferred.  In addition, if the 
inputs were set to be those that were described in the first change, then we could add another 
input describing how far to the sides of each input the program should look for the peak, giving 
even more control to the user. Implementing this new program structure would require a 
reordering of the program, the breaking up of the main loop, and a few other substantial changes. 
However, it would allow for MassNMRProcessing to be the only program used when integrating 
long series of NMR, and could provide the user with additional control over this process, both of 
which are worthy goals for this program. 
1.5 DPDS and a Six-Membered Transition State for the Reduction of Phosphine 
Oxides 
1.5.1 Initial NMR Studies 
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With MassNMRProcessing complete, we began to run detailed NMR time courses on the 
reduction of our phosphine precatalysts with phenylsilane. We used variable temperature NMR, 
setting the NMR to the desired temperature before reaction initiation. All of the components were 
then mixed at room temperature in an NMR tube which was loaded into the NMR spectrometer, 
where the reaction was monitored in 2-4 minute increments. We fixed the concentration of 
precatalyst to 0.04 M and the concentration of phenylsilane to 0.4 M for our precatalyst 
comparison. Setting the temperature of the NMR to 80 °C, we monitored the reduction of 1PPO, 
TMPPO, TMBPO, and TMPyrPO in d8-toluene, with TPPO as a control (Figure 1.12)  
 
Figure 1.12. Reaction Progress Curves for the Reduction of Phosphine Precatalysts by 
PhSiH3 at 80 °C in Toluene. [PO] = 0.04 M. [PhSiH3] = 0.4 M. 
The data obtained by this method appears much more precise than the data without VT-NMR 
(Figures 1.3-1.6), with the shapes of each of the curves quite clear. Near the end of the time 
courses, accuracy does appear to decrease, but we are far more interested in studying the initial 
part of the reaction. During the early time points, it is now clear the reduction rate of each of the 
precatalysts increases, which confirms what we were observing earlier in Figure 1.3. With this 
observation in the reaction progress curves for four separate precatalysts, we can now state with 
near certainty that the conventional understanding of how the reduction of phosphine oxides by 
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silanes proceeds is incorrect. It is also noteworthy that we observe substantial differences in the 
reduction rate between the precatalysts, with TMPyrPO being the fastest and 1PPO probably the 
slowest. As expected, TPPO displays no reduction during the time scale monitored.  
To quantify these observations, we first fit each of the curves in Figure 1.12 to either a single 
exponential or the difference of two exponentials (double exponential fitting) by minimizing the 
variance over the entire curve. Graphical overlays of the fitting with each individual curve are 
shown in Figure 1.13. As one would expect, it seems clear that from a visual standpoint double 
exponential fitting is far better than single exponential fitting. To quantify the degree of 
superiority, we calculated the variance per data point for both single and double exponential 
fitting, which is shown in Table 1.2. We are using this in place of the Pearson correlation 
coefficient, as the coefficient is not as informative for non-linear fitting. The numerical data 
confirms the visual observations, as double exponential fitting is 4 to 12 fold superior by the 
chosen metric 
Table 1.2. Numerical Comparison of the Quality of Fitting between Using a Single 
Exponential or Two Exponentials 
 
Entry Variance (%PO Reduced)2 # Data Points Variance Per Data Point 
1PPO-Single 612.79 26 23.57 
1PPO-Double 60.93 26 2.34 
TMPPO-Single 468.99 28 16.74 
TMPPO-Double 37.93 28 1.35 
TMBPO-Single 215.23 16 13.45 
TMBPO-Double 35.14 16 2.20 
TMPyrPO-Single 133.23 14 9.52 
TMPyrPO-Double 37.09 14 2.65 
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Figure 1.13. Graphical Comparison of the Quality of Fitting between Using a Single 
Exponential or Two Exponentials 
Next, we wanted to quantify the differences in rate between the phosphine oxide precatalysts. 
From the single exponential fitting, we obtained the rate constant (k) for the exponential for each 
of the precatalysts, which is shown in Table 1.3. While this affords a convenient single-number 
comparison, we wanted to use additional metrics due to the inaccuracy of the single exponential 
fitting (Table 1.2). As such, we also include the time each reduction takes to become 50 and 90% 
finished (Table 1.3) using the double exponential fitting rather than the raw data to avoid noise-
induced errors. Taken together, these results suggest that TMBPO is about 2X faster than 1PPO 
and TMPPO, which are reduced at similar rates. TMPyrPO is the fastest of the four, with a 
reduction rate about 4X faster than 1PPO and TMPPO. 
Table 1.3. Numerical Comparison of the Rates of Reduction of the Precatalysts by 
PhSiH3. k is from single-exponential fitting, while t50% and t90% are from obtaining the 
equation describing the double exponential fitting and setting it to 50 and 90 percent, 
respectively. [PO] = 0.04 M. [PhSiH3] = 0.4 M 
Precatalyst k (min)-1 t50% (min) t90% (min) 
1PPO 0.028 37.3 91 
TMPPO 0.027 36.5 92 
TMBPO 0.054 16.4 48 
TMPyrPO 0.103 8.4 21 
TPPO ND ND ND 
  53 
 
1PPO and TMPPO being reduced at the same rate established that our original hypothesis 
that increasing the ring strain of the phosphorous catalyst through switching from a 5-membered 
phospholane to a 4-membered trimethylphosphetane would improve the rate of reduction was 
incorrect. The trimethylphosphetane, however, is more sterically hindered than a phospholane 
ring, which could also impact the rate of reduction. Therefore, it is premature to state that there 
can be no benefit obtained from additional ring strain, it is possible that the removal of the 
methyls would improve the rate of reduction to be faster than TMPPO. Sadly, this theory is not 
testable, as phosphetanes with less than three substituents on the phosphetane ring cannot be 
synthesized using current methods. 
The fact that TMPyrPO > TMBPO > TMPPO in reduction rate actually validates our 
hypothesis that increased electron density on the oxygen of the phosphine oxide, and not the 
phosphorous, is what facilitates reduction with phenylsilane. The slight increase in reduction rate 
of TMBPO as compared to TMPPO is roughly what we anticipated based on the results from 
O’Brien and coworkers.82 However, we projected that the resonance donation from the amine 
would result in a greater degree of enhancement than what was observed. We decided to test 
whether or not TMPyrPO reduces at a reasonable rate at room temperature and whether this 
eliminates its aforementioned over-reduction. 
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Figure 1.14. The Observed Rates of Reduction of 1PPO, TMPPO, and TMPyrPO with 
PhSiH3 at 23 °C. [PO] = 0.04 M. [PhSiH3] = 0.4 M 
Figure 1.14 demonstrates that reduction of TMPyrPO does complete after six-and-a-half 
hours. Based on previous reports, the observed rate is fast enough for a catalytic-in-phosphine 
reaction to complete within 24 hours using 10-15 mol% of precatalyst. Unfortunately, we still 
observed significant degradation to the secondary phosphetane. Therefore our initial hypothesis in 
the design of TMPyrPO did furnish a precatalyst that undergoes facile reduction at room 
temperature, but its lack of stability limits its usefulness. 
Given the superior data acquired with the new method (Figure 1.12), we wanted to retest our 
results that indicated a dependence of the rate on the concentration of phosphine oxide.  Testing 
similar concentrations of TMPPO and phenylsilane as were previously chosen (Figure 1.7), we 
obtained the data shown in Figure 1.15A. With this data, it is clear that increasing the 
concentration of TMPPO does in fact increase the percentage rate of its reduction. We set out to 
determine the origin of this increase in combination with the observed “lag phase” in every single 
reduction progress curve with PhSiH3. 
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Figure 1.15. The Reduction Rate Dependence on the Concentration of TMPPO. All 
reductions were run with phenylsilane = 0.8 M in toluene at 80 °C. (A) Graphical 
comparison of the rates of reduction with differing concentrations of TMPPO. (B-D) 
Fitting the curves from part A. (E) Numerical comparison of the rates of reduction from 
B-D.  
1.5.2 DPDS 
As previously mentioned, we had ruled out the possibilities of phosphine pre-activation or a 
multi-step mechanism being responsible for the observed increase in precatalyst reduction rate 
over the first few minutes using phenylsilane. Silane preincubation without any additives 
provided a minimal increase in rate at most (Figure 1.4) and did not change the curve shape to a 
single exponential, so it was unlikely that silane pre-activation in such a manner was responsible 
for the “lag phase”. We thus hypothesized that phenylsilanol and/or phenylsilanediol were 
substantially more rapid reductants than phenylsilane, as it was the only other explanation we 
could conceive which could explain the observed behavior. 
Phenylsilanol is known to equilibrate with diphenyldisiloxane (DPDS), with the equilibrium 
favoring the disiloxane in organic solvents. DPDS was synthesized in a single step from 
phenyl(chloro)silane in good yield (Scheme 1.3), and tested for its activity in reducing phosphine 
oxides. We were excited to find that DPDS completely reduced both 1PPO and TMPPO within 
5 minutes at 80 °C. When tested at room temperature, we found DPDS competently reduced 
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1PPO and TMPPO in under three hours. To monitor this reaction more closely, we obtained 
reduction progress curves of the reductions of our suite of precatalysts with DPDS at room 
temperature, which are shown in Figure 1.16. TPPO is again shown as a control. 
 
Scheme 1.4. The Synthesis of DPDS and its Equilibration with Phenylsilanol 
 
Figure 1.16. Reaction Progress Curves for the Reduction of Phosphine Precatalysts by 
DPDS at 23 °C in Toluene. [PO] = 0.04 M. [DPDS] = 0.3 M. 
Clearly, DPDS is a remarkably potent reductant for the phosphorous heterocycles we 
synthesized. Both TMBPO and TMPyrPO are reduced to completion in 30 minutes. TMPPO 
and 1PPO, while slower, are reduced on a time scale that would certainly facilitate room 
temperature catalytic-in-phosphine reactions. These reactions represent the first reported example 
of additive-free room temperature reduction of phosphine oxides using silane reagents. The 
curves in Figure 1.16 also show a high degree of single-exponential character, with no visible 
“lag phase”, validating our hypothesis of phenylsilanol being responsible for the “lag phase” via 
it having a higher reductive potency than commercially available phenylsilane.  
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An obvious next step was to test the rate of reduction of TPPO with DPDS at elevated 
temperature. Monitoring this reaction with 31P NMR (Figure 1.17), we found that TPPO is 
completely reduced at 110 °C in 5 hours, again with single-step kinetics. This is the fastest known 
reducing system for triphenylphosphine oxide at 110 °C,83,84 which will be further elaborated on 
later in this document. 
 
Figure 1.17. A Reaction Progress Curve for the Reduction of TPPO by DPDS at 110 °C 
in Toluene. [TPPO] = 0.04 M. [DPDS] = 0.5 M. 
1.5.3 Other Silanes 
The impressive gains in reductive activity that we obtained by substituting DPDS for 
phenylsilane suggested a more thorough investigation of silane materials would be valuable. 
Previously, we performed a silane screen with commonly utilized silanes, but we wanted to 
specifically try silicon hydride compounds that would represent different classes. Examining what 
was commercially available, we purchased two compounds that fulfilled the desired criteria, n-
hexylsilane and 1,1,3,3-tetramethyldisilazane (TMDSA). 
n-Hexylsilane was of interest because it was a tri-hydrido alkyl silane, and to our knowledge 
a member of that class had not been tested for its reductive potency against phosphine oxides. 
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Unfortunately, in isolated reduction studies in THF, DCM, and toluene at 80 °C, it was notably 
slower than phenylsilane at reducing each of our phosphine precatalysts. 
The other silane we chose, TMDSA, is a member of the hydrido-disilazane class of 
compounds, of which none had been previously evaluated. Addition of TMDSA to 1PPO in THF 
furnished no reduction, but using the same combination in DCM produced 61% of the reduced 
phosphine in 30 minutes at 80 °C (Figure 1.18), which is quite fast. However, the reaction was 
heated for 5.5 more hours, and no further reduction was observed. At this point, the reaction 
(which had taken place in an NMR tube) was cooled to ambient temperature and opened. 
Notably, substantial pressure had built up, even after cooling, and the released gas reeked of 
ammonia. Several reports on the synthesis of amino-silanes suggest that they are very unstable,85 
so we thought perhaps TMDSA was converted to TMDSO by the small amount of water that is 
present in the NMR tube. TMDSO does not reduce 1PPO at 80 °C (Table 1.1, Figure 1.18), so 
such a conversion would explain the lack of reduction after 30 minutes, as well as why re-opened 
bottles of TMDSA (which smell strongly of ammonia) were inactive. 
 
Figure 1.18. The Reduction of 1PPO by TMDSO and TMDSA at 80 °C in CH2Cl2. 
[1PPO] = 0.04 M. [TMDSA] = 0.4 M. [TMDSO] = 0.6 M 
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1.5.4 A Six-Membered Transition State 
The striking difference in activity between TMDSO and TMDSA was perplexing as the only 
difference between the two silanes is the identity of the heteroatom, and based on precedent, 
greater electron-deficiency on the silicon center correlated with faster reduction.86 Even if they 
were switched, and TMDSO was the active one, it appeared rather unlikely that the rather small 
difference of electron density on the silicon atoms could explain the gulf in reactivity. We thus 
looked for alternative ways to explain the result in Figure 1.18.  
The only justification that appeared to contain any merit was the proposal of TS-2, a 6-
membered transition state for the reduction of phosphine oxides by silanes. In TS-2, the hydride 
is delivered directly to phosphorous following formation of a hydrogen bond between the silane 
and the oxygen atom of the phosphine oxide. TS-1, the 4-transition state that has long been 
postulated for this reduction,87 is known to be quite high in energy,88 so it appeared quite possible 
that the 6-membered nature of TS-2 makes it a lower-energy alternative. The difference in 
reactivity is thus explained by the fact that TMDSA contains a hydrogen bond donating moiety, 
and could thus access TS-2. TMDSO, on the other hand, is known to be a particularly stable 
disiloxane, even in an aqueous environment, and thus cannot form the key hydrogen bond.89 
 
Figure 1.19. Marsi’s 4-Membered Transition State (TS-1) and Our Proposed 6-
Membered Transition State (TS-2) for the Low-Temperature Reduction of Phosphine 
Oxides by Silanes 
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With further examination, we realized that TS-2 could explain the observed difference in 
reactivity between phenylsilane and phenylsilanol (in equilibrium with DPDS). Phenylsilanol can 
form the hydrogen bond, whereas reduction with phenylsilane necessitates going through TS-1. 
Even more notable is the fact that the three most commonly employed silanes (phenylsilane, 
diphenylsilane, and trimethoxysilane) can form hydrido-silanols by reacting with water, whereas 
the inactive (except at 300 °C) mono-hydrido silanes (triethyl-, triphenyl-,  tris(trimethylsilyl)-, 
etc.) cannot form hydrogen-bond donating species and thus could only reduce phosphine oxides 
through TS-1. 
The addition of acids and bases to a solution containing disiloxanes is known to shift the 
disiloxane-silanol equilibrium towards the silanol side. We thus reasoned that addition of acids or 
bases should facilitate phosphine oxide reduction with TMDSO. This was tested through the 
catalytic addition of protic acids, Lewis acids, and potassium t-butoxide to solutions of TMDSO 
and 1PPO. Potassium t-butoxide caused complete degradation of the phosphorous precatalyst, 
but use of both protic and Lewis acids facilitated reduction (Figure 1.20, 1.21). Just as one would 
expect if the equilibrium is responsible for the reductive activity, the strongest of the protic and 
Lewis acids promoted the most reduction. Reaction mixtures including TFA went much faster 
than those using AcOH, and usage of ZnCl2 was better than MgCl2 which in turn was superior to 
LiCl, which follows the presumed trend of Lewis acidity. These results strongly suggest that TS-2 
is indeed a valid transition state and is much lower energy than TS-1. At this point, we noted that 
we had no direct evidence for TS-1 occurring in any of our reaction mixutes, and thus questioned 
whether TS-1 was even a valid transition state for this reaction at 110 °C or below (i.e. 
triphenylsilane does reduce phosphine oxides when heated to 300 °C, so TS-1 is certainly valid at 
intense temperatures90). 
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Figure 1.20. The Reduction of 1PPO by TMDSO and either AcOH or TFA at 80 °C in 
THF. [1PPO] = 0.04 M. [TMDSO] = 0.6 M. [Acid] = 0.2 M 
 
Figure 1.21. The Reduction of 1PPO by TMDSO and a Lewis Acid at 80 °C in THF. 
[1PPO] = 0.04 M. [TMDSO] = 0.6 M. [Lewis Acid] = 0.2 M 
1.6 Proof that Only the 6-Membered Transition State Occurs at Reasonable 
Temperatures 
1.6.1 The Trajectory of Reaction Progress Curves of Phenylsilane-Mediated 
Reduction 
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If TS-1 is not a valid transition state at 80 °C, then phenylsilane cannot be an actual 
reductant, but must instead react with water to form phenylsilanol, the active reagent. Proof of 
such a mechanism would thus lend strong evidence towards the hypothesis that low temperature 
phosphine oxide reduction must proceed through TS-2. If phenylsilane itself is a competent 
reductant, concentrations of phenylsilanol and phenylsilanediol will either reach or remain below 
equilibrium concentrations following initiation of the reaction, which would limit the magnitude 
of the increase in reduction rate. This is shown below, comparing the initial rate to the rate when 
50% of the phosphine oxide has already been reduced. 
 
 
Figure 1.22. Kinetic Schematic of the Reduction of Phosphine Oxides by Phenylsilane 
Assuming Phenylsilane itself is Competent 
Figure 1.22 shows the mechanism of phosphine oxide reduction by phenylsilane while 
assuming that phenylsilane itself is a capable reductant, where PO refers to unreduced phosphine 
oxide and P the reduced phosphine. Inferring that this mechanism is correct, we can write the rate 
of reduction as the change in [PO] with respect to time: 
 
Due to the fact that we are operating in pseudo-first order conditions with an excess of 
phenylsilane: 
 
Now, at time t = 0, it is also known that:  
 
The initial rate of phosphine formation is thus: 
  63 
 
To prove that the maximum rate at 50% PO reduced is 3/2 the initial rate of reduction, we 
first write the rate of reduction where half the PO has already been reduced. 
 
Evaluating the above equation term by term, it is clear that the first term is equal to half of the 
initial rate.  To evaluate the second term, we note that this term would be at a maximum when the 
concentration of phenylsilanol is at a maximum.  From the proposed mechanism, the 
concentration of phenylsilanol will reach a maximum at the time its rate of formation equals its 
rate of consumption, or where the derivative of the concentration of phenylsilanol is zero.  We 
then write the derivative of the concentration of phenylsilanol with respect to time at 50% PO 
reduced. 
 
Setting that derivative to 0, we obtain: 
 
This means the second term can, at a maximum, be equal to half the initial rate.   
We can apply the same strategy to the third term.  The concentration of phenylsilanediol will 
also be at a maximum when its rate of formation equals its rate of consumption.  The derivative 
of the concentration of phenylsilanediol at 50% PO reduced is: 
 
Setting this derivative to 0: 
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Now, we have already shown that the maximum the term on the left could be is half the initial 
rate.  If this is the maximum that the term on the right could be, we have now shown that the 
maximum all three terms can be is just half the initial rate.  Adding up all of them, we find that 
the maximum rate of phosphine oxide reduction following this mechanism at 50% PO reduced is 
just 3/2 the initial rate. 
 
Now, it is worth stating explicitly that this derivation of the maximum fold rate increase 
assumes that the concentrations of both phenylsilanol and phenylsilanediol have reached 
equilibrium. It is entirely possible, perhaps even likely, that this is not the case, which would 
lower the maximum fold rate increase. 
With the maximum fold increase at 50% reduction established, we now need to determine 
whether the curves in Figure 1.12 provide values under that maximum. To do this, we used the 
double-exponential fitting from Figure 1.13 to obtain an equation for a smooth curve that closely 
follows the raw data. This equation provides an excellent estimate of the actual time to 50% 
reduction and allows for the calculation of the derivative at each time point. The TMPyrPO 
reduction curve is removed from this analysis since the resulting phosphine is further reduced 
with cleavage of the P-N bond during the reaction. We also found that when we just took the 
derivative of the fitted double exponential equation, a fitting artifact caused us to obtain negative 
derivatives for the very early time points. Therefore, the initial rate was calculated from the slope 
of the line between the initial point and the first time point or the initial time point and the second 
time point. This practice of listing the average rate observed over the first 1–5 minutes as the 
initial rate almost certainly overestimates it. Using these methods, we calculated the rate fold 
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increase at 50% reduction. The double exponential fitting and the derivative curves used to 
calculate the rate fold increase are shown in Figure 1.23. 
 
Figure 1.23. Derivative Curves and Double Exponential Fitting of Reaction Progress 
Curves from Precatalyst Reduction by Phenylsilane. (a) Comparison between raw data 
(from Figure 1.12) and double exponential fit for the reduction of 1PPO (left), TMPPO 
(center), and TMBPO (right) by phenylsilane at 80 °C. (b) Derivative curves of the fit 
from part (a) with the fold increase in reduction rate at 50% conversion indicated. 
With all three of our phosphorous precatalysts, more than a 1.5X increase in reduction rate is 
observed at 50% reduction. It is thus quite likely that phenylsilane requires a pre-activation by 
reacting with water to form phenylsilanol, which is then the active species, reducing phosphine 
oxides by proceeding through TS-2.  
1.6.2 Diphenylsilane Series 
While the kinetic evidence for phenylsilane reduction of phosphine oxides only proceeding 
through TS-2 is quite strong, we wanted further experimental evidence. We thus designed a series 
of Si, Si-diphenylsilanes that are quite similar in structure, but should have dramatically different 
reactivities if our hypothesis is correct. The three that were tested are 1,1,3,3-
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tetraphenyldisiloxane (TPDS), diphenylsilane, and methyldiphenylsilane (MDPS). TPDS should 
equilibrate with diphenylsilanol, the presumed active species, and should thus be a more rapid 
reductant than diphenylsilane due to the pre-activation already being complete. MDPS, on the 
other hand, cannot form a hydrido-silanol species to reduce phosphine oxides through TS-2, so it 
should be completely inactive. We synthesized TPDS from diphenylchlorosilane in good yield 
(Scheme 1.5), and compared the three Si, Si-diphenylsilanes for their reductive capacities against 
TMPPO (Figure 1.24). 
 
Scheme 1.5. Synthesis of TPDS and its Equilibration with Diphenylsilanol 
 
Figure 1.24. Reaction Progress Curves of the Reduction of TMPPO by the 
Diphenylsilane Series. [TMPPO] = 0.04 M, [TPDS] = 0.3 M, [Ph2SiH2] = 0.4 M, [MDPS] = 
0.6 M 
The reactivity of the three silane reagents was precisely in line with our expectations. TPDS 
was faster than diphenylsilane, and MDPS was inactive under the reaction conditions for 7 hours. 
  67 
These results provide further support for our proposed mechanism of silanol-mediated reduction 
of phosphine oxides and argue against reduction through non-silanols. 
1.6.3. Additional Evidence 
We were also able to find additional evidence from the literature that supports the hypothesis 
that phenylsilane and diphenylsilane require preactivation to a hydrido-silanol to furnish the 
reduced phosphine. In their seminal work on the reduction of phosphine oxides with silanes, 
Fritzsche and coworkers used 0.67 equivalents of phenylsilane to reduce a full equivalent of 
phosphine oxide.91 Marsi then reported the same substoichiometric usage of phenylsilane for 
reduction ten years later.92 However, no one has ever reported the substoichiometric usage of 
diphenylsilane to reduce a full equivalent of a phosphine oxide.9394 All known procedures use at 
least 1.1 equivalents of diphenylsilane, which should not be necessary if both diphenylsilane and 
diphenylsilanol were competent reductants. Similarly, if phenylsilane could reduce a phosphine 
oxide three times (via phenylsilanol and phenylsilanediol generated following the initial 
reduction), then we should observe its usage at around 0.4-0.5 equivalents, which has never been 
reported. 
Another interesting piece of evidence is from a procedure for the reduction of phosphine 
oxides written by Marsi.95 Under the heading “Typical Reaction of Phenylsilane with Phosphine 
Oxides.”, he writes: “The phosphine oxide (10 mmol) and 6.7 mmol of freshly distilled 
phenylsilane are added together in a 10-ml pear-shaped flask fitted with a small condenser. … If 
the reaction does not commence spontaneously, the mixture is heated carefully with an oil bath. 
Heating is especially necessary if the oxide is a solid to effect solution of the oxide with 
phenylsilane. Initial slow evolution of hydrogen signals the onset of the reaction.” This means 
that despite Marsi’s proposed mechanism (Scheme 1.1) where he proposes the production of 
hydrogen post-reduction, he observes hydrogen formation at the beginning of the reaction. This is 
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exactly the sort of behavior we would expect if our proposed mechanism is correct. The “onset of 
the reaction” is signaled by the “initial slow evolution of hydrogen”, which is occurring because 
phenylsilane is reacting with water to form phenylsilanol. 
Taken together, we believe that the pieces of evidence presented in the end of section 1.5 and 
the entirety of section 1.6 point very strongly towards our theory that all reduction of phosphine 
oxides below 120 °C or so proceeds through TS-2.  
1.7 Completing the Mechanism of Phenylsilane-Mediated Reduction of Phosphine 
Oxides 
1.7.1 Benzoate as a Catalyst for Rapid Reduction with Phenylsilane 
Despite our acceptance that silanes reduce phosphine oxides through TS-2, a few questions 
remained about smaller mechanistic details, specifically in regards to phenylsilane. The first of 
these is: how does phenylsilane react with water to form phenylsilanol? In Figure 1.4 we showed 
that heated preincubation of phenylsilane in THF produced an insignificant increase in the rate of 
reduction. Clearly, phenylsilanol was not formed during this preincubation, as the rate increase 
would have been much more pronounced, so another explanation is necessary for how to explain 
the in situ formation of phenylsilanol. 
The answer came through the results of an investigation of the mechanism of the room 
temperature catalytic Wittig reaction reported by O’Brien and coworkers. The addition of benzoic 
acid, DIPEA, and phenylsilane facilitated room temperature reduction of 1PPO and another 
phospholane precatalyst. It has been shown that DIPEA and benzoic acid individually provide 
almost no improvement in the rate of phenylsilane reductions, so we wanted to investigate 
whether the drastic rate improvement was due to the combination of the two, or whether a proton 
exchange between them was producing a single active species.  
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Scheme 1.6. Synthesis of DIPEA-HCl and Tetrabutylammonium p-nitrobenzoate 
Diisopropylethylamine (DIPEA)HCl and Tetrabutylammonium p-nitrobenzoate were 
synthesized as shown in Scheme 1.6, and each were added to phenylsilane reductions of 
TMPPO. The benzoate caused vigorous production of gases in the NMR tube upon addition, and 
formed substantial amounts of the reduced product at room temperature. DIPEAHCl was added 
without a physically observable effect, though upon heating to 80 °C, the reduction rate was 
improved compared to the control, finishing within 15 minutes of initiation. Therefore, the 
observed improvement in the catalytic Wittig reaction is due to both components, but mostly 
from in situ carboxylate formation. Further testing with the benzoate demonstrated that vigorous 
bubbling initiated upon addition to a solution of phenylsilane regardless of whether the phosphine 
oxide was present. Given the rapid reduction with the benzoate, we concluded that the gas is 
likely hydrogen produced from the reaction of phenylsilane with water to form phenylsilanol. 
1.7.2 An Oxyanionic Catalyst is Necessary for Phenylsilanol Formation 
At this point, we proposed that phenylsilane requires a Lewis base to activate it to 
phenylsilanol, likely through the mechanism shown in Scheme 1.7. In this mechanism, the Lewis 
base donates electrons density to the electron-poor silicon atom of phenylsilane, forming a 
transient pentacoordinate silicon species. We advocate that the hydride is donated from this 
species to water, forming hydrogen gas and hydroxide ion, which displaces the Lewis base as a 
ligand on the silicon atom to afford phenylsilanol. Phosphine oxide, which has substantial Lewis 
basic character, is hypothesized to be the activating agent during additive-free phenylsilane 
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reductions. This proposed mechanism is also consistent with our preincubation trials, and can also 
account for the increased rate observed with DIPEA-HCl by projecting that the increased acidity 
of the solution facilitates more rapid hydride donation. 
 
Scheme 1.7. Proposed mechanism for Lewis-Basic Activation of Phenylsilane to React 
with Water. The Lewis Base with oxyanionic character donates electron density into the 
silicon atom, allowing for hydride donation from phenylsilane to form phenylsilanol and 
hydrogen gas. 
To test whether or not phosphine oxides are acting as Lewis-basic catalysts in the formation 
of phenylsilanol, we decided to add Lewis acids to reaction mixtures to potentially block the 
activation of phenylsilane. Specifically, we chose to add the same Lewis acids that were tested for 
competency with TMDSO in Figure 1.21.  The results, which are shown in Figure 1.25, are 
striking. Zinc chloride, which was the strongest promoter of reduction with TMDSO, completely 
abolishes all of the reductive activity of phenylsilane.  The fact that absolutely zero reduction is 
observed with zinc chloride, combined with it promoting reduction using TMDSO, strongly 
suggests that the Lewis acid is inhibiting the formation of phenylsilanol, and not the subsequent 
reduction. Lithium chloride, which was presumably not a strong enough Lewis Acid to induce 
dimethylsilanol formation from TMDSO, also substantially inhibits the reaction, though it does 
not completely stop it. The observed trend in reactivity is the exact opposite of that observed 
when using TMDSO, providing strong evidence for our hypothesis of phosphine oxide acting as 
a Lewis-basic catalyst for the reaction of phenylsilane with water. 
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Figure 1.25. Reaction Progress Curves of the Reduction of 1PPO by Phenylsilane with 
or without Lewis Acid Additives. [1PPO] = 0.04 M, [PhSiH3] = 0.4 M, [LiCl] = 0.2 M, 
[ZnCl2] = 0.1 M 
Next, we wanted to test additional Lewis-basic compounds for their competency in 
phenylsilanol formation. DIPEA, highly electron donating tributylphosphine, and sterically 
unencumbered n-propylamine were added to phenylsilane-mediated reductions of 1PPO. To our 
surprise, none of these additives significantly affected the rate of formation of the reduced 
product. Since these are nitrogen and phosphorous-based Lewis acids, we surmised that perhaps 
the Lewis-base needed to have oxy-anionic character. When previously tested, potassium tert-
butoxide produced large amounts of hydrogen gas. The observed trend could be due to the 
naturally strong affinity between oxygen and silicon, and the considerably lower affinity that 
silicon has for nitrogen or phosphorous, though we have not thoroughly examined this.  
Regardless, it does appear that only oxygen-based Lewis basic compounds promote activation of 
phenylsilane to phenylsilanol. 
1.7.3 Comparing Rates of Precatalyst Activation of Phenylsilane 
We desired to test additional oxy-anionic additives to test whether stronger oxy-anionic 
character promoted faster activation of phenylsilane. However, most compounds considered were 
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either too weak (ketones, aldehydes, carboxylic acids, amides) or too strong (alkoxides). We 
could have tested a series of carboxylates with different pKa values, or perhaps tried ureas or 
sulfoxides, as these compounds are probably in the “sweet spot” for reactivity. That would 
certainly be useful in the future, but we decided to model our existing data of phenylsilane 
reduction of our precatalysts, as this would show whether or not our proposed mechanism of 
reduction could provide a reasonable fit to the data in addition to answering the desired question. 
We already know the electronic trend, as TMPyrPO has the most oxyanionic character of the 
synthesized precatalysts, followed by TMBPO and then TMPPO and 1PPO in an unknown 
order. We also know that the overall reduction rate follows the trend TMPyrPO > TMBPO > 
TMPPO ≈ 1PPO, so the challenge is to tease out the rates of the individual steps from the overall 
data. 
 
Figure 1.26. Kinetic Schematic of the Reduction of Phosphine Oxides by Phenylsilane 
Including Phosphine Oxide Catalyzing the Initial Reaction of Phenylsilane with Water 
We used the scheme shown in Figure 1.26 as the presumed mechanism for reduction of each 
of the phosphine oxides. As the concentrations of phosphine oxide and reduced phosphine are 
known at each data point, along with the initial concentration of phenylsilane, the goal was to 
obtain specific values of k1, k2, and k3 through fitting the data. Each phosphine oxide is treated as 
a catalyst in the initial activation, which is important as that means the concentration of phosphine 
oxide will affect the rate of this step. We also considered taking into account the concentration of 
water, but decided against this, as it will be constantly changing according the many disiloxane-
silanol equilibra present in the reaction mixture, each with an individual and unknown 
equilibrium constant. 
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First, we obtained the following equations for the derivatives of the concentrations of each of 
the components with respect to time. 
 
 
 
 
 
 
Then, the process was initiated by setting the initial concentration of phosphine oxide to 0.04 
M, the initial concentration of phenylsilane to 0.4 M, and the initial concentrations of the other 
components to 0. Guesses were selected for the values of each of the rate constants, and the 
concentrations of each of the components were calculated using Excel in an iterative process to 
create simulated reduction progress curves using the equations above. The time scale was set to 
0.1 seconds per iteration, so the derivative was recalculated and the concentrations adjusted every 
0.1 seconds along the curve. The calculated concentration curves of phosphine oxide were 
overlaid with the curves from Figure 1.12, and iterations were continued until the data suggested 
that 95% of the phosphine oxide had been reduced (at this point the data was known to be less 
accurate). 
We then utilized Excel Solver to solve for the rate constants.  This was done by minimization 
of the sum of the variance between the experimental concentration of phosphine oxide at each 
data point and the simulated concentration of phosphine oxide at the closest time point calculated. 
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The rate constants were allowed to float, however, we were forced to choose k3 to be a fixed 
multiple of k2 in order to obtain a finite number of solutions. Each fixed multiple pairing 
produced two solutions of k1 and k2/k3 that fit each precatalyst reduction curve, however, each 
time we were able to rule one out, as one solution would describe a system where almost all of 
the phenylsilane gets converted to phenylsilanol, and the other a system where most of the 
phenylsilane remains at the end of the reaction. When monitoring the reaction by 1H NMR, it is 
clear that most of the phenylsilane remains following completion, so we chose the appropriate set 
of rate constants. 
First, we chose to confirm that the proposed mechanism and rate constant combinations did in 
fact result in adept fitting of our experimental reduction curves (Figure 1.27). We wanted to limit 
the number of analyses as the relationship between k2 and k3 had to be manually defined, and thus 
decided to run the simulation with k3 = k2, k3 = 10k2, and k3 = ∞.  These were chosen because a 
wide range of ratios was desired and, at least at the time, it seemed unlikely that k3 would be 
slower than k2 due to the decreased electron density on silicon of phenylsilanediol as opposed to 
phenylsilanol.  Eliminating all of the solutions that had k1 fast and k2 slow, we successfully 
obtained a single pair of rate constants for each ratio of k2 and k3/phosphine oxide combination, 
which are shown in Table 1.4.  A graphical comparison each of the simulations with the data 
modeled is shown in Figure 1.27. 
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Table 1.4. Rate Constants Obtained through Simulation of Reaction Progress Curves for 
the Reduction of Phosphine Oxides by Phenylsilane. All rate constants are in (M-1s-1) 
 
 k3 = k2 k3 = 10k2 k3 = ∞ 
 k1 k2 k1 k2 k1 k2 
1PPO 0.049 1.83 0.051 1.14 0.058 0.87 
TMPPO 0.038 3.01 0.039 1.90 0.040 1.67 
TMBPO 0.077 8.23 0.078 5.46 0.079 5.02 
TMPyrPO 0.133 25.0 0.134 16.7 0.135 15.4 
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Figure 1.27. Graphical Comparison of Reaction Progress Curves of the Reduction of 
Phosphine Oxides by Phenylsilane and the Fit Obtained by the Indicated Ratio Between 
k2 and k3. k2 and k3 are from Figure 1.26 
The simulation curves mirror the actual data quite nicely. The proposed mechanism for 
phenylsilane reduction certainly could produce the data in Figure 1.12, which was pleasing to 
confirm as so many other mechanisms were able to be ruled out simply because they could not 
produce the obtained data.   
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The other goal of this analysis was to allow for a comparison of which phosphine oxides 
activate phenylsilane to phenylsilanol the fastest (as well as which are reduced the fastest by 
phenylsilanol/phenylsilanediol).  Clearly, with our method of analysis, we cannot differentiate 
between k3 and k2, nor use the absolute values of the rate constants, as they change based on the 
relationship chosen between k3 and k2.  However, the data in Table 1.4 can still be used quite 
effectively, as the relative rates of the different phosphine oxides can be compared since the 
trends stay the same regardless of the relationship between k3 and k2. The key findings can be 
summarized in two points. 
1. 1PPO activates phenylsilane to phenylsilanol faster than TMPPO but is reduced by the 
produced silanols slower than the phosphetane. 
2. The phosphetanes follow a clear trend demonstrating adding electron density to the 
phosphine oxide causes both faster activation of phenylsilanol and faster reduction by silanols 
The first point confirms the expected differences in reactivity between 1PPO and TMPPO 
based on the reduction curves in Figure 1.12 and Figure 1.16.  The two phosphine oxides are 
reduced at similar rates in Figure 1.12, while in Figure 1.16, TMPPO is reduced nearly twice as 
fast as 1PPO.  The difference in Figure 1.16 suggests silanols reduce TMPPO faster than 1PPO 
(based on the Arrhenius equation, which is an oversimplification), indicating that the similar rates 
observed in Figure 1.12 would be a result of faster phenylsilane activation by 1PPO. This is 
interesting because 1PPO and TMPPO likely have fairly similar amounts of electron density on 
the phosphine oxide, making it likely that the differences in ring strain/steric hindrance are 
causing the differing rates of the steps. 
The second point, that adding electron density to the phosphine oxide causes both faster 
activation and reduction, provides further support for our theory that oxygen-based Lewis basicity 
is necessary for phenylsilanol formation. It appears that the greater the degree of oxyanionic 
  78 
character, the more facile the activation of phenylsilane.  It is important to note, for future 
phosphine design, that greater electron density on the phosphine oxide does in fact causes faster 
reduction with silanols, and not just faster pre-activation of the reductant.  
1.7.4 The Water Cycle 
At this point, we had concluded that phenylsilane itself has no reducing capacity towards 
phosphorous precatalysts, but requires phosphine oxide to catalyze a reaction between it and 
water, forming hydrogen gas and phenylsilanol, the active reductant. Though this interpretation of 
the data made sense, we were concerned about the quantity of water that would be required to be 
present to react with the required amount of phenylsilane. It has been shown that the disiloxane-
silanol equilibrium heavily favors disiloxane bond formation, especially with silanediols or 
silanetriols.96 Therefore, only a small amount of water is necessary at the beginning of the 
reaction, as the water that reacts with phenylsilane at the beginning is regenerated following 
condensation of phenylsilanetriol into silyl-oxy polymers (Scheme 1.8). Specifically, 3/2 of an 
equivalent of water is generated following condensation for each molecule of phenylsilane that 
requires activation, which explains Marsi’s observation that water is generated over the course of 
the reaction.97 This regeneration creates a “water cycle” that is occurring during phosphine 
formation, which is shown in Scheme 1.8. 
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Scheme 1.8. The Reaction of Water with Phenylsilane and Generation of Water 
Following Condensation of Phenylsilanetriol to form the “Water Cycle”. Phenylsilanetriol 
is certainly not the only silanol that condenses to form disiloxane linkages, but it is 
illustrated as such in this cycle to show that 3/2 of an equivalent of water is generated for 
each molecule of water that react with phenylsilane. 
1.8 Reinterpretation of Previous Reports 
1.8.1 Ashfeld’s Traceless Staudinger Ligation 
A natural result of overturning postulates that have held for the last 40 years is that many 
results that were previously considered strange now make sense, and explanations built off of the 
incorrect postulates need to be revised. We set out to do just that, with the first mystery already 
unraveled when we demonstrated why addition of benzoic acid to a basic catalytic Wittig solution 
facilitates room temperature recycling.98 
Ashfeld and coworkers reported a catalytic-in-phosphine Staudinger ligation, which we were 
particularly interested in investigating as the conditions reported appeared inconsistent with our 
results.99 Specifically, the reaction is purported to involve reduction of TPPO with phenylsilane 
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while heating to only 60 °C. The overall reaction scheme and the proposed mechanism are shown 
in Scheme 1.9. 
 
Scheme 1.9. General Scheme for Ashfeld’s “Traceless Staudinger Ligation” and the 
Reported Mechanism of the Reaction. 
As we found that TPPO could be reduced by DPDS in a reasonable time frame at 110 °C 
(Figure 1.17), we were skeptical that a reaction that used phenylsilane and required 10 turnovers 
of phosphine could proceed at 60 °C. Therefore, we decided to test the validity of such a 
reduction under the reported conditions. While planning the experiments, we realized that if some 
of the aza-ylide is hydrolyzed, it will form triphenylphosphine oxide and an amine. The amine 
would then interact with the carboxylic acid that is already present to form carboxylate, which 
would in turn form phenylsilanol from phenylsilane. All of this could occur without any loss in 
yield, as 1.2 equivalents of azide were reported to be the optimal conditions. Therefore, we 
decided to test the reduction of TPPO under what we viewed as the best possible reducing 
conditions achievable with the reported chemicals. We added phenylsilane (1.0 equiv.), PNBA 
(1.2 equiv.), and N-benzylmethylamine (1.0 equiv.) to TPPO (0.1 equiv.) and heated this to 60 
°C for 16 hours (the amount of time reported for these reactions). Taking phosphorous NMR, we 
found that 49% of the TPPO was reduced, so the half-life of reduction under these “ideal” 
conditions was almost exactly 16 hours. Even if these unrealistically favorable reduction 
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conditions were achieved, the reaction could not have proceeded under the mechanism proposed, 
as the half-life of this reduction would have to be in the 2-3 hour range. 
Next, we decided to probe the reaction conditions, partially due to the suspicious lack of a 
reported stoichiometric trial without silane during the initial optimization. We exchanged 4-
trifluoromethylbenzoic acid out for PNBA, but otherwise utilized the exact optimized conditions 
reported, and obtained a 62% yield (Entry 1 in Table 1.5).  Switching the phosphine from TPP to 
TPPO greatly decreased the yield to 23% even with an increased reaction time of 24 h (Entry 2 in 
Table 1.5). This only further confirmed our doubts about the actual mechanism of the reaction, as 
this yield is much more in line with what could occur based on our isolated reduction study. Next, 
we tested the effects of increasing the temperature to 110 °C, a much more typical temperature 
for these catalytic-in-phosphine reactions, and found that it had an insignificant effect on the yield 
(Entry 3 in Table 1.5). 
Table 1.5. Catalytic and Stoichiometric Staudinger Ligation Reactions. Entry 4 furnished 
16% of benzylamine, while Entry 5 afforded a quantitative yield of benzylamine 
  
 
Entry Phosphine Phosphine Loading Silane Temperature (°C) Isolated Yield 
1 TPP 17 mol% Yes 60 62 
2 TPPO 17 mol% Yes 60 23 
3 TPP 17 mol% Yes 110 65 
4 TPP 17 mol% No 60 0 
5 TPP 110 mol% No 23 0 
6 TPP 110 mol% No 60 0 
7 TPP 110 mol% No 110 0 
 
Finally, we ran the stoichiometric trial that should have been present in Ashfeld’s report. The 
conditions remained exactly the same except that the silane was removed and we used an excess 
of TPP. Regardless of temperature (Entries 5-7 in Table 1.5), we found that no product was 
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formed. Instead, we isolated a quantitative yield of benzylamine post-workup, the Staudinger 
reduction product. To be thorough, we also tested removal of the silane while using a catalytic 
amount of TPP, and again isolated no product.  
We were now 100% certain that the proposed mechanism was incorrect, as the failed 
stoichiometric runs proved that the amide coupling was silane-mediated. While seeking to 
determine an alternative mechanism that could explain the formation of the product while 
remaining concurrent with our reduction experiment, we found a report by Ruan and coworkers 
that used phenylsilane as an amide coupling reagent.100 Their conditions were remarkably simple, 
with no heat or additives required, just carboxylic acid, amine, and silane. Denton and coworkers 
later used this reaction to do an amidation/reduction combination reaction.101 With the results in 
Table 1.5, it is extremely likely that this phenylsilane-mediated amide coupling is the actual 
mechanism for product formation in Ashfeld’s reaction. 
Then, all we had to do was explain how the amine was formed in quantitative yield with a 
catalytic amount of phosphine. We propose that following Staudinger reduction to form the 
phosphine imine, it is reduced by phenylsilanol, giving the amine and recycling the TPP. It is 
quite possible that this P=N bond reduction could occur at 60 °C, as at least in certain cases (vide 
infra), the P=N bond is much more rapidly reduced than the P=O bond. With our investigation 
complete, we propose the mechanism shown in Scheme 1.10, a catalytic-in-phosphine Staudinger 
reduction combined with phenylsilane-mediated amide coupling, as what is actually occurring 
under Ashfeld’s conditions. 
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Scheme 1.10. Our Proposed Mechanism for Ashfeld’s “Traceless Staudinger Ligation”. 
1.8.2 Lemaire’s Reduction using Ti(OiPr)4/TMDSO 
The final set of reports that we wanted to investigate were those of Lemaire and coworkers, 
who published multiple papers on Ti(OiPr)4 catalyzed reduction of phosphine oxides with 
TMDSO.102103104 As mentioned previously, they performed 29Si NMR studies and electron 
paramagnetic resonance (EPR) spectroscopy to obtain information about the nature of the 
intermediates and products of the reduction.105 Based on this information, they proposed the 
mechanism shown in Scheme 1.2, which, if true, would be quite interesting as it is quite different 
from any other known silane-mediated reduction of phosphine oxides. 
The proposed phosphine radical was of particular interest to us, as it would represent a non-
hydride based mechanism of reduction. To begin our investigation, we designed the phosphine 
oxide TMCypPO (Scheme 1.11), which would be able to facilitate a so-called “radical clock” 
experiment where a cyclopropyl ring is adjacent to the location of the proposed radical center. 
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Scheme 1.11. Synthesis of TMCypPO. 
TMCypPO was synthesized in poor yield through the addition of cyclopropyl magnesium 
bromide to 2,2,3-trimethyl-1-chlorophosphetane oxide.  Since cyclopropyl represents the fastest 
known “radical clock”, if a phosphorous-centered radical is generated during reduction of 
TMCypPO under Lemaire’s conditions, we should observe the presence of 1-n-propyl-2,2,3-
trimethylphosphetane following completion of the reaction. This occurs through generation of a 
phosphonium ylide, which is known106 to react with water to form the corresponding phosphine 
oxide, 1-n-propyl-2,2,3-trimethylphosphetane oxide in our specific case. As an excess of silane 
reductant is used, the n-propyl phosphine oxide will also be reduced (Scheme 1.12) 
 
Scheme 1.12. Formation of 1-n-Propyl-2,2,3-trimethylphosphetane through Phosphine-
Centered Radical Formation 
In our actual test, we submitted TMCypPO to the conditions reported by Lemaire and 
coworkers, and compared the results to a reduction of TMCypPO with DPDS at room 
temperature. Initially we wanted to use 1H NMR to watch for formation of peaks with shifts that 
would correspond to an n-propyl group, but those experiments were inconclusive. Instead, we 
used LC-MS analysis, watching for the formation of both reduced TMCypPO [M] and [M+2], 
which would be the reduced n-propyl compound. With both DPDS and Lemaire’s conditions, a 
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[M+2] peak was observed (Section 1.15), but its intensity was approximately 0.01% of the [M] 
peak, which is the expected amount of [M+2] that would be observed from just the presence of 
[M] with natural isotopic abundance. This indicates that a phosphorous-centered radical is not an 
intermediate that occurs under Lemaire’s conditions. 
Therefore, a new mechanism had to be proposed that could account for the lack of a 
phosphine radical as well as all of the NMR and EPR studies.107 A report by Samuel and 
coworkers describes the disproportionation of TMDSO by bis-cyclopentadienyl titanium (III) 
complexes, including characterization of additional reaction products by X-ray crystallography, 
NMR, IR, and GC studies.108 This work is slightly different from the Lemaire reports, as no 
phosphine oxide is added to the reaction mixture, but it both adds to and confirms the proposed 
intermediates from Lemaire, including the formation of a titanium (III) hydride species. In 
particular, the key result from Samuel and coworkers that drives our proposed mechanism 
(Scheme 1.13) is the combination of a titanium hydride and a silyl-titanium species to form a 
bimetallic intermediate which dissociates to form a hydridosilyloxy-titanium (III) compound and 
a dimethylsilyl-titanium (III) species. The hydridosilyloxy-titanium species, in the presence of 
phosphine oxide, is perfectly positioned to undergo reduction via the 6-membered transition state 
with the Ti(III) acting like a gigantic proton (Scheme 1.13). 
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Scheme 1.13. Our Proposed Mechanism for Ti(OiPr)4/TMDSO Catalyzed Reductions of 
Phosphine Oxides. Structures in red have been observed by NMR, EPR, and/or have 
been isolated 
The rest of our mechanism accounts for each of the intermediates identified by both Samuel 
and Lemaire.109110 Samuel and co-workers collected the gas released from these 
disproportionation reactions and found it was dimethylsilane. They proposed it is formed from the 
reaction of dimethylsilyltitanium (III) with TMDSO, which we have included in the bottom half 
of Scheme 1.13. The 29Si NMR studies conducted by Lemaire and co-workers revealed multiple 
species that cannot be accounted for by Samuel’s mechanism, which we attribute to Lemaire 
using the system to reduce phosphine oxides. The EPR-observed Si-Si bond can be explained by 
the fact that Ti(iOPr)4 is the reagent used by Lemaire, but Ti(III) is observed and is proposed to 
perform the reaction, so a small amount of TMDSO must be acting as a suicide reagent to reduce 
the Ti(IV). Lemaire and coworkers only observe a small amount of the silylsilane by NMR, 
which makes sense with our mechanism as the titanium is catalytic with respect to the amount of 
TMDSO and the reaction propagation cycle does not require another Ti(IV) to Ti(III) 
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transformation. The only area that our proposed mechanism is incongruent with the results 
reported by Lemaire and coworkers is that they specifically note not observing a titanium(III) 
hydride species by EPR. However, these EPR studies were conducted at titanium concentrations 
that are 32-fold less than the catalytically-relevant system, and Samuel indicates that the proposed 
titanium hydride may be short-lived or exist as a dinuclear titanium complex with high valency. 
This high valency complex is actually supported by the data from Lemaire’s EPR studies. 
Therefore, our new mechanism for the Ti(iOPr)4-catalyzed reduction of phosphine oxides by 
TMDSO takes into account observations of titanium-catalyzed disproportionation of TMDSO, 
the 29Si NMR studies, the EPR studies, and the lack of a phosphorous-centered radical. This 
mechanism does suggest that two equivalents of silylhydride are required to reduce a single 
equivalent of phosphine oxide, and that some TMDSO is require for suicide activation, which 
confers nicely with Lemaire’s usage of no less than 1.25 equivalents of TMDSO. Finally, the 
new mechanism utilizes the Ti(III) as if it were essentially a giant proton for reduction through 
the 6-membered transition state. 
1.9 Disiloxane Synthesis and Testing 
1.9.1 DMDPDS Synthesis and Testing 
We now desired to return to the original goal of improving phosphorous recycling and 
phosphine synthesis. Currently, only three disiloxanes had been tested for their reductive 
potential: DPDS, TPDS, and TMDSO, each with drastically different reactivities. Since 
disiloxanes only require equilibration with water to form a silanol, we wanted to pursue the 
synthesis of additional disiloxane materials. With our previous method of purchasing a 
commercially available chlorohydridosilane, dissolving it in diethyl ether, and pouring this over 
ice, we were able to make one more disiloxane for testing: 1,3-dimethyl-1,3-diphenyldisiloxane 
(DMDPDS) (Scheme 1.14). We then tested its effectiveness in reducing TMPPO. It was found 
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to be much slower than even TPDS, much less DPDS; however, we got a very interesting result 
when testing its reductive potential in THF versus toluene (Figure 1.28). 
 
Scheme 1.14. Synthesis of DMDPDS and its Equilibrium with Methylphenylsilanol 
 
Figure 1.28. Reaction Progress Curves for the Reduction of TMPPO with DMDPDS at 
80 °C. [TMPPO] = 0.04 M, [DMDPDS] = 0.3 M 
 
DMDPDS reduces TMPPO much faster in THF than it does in toluene. In fact, fitting the 
data in Figure 1.28 to single-exponential curves reveals that the rate of reduction is almost exactly 
20-fold higher in THF than it is in toluene. With most conditions we have observed a minimal 
difference in reduction rate between solvents, provided solubility of all of the reagents is not in 
question. However, observing the difference in reduction rate between TPDS and TMDSO, and 
knowing that TMDSO is a particularly stable disiloxane,111 we propose that phenyl substituents 
on a disiloxane greatly assist in driving the disiloxane-silanol equilibrium towards the silanol 
when compared to methyl groups. A reasonable explanation for this would be the fact that a 
phenyl group could help stabilize (through resonance) a negatively-charged pentavalent silicon 
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species that could be an intermediate in the reaction of a disiloxane with water. It could also be 
due to methyl being less electron withdrawing than phenyl, making DPDS have less electron 
density on the silicon than TMDSO, opening it up for more nucleophilic attack. With this theory, 
we attribute this massive difference in the reactivity of DMDPDS in THF and toluene to the two 
solvents’ differential affinity for water, as there is likely much more water in THF than there is in 
toluene.  
Now, we have not commonly observed large differences in the rate of reduction when 
switching solvents, which does call into question the suppositions above. However, I believe that 
the lack of differences in rate between solvents despite substantially differing in the amount of 
water available to form silanols can be rationalized quite well. In the case of THF vs toluene, 
THF has a lot more water, and thus with it as the solvent, more silanol should be present in a 
DPDS-facilitated reduction of a precatalyst. However, THF is a hydrogen-bond acceptor, and the 
additional water is both a hydrogen-bond acceptor and donor. Reductions in THF could thus be 
predicted to undergo TS-2 substantially less, as forming the hydrogen-bond between the silanol 
and the phosphine oxide will be more intermittent, and when this bond does form, it will be 
weaker. We propose that this difference in reactivity balances out the greater amount of silanol 
that is present in THF in most cases. There may be incidents where this balance does not even 
out, and since there are relatively few other explanations that rationalize the difference in Figure 
1.28, it appears likely that DMDPDS is one of them. 
1.9.2 Ball-Milling Synthesis of Disiloxanes 
Now that we had established that hydrido-disiloxanes bypass the pre-activation step 
necessary when using hydrido-silanes to reduce phosphine oxides, we sought to synthesize such 
disiloxanes via a more cost-effective method in order to obtain significant amounts of these 
compounds for use in chemical reactions. Synthesis of disiloxanes from the corresponding 
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chloro-silanes requires a very simple procedure that is high yielding. However, synthesizing 
chlorohydridosilanes has been shown to be challenging. The best general scheme known for 
generation of such silanes appeared to be a copper-based synthesis that utilized “ceramic spheres” 
to break apart the reaction. As the methods for synthesis of symmetrical disiloxanes from 
chlorohydridosilanes appeared to be rather robust, we designed a simple, 1-pot procedure to 
obtain these disiloxanes from the corresponding silane (Scheme 1.15). 
 
Scheme 1.15. One-pot Procedure to Synthesize Symmetrical Disiloxanes from the 
Corresponding Silane. DPDS and phenylsilane are shown as representative examples in 
the scheme 
The synthesis of DPDS begins with the complexation of CuCl2 and catalytic CuI in diethyl 
ether for 30 min in the presence of either chrome or ceramic spheres. Phenylsilane is then added 
and the reaction is ball-milled at 350 rpm at ambient temperature under air with an overhead 
stirrer for 1.5 h until 100% conversion has been noted by 1H NMR to afford the intermediate 
chlorophenylsilane. The reaction mixture is filtered directly onto ice chips and extracted with 
diethyl ether to afford DPDS in 93% percent yield and approximately 95% purity, which is 
sufficient for most applications.  Distillation under high-vacuum can be performed to provide 
DPDS in >99% purity and 88% overall yield in cases where higher purity is required (Table 1.6, 
Entry 1). The reaction is scalable and does not require increased reaction times to obtain purified 
product. For example, DPDS is obtained in an 88% yield on a 10 gram scale in less than three 
hours.  
We were particularly interested in synthesizing large amounts of DPDS via a reasonably cost-
efficient method, but wanted the scope of this reaction to be quite general so that novel 
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disiloxanes could be created. We found that the reaction conditions could easily be extended to 
secondary arylsilanes as well as alkylsilanes, as diphenylsilane and n-hexylsilane were readily 
converted to TPDS and 1,3-di-n-hexyl-disiloxane (DHDS) in 90% and 85% yield, respectively 
(Table 1.6, Entries 2-3). 
Table 1.6. Synthesis of DPDS, TPDS, and DHDS via the One-Pot Copper-Based 
Procedure 
 
Entry Product Yield (%) 
1 
 
88 
2 
 
90 
3 
 
85 
 
1.9.3 DHDS Synthesis and Testing 
With a medium-scale (10 g), single-step synthesis of disiloxanes from silanes ironed out, we 
decided to test DHDS, the last unique disiloxanes that could both be synthesized from a 
commercially available silane and would likely have reductive activity against phosphine oxides. 
DHDS was evaluated for its reductive capacity against 1PPO at elevated temperature. DHDS 
showed moderate activity against 1PPO at 80 °C, certainly enough to facilitate a catalytic-in-
phosphine reaction at that temperature. However, the rate was still far too slow for DHDS to be 
used as a reasonable alternative to DPDS. We therefore set DHDS aside and concluded the 
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synthesis of new disiloxanes, choosing to move forward into reactions with our most promising 
reducing agent, DPDS. 
 
Figure 1.29. Reaction Progress Curve of the Reduction of 1PPO by DHDS at 80 °C in 
THF. [1PPO] = 0.04 M, [DHDS] = 0.3 M 
1.9.4 Evaluation of DPDS 
With a convenient, large-scale synthesis of DPDS secure, we wanted to test it for its stability 
and functional group compatibility before taking it into reactions. DPDS exhibited exquisite 
benchtop stability with virtually no degradation occurring after 2 weeks, and less than 2% 
degradation over a 6 month period. Satisfied, we tested it for its functional group compatibility. 
At room temperature, DPDS displayed no reactivity with alcohols, aldehydes, carboxylic acids, 
cyano groups, and nitro groups for up to 16 hours. At 80 °C, DPDS still displayed no reactivity 
with aldehydes, cyano groups, and nitro groups, but displayed minimal reactivity with carboxylic 
acids (Figure 1.30) and substantial reactivity with alcohols (Figure 1.31 & Table 1.7). Alcohol 
reactivity at elevated temperature was expected given the projected ease of substituent 
replacement on the silicon between a silanol and an alcohol. Following isolation of the products 
through column chromatography, we recovered the alcohol in 97% yield with a basic workup, 
suggesting that DPDS forms an extremely weak silyl “protecting group” that is unstable. This 
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reactivity could be problematic if DPDS is used at high temperature in a reaction that necessitates 
an alcohol taking place in the reaction, but otherwise appears quite benign since the silyl group 
cleaves during a workup. We noted that the reactivity of DPDS with alcohols at elevated 
temperature is increased when a benzoic acid is included in the reaction mixture (Table 1.7, 
entries 7 & 8), which makes sense as acids are known to facilitate ligand exchange at silicon. The 
reactivity of DPDS with carboxylic acids at 80 °C was minimal for up to 17.5 hours, though it did 
become substantial after multiple days (Figure 1.30). We were very satisfied with this overall 
functional group compatibility profile, and decided to move on to using DPDS in reactions. 
 
Figure 1.30. Evaluation of the Reactivity of DPDS with 3-(Trifluoromethyl)-Benzoic Acid 
at 80 °C. Reactivity is not noted at 1.5 h (top) and appears minimal at 17.5 h (middle), 
but grows to be substantial by 40.5 h (bottom) 
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Table 1.7. The reaction of 4-(trifluoromethyl)benzyl alcohol and DPDS with or without 
benzoic acid additives. 
 
Entry Benzoic Acid T (°C) Time (Min) % Alcohol Remaining 
1 None 23 1080 >95 
2 None 23 2520 >95 
3 p-Nitrobenzoic acid 23 1080 >95 
4 p-Nitrobenzoic acid 23 2520 >95 
5 None 80 1050 57 
6 None 80 2430 16 
7 3-(Trifluoromethyl)-benzoic acid 80 1050 25 
8 3-(Trifluoromethyl)-benzoic acid 80 2430 0 
 
 
Figure 1.31. Evaluation of the Reactivity of DPDS with 4-(Trifluoromethyl)-Benzyl 
Alcohol at 23 and 80 °C. (A) The reaction at 23 °C for 0 h (top) and 42 h (bottom). (B) 
The reaction at 23 °C with p-nitrobenzoic acid for 0 h (top) and 42 h (bottom). (C) The 
reaction at 80 °C for 1.5 h (top), 17.5 h (middle), and 40.5 h (bottom). (D) The reaction 
with 3-(trifluoromethyl)-benzoic acid at 80 °C for 1.5 h (top), 17.5 h (middle), and 40.5 h 
(bottom). Large black numbers indicate the integrations of the peaks 
0.15 
1.28 
3.00 
1.72 
0.16 2.51 
2.97 0.29 
0.73 2.69 
3.38 
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1.10 DPDS in Catalytic-in-Phosphine Reactions 
1.10.1 A Room Temperature Catalytic-in-Phosphine Mitsunobu 
We chose to first explore the usage of DPDS in room temperature variants of catalytic-in-
phosphine reactions. Naturally, we first turned towards the Mitsunobu reaction, as improving it 
was the original focus of this work. We thus set up a catalytic Mitsunobu reaction using 
extremely similar conditions as the work published by Buonomo and Aldrich,112 with the only 
differences being a switch to room temperature and replacement of phenylsilane with DPDS 
(Scheme 1.16). Unfortunately, this did not furnish even trace amounts of the desired product. This 
was quite surprising, but additional attempts produced the same results. In every reaction, the 
alcohol and carboxylic acid were still present, the precatalyst was reduced, and no DIAD 
remained. 
 
Scheme 1.16. Attempt at Developing an Ambient Catalytic-in-Phosphine Mitsunobu 
Reaction 
As all of the DIAD disappeared by the end of the reaction, we investigated potential 
reactivities between DPDS and DIAD. To our surprise, DPDS did not react with DIAD when 
they were incubated together, even with the addition of heat, alcohol, and/or benzoic acid. 
However, we were able to ascertain what was going on through a clever experiment where we 
added benzoic acid, DIAD, and DPDS to a solution of THF and heated this for 2.5 h, monitoring 
with 1H NMR. We then opened the tube and added TMPPO, which should quickly get reduced to 
the phosphine form, and again monitored this for 20 hours, this time at room temperature. As can 
be seen in Figure 1.32, both the methine and methyl protons on DIAD undergo a substantial 
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upfield shift during this time, indicating reduction of DIAD to form the hydrazine. The initial 
heating was performed to demonstrate that DIAD was present before the addition of TMPPO, 
that addition of the precatalyst initializes reduction to the hydrazine. 
 
Figure 1.32. Evaluation of the Reactivity of DPDS with DIAD with Phosphine Present. 
Top: 1H NMR spectra of a reaction mixture containing DIAD, TMPPO, DPDS, and 3-
(trifluoromethyl)-benzoic acid 17 minutes after the addition of TMPPO. Bottom: 1H NMR 
spectra of the same reaction mixture 20 hours post-addition. Note the upfield shift of 
both the methine (A) and methyl (B) protons. 
This experiment expertly demonstrates that phosphine is key to the observed hydrazine 
formation. Phosphines are known to react with DIAD to form the Huisgen intermediate, as shown 
in Scheme 1.17, which we propose is the species that gets reduced by DPDS. The Huisgen 
intermediate has several similarities to a phosphine oxide or phosphine imine, including a 
tetravalent structure at the phosphorous center with an electron-deficient phosphorous atom. 
These similarities lend credence to the idea that this intermediate is the species that is reduced by 
DPDS. Potentially due to the formal positive charge present on the phosphorous, the Huisgen 
intermediate must be particularly rapidly reduced by DPDS, since zero product formation is 
observed under the conditions in Scheme 1.16 (Earlier scheme). This issue persisted regardless of 
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the choice of precatalyst, so we decided to move on to the development of other room 
temperature catalytic-in-phosphine reactions with DPDS. 
 
Scheme 1.17. Reduction of the Huisgen Intermediate by DPDS Prevents Development 
of a Room Temperature Catalytic Mitsunobu Reaction. 
1.10.2 Room Temperature Catalytic-in-Phosphine Wittig Reactions with DPDS 
In contrast to the catalytic Mitsunobu, we were successful in developing catalytic Wittig 
reactions, catalytic Appel reactions, and catalytic Staudinger reductions with DPDS that proceed 
under ambient conditions. Each of these reactions are run without any special considerations, 
such as the exclusion of air or water, and are thus truly “dump and stir” reactions. In every 
methodology, we ran multiple substrates to demonstrate the potential for ambient, additive-free 
phosphine recycling and to show the efficacy of DPDS in each one. However, we should note 
that we did not fully optimize these methodologies. This is why there is a limited number of 
substrates, and many of the yields could probably be improved by attempting a greater range of 
conditions. 
For the catalytic Wittig, we determined the optimal number of equivalents of DPDS by 
testing the reaction of benzaldehyde with ethyl bromoacetate using DIPEA as the base and 10 
mol% of 1PPO for the precatalyst (Table 1.8). We found that using 1.0 equivalents of DPDS 
provided a 77% yield (99% based on recovered starting material (BRSM)) of the product with an 
excellent E:Z ratio. Using these conditions, we tested the efficacy of several other substrates, 
changing both the aldehyde and the ylide precursor, and found that the reactions proceeded with 
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yields in the 75% range for disubstituted alkenes (Table 1.9). With the trisubstituted alkene, our 
yield decreased to 54%, which is commensurate with a decreased yield observed by O’Brien and 
coworkers.113 As little to no optimization was performed on the trisubstituted alkene, it is likely 
that the formation of such alkenes could be improved with additional time and effort. 
Table 1.8. The Dependence of Yield on Equivalents of DPDS in Room Temperature 
Catalytic Wittig Reactions 
 
Table 1.9. Catalytic Wittig Reactions Employing DPDS at Room Temperature 
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1.10.3 Room Temperature Catalytic-in-Phosphine Staudinger Reductions with 
DPDS 
The next reaction that we explored was the Staudinger reduction, seeking to develop the first 
catalytic-in-phosphine method under ambient conditions. DPDS-mediated catalytic Staudinger 
reductions proceeded smoothly, using 10 mol% 1PPO and 1.0 equivalents of the silane to reduce 
multiple benzyl azides and an aliphatic azide to the corresponding amine in high yields over 18 
hours at 23 °C (Table 1.10). It is again notable that the reducible nitro group remains completely 
untouched by this method. The stability of the primary alkyl chloride (entry 4) is also impressive. 
Table 1.10. Catalytic Staudinger Reactions Employing DPDS at Room Temperature 
 
1.10.4 Room Temperature Catalytic-in-Phosphine Appel Reactions with DPDS 
Finally, we performed catalytic Appel reactions using the bromonium donor originally 
identified by van Delft and coworkers.114 Initially we used 10 mol% of the precatalyst 1PPO, but 
van Delft and coworkers specifically noted that at high temperature 1PPO is too nucleophilic and 
reacts with the bromine containing products.115 Phosphetanes are known to have very low 
nucleophilicity,116 so we decided to test the precatalyst TMPPO in place of 1PPO. This switch 
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improved each of the yields by up to 15%, presumably due to better stability of the products when 
in the presence of the phosphine. Overall, our yields are increased compared to the original 
version at 80 °C developed by van Delft and coworkers.117 We were unable to overcome the key 
limitation of their original methodology, the lack of product formation when the substrate is a 
secondary alcohol, meaning our methodology is improved compared to theirs, but would benefit 
from additional development. 
Table 1.11. Catalytic Appel Reactions Employing DPDS at Room Temperature 
 
The development of these three ambient catalytic-in-phosphine reactions demonstrates the 
wide utility and chemoselectivity of DPDS in facilitating in situ phosphine recycling. We believe 
that DPDS will become the reagent of choice for phosphine recycling, due to its impressive 
bench-top stability, excellent chemoselectivity, remarkable potency, and broad applicability 
across reaction classes. Using it is also both simple, as it requires no additional additives, and 
cheap, as per our previously described large-scale synthesis. 
1.11 Isolated Phosphine Oxide Reductions with DPDS 
1.11.1 DPDS is a Superior Reducing Agent for TPPO 
Having explored the phosphine recycling applications for DPDS, we next wanted to 
investigate its applicability in the broader area of general phosphine oxide reduction. New 
  101 
phosphine ligands are continually being designed to tune the electronic and steric properties of 
transition metal complexes, facilitating access to novel transformations and the improvement of 
existing methods. As mentioned previously, the final step in the synthesis of many phosphine 
ligands is reduction of the corresponding phosphine oxide,118 and the broad range of functional 
groups present in these ligands119 necessitate agents and conditions that chemoselectively react 
with the P=O bond. 
Currently, the state-of-the-art reduction conditions are overnight reactions utilizing a silane at 
temperatures upwards of 100 °C in combination with a catalytic additive. Lemaire and co-
workers described the use of Ti(OiPr)4 and 1.25 equiv of TMDSO,120 while Beller and co-
workers disclosed that 15 mol% bis-(p-nitrophenyl)-phosphoric acid (BNPA) promotes reduction 
with diethoxymethylsilane (4 equiv).121 Lemaire’s method is more atom economical but lacks 
broad functional group tolerance, while the conditions reported by Beller have improved 
chemoselectivity but require a full 4 equiv of silane to be heated with the phosphine oxide for 48 
h and can still require protecting groups for certain chemical moieties. Laboratory-scale syntheses 
of phosphines would be greatly enhanced with a rapid, chemoselective, and low-temperature 
method for reduction of phosphine oxides, eliminating protecting group usage and broadening the 
applicability of this process, while industrial-scale syntheses would benefit from a more atom-
economical and additive-free method to reduce waste generation and improve the ease of 
purification. 
In our initial foray with TPPO, we used 12.5 equivalents of silane in order to obtain pseudo-
first order conditions with respect to the phosphine (Figure 1.17). This is far too many equivalents 
to by synthetically useful, so we started anew in attempting to develop an additive-free system in 
toluene using TPPO as our model substrate. To make our system as simple to implement as 
possible, we performed all reactions without the exculsion of air or water. Heating to 110 °C for 
24 h sans additives, a substoichiometric amount of DPDS (0.75 equiv) provided an 80% yield of 
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triphenylphosphine (Table 1.12, Entry 1), which highlights the impressive activity of this new 
reagent. However, to complete reduction within 24 h, a slight excess of DPDS was required 
(Table 1.12, Entry 2). An investigation of “green” solvents indicated that toluene (PhMe) and 
tert-butyl acetate (TBAc) were optimal for this reduction. Switching the solvent to TBAc for 
better solubility, we consistently obtained a 99% yield of triphenylphosphine using 1.25 
equivalents of DPDS in 24 h (Table 1, Entry 5). 
Table 1.12. The Optimization of Additive-Free Phosphine Oxide Reductions with DPDS. 
Yields are the average from two reactions at 0.5 mmol scale after 24 h. 
 
Entry X Equiv. Solvent Yield (%) 
1 0.75 PhMe 80 
2 1.5 PhMe 99 
3 1.0 TBAc 90 
4 1.1 TBAc 97 
5 1.25 TBAc 99 
 
A real-time comparison of our optimized reaction to those reported by Beller and Lemaire 
revealed that our system, under “dump-and-stir” conditions as described above, is the fastest of 
the three (Figure 1). Notably, Lemaire’s conditions struggled without the exclusion of air and 
water, while Beller’s method undergoes a reaction trajectory that matches a single-exponential 
due the fact that a large excess of silane (4 equiv) was employed. Despite utilizing no additives 
and only a stoichiometric amount of silane, our system completes reduction in approximately half 
of the time of the current state-of-the-art conditions. 
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Figure 1.33. Comparison of the Reduction Rates of Our System, Lemaire’s, and 
Beller’s. All reductions were run under “dump and stir” conditions without the exclusion 
of air or water. 
1.11.2 The Energy of Activation of Phosphine Oxide Reduction with DPDS 
We next investigated the energies of activation with Arrhenius analysis, specifically to 
compare the activation energies we observe between acyclic and cyclic precatalysts, as well as to 
compare it with the relevant predicted transition state energies. The reduction of TPPO by DPDS 
was found to have an activation barrier of only 18.0 ± 1.1 kcal/mol (Figure 1.34). While ring 
strain is well-known to enhance the rate in which the P=O bond is reduced, only a modest 
decrease in the activation barrier is observed with TMBPO (ΔG++ = 14.2 ± 0.9 kcal/mol, Figure 
1.35). Notably, these observed energies of activation are significantly lower than those calculated 
by Krenske (27.2 kcal/mol) for the 4-membered transition state resulting from a [2+2] reaction 
between hydridosilanes and phosphine oxides (TS-1). We credit this significant difference to the 
lower energy of the six-membered transition state (TS-2) achieved by the combination of 
hydrogen-bond donating silanols and phosphine oxides. These data are further evidence towards 
the assertion that hydridosilanes are incompetent reductants at temperatures below 120 °C. 
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Figure 1.34. Arrhenius Analysis of the Reduction of TPPO by DPDS. Each data point is 
from obtained from reaction progress curves run in triplicate. 
 
Figure 1.35. Arrhenius Analysis of the Reduction of TMBPO by DPDS. Each data point 
is from obtained from reaction progress curves run in triplicate. 
1.11.3 The Substrate Scope of Additive-Free Reduction with DPDS 
Returning to our optimized “dump and stir” conditions for the reduction of TPPO to 
triphenylphosphine, we examined the scope of DPDS reduction with a diverse panel of acyclic 
phosphine oxides (Table 1.13). Both electron-rich and electron-deficient tertiary phosphine 
oxides were cleanly reduced producing high yields of the corresponding phosphines with yields 
ranging from 80–99%. Somewhat surprisingly, trialkylphosphine oxides reduced more slowly 
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than phosphines bearing an aryl substituent. The reaction also worked well on 10 mmol scale, as 
the reduction of TPPO again occurred in quantitative yield. Bidentate phosphine oxides were also 
successfully reduced (Table 2, entries 5–9) with high fidelity in yields ranging from 75–94%. 
Reduction of chiral phosphine oxide to the corresponding phosphine occurred with retention of 
configuration, consistent with our proposed mechanism. Lastly, the secondary phosphine oxide 
diphenylphosphine oxide was by far the most rapidly reduced, with quantitative conversion in 10 
minutes. 
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Table 1.13. The Substrate Scope of Additive-Free Reductions of Phosphine Oxides by 
DPDS. Yields are the isolated average from two reactions at 0.5 mmol scale.  
 
Entry Phosphine Yield (%) 
1 
 
99 
2 
 
80 
3 
 
93 
4 
 
87 
5 
 
88 
6 
 
94 
7 
 
79 
8 
 
75 
9 
 
>99 
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1.11.4 Room Temperature Reduction of Acyclic Phosphine Oxides with DPDS in 
Combination with BNPA 
Even though our reduction of phosphine oxides with DPDS represents the mildest conditions 
for this functional group transformation, we were interested in slashing promiscuous reactivity 
even further. We were encouraged to pursue reduction at ambient temperatures by the results of 
our Arrhenius analyses, as only a modest decrease in activation energy would be needed. To this 
effect, we investigated the combination of DPDS with Beller’s phosphoric acid additive (BNPA), 
in an attempt to reduce the heat needed for these reductions. We noted that BNPA facilitated 
reduction with alkoxysilanes and hoped that this additive would bolster reactivity with our 
disiloxane. Our previous results also indicated compatibility between unprotected alcohols and 
DPDS, with or without an additive, as long as the temperature was maintained around ambient 
temperature (Table 1.7, Figure 1.32). We were delighted to find that addition of a combination of 
BNPA and DPDS to a solution of TPPO in EtOAc (used for solubility of BNPA) furnished the 
phosphine product in quantitative yield after 48 hours. Applying similar conditions (2.5 equiv 
DPDS per P=O bond, 20 mol% BNPA per P=O) to a range of acyclic phosphorous(V) oxides 
consistently afforded the product phosphines in both high yield and high specificity (Table 1.14). 
In parallel to our additive-free reductions, reducing electron-rich phosphine oxides with multiple 
alkyl substituents was slower, requiring a 70 hour reaction time. While these phosphine oxides 
were reduced rather slowly, the corresponding phosphines were produced in exquisite purity, 
oftentimes requiring simple filtration through a silica-gel plug. Similar to our methodology 
employing solely DPDS, a wide range of functional groups were tolerated, as mono- and bis-
phosphine oxides were reduced efficiently, with high selectivity. 
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Table 1.14. The Substrate Scope of Room Temperature Reductions of Phosphine 
Oxides by DPDS and BNPA. Yields are the isolated average from two reactions at 0.5 
mmol scale.  
 
Entry Phosphine Yield (%) 
1 
 
99 
2 
 
84 
3 
 
92 
4 
 
82 
5 
 
96 
6 
 
89 
7 
 
83 
8 
 
>99 
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1.12 Conclusion 
Our initial interest in developing a room-temperature catalytic-in-phosphine reaction led us to 
design phosphetane precatalysts which were hypothesized to lower the energy barrier to silane-
mediated reduction through increased ring strain and/or electron density on the oxygen of the 
P=O. These catalysts only provided a mild increase of the rate of reduction and displayed 
substantial stability concerns, but we observed that a conventional understanding of the reduction 
process could not account for a post-initiation rate increase. However, our data was of insufficient 
quality to definitively prove mechanistic theories, so we switched to VT-NMR and wrote a 
program that auto-integrated our NMR spectra. This new method of data collection facilitated a 
comprehensive kinetic and mechanistic investigation into silane-mediated phosphine oxide 
reduction. This led to several breakthroughs, with the most important likely the discovery that 
silane reduction of phosphine oxides at temperatures lower than 120 °C does not proceed through 
TS-1, but rather through the 6-membered transition state TS-2. Therefore, only hydrido-silanols, 
hydrido-disilazanes, or metallic hydrido-silyl-oxy species can reduce phosphine oxides at such 
temperatures, a theory that explains numerous reported reactivity trends among silane species. 
We also thoroughly characterized the reductive process with phenylsilane, demonstrating that 
it requires a Lewis-basic catalyst to activate it to form phenylsilanol. In typical reduction systems 
with phenylsilane, the phosphine oxide serves as this catalyst. Synthesis of DPDS, which 
equilibrates with phenylsilanol in solution, allowed reduction to bypass that unproductive pre-
activation step, and furnished by far the most potent silane reductant to date. DPDS was 
evaluated for its functional group tolerance, which was found to be exceptional, with the only 
blemish being a transient protection of alcohols when heated to 80 °C. Ironically, we could not 
accomplish our original goal of developing a room temperature catalytic Mitsunobu due to rapid 
reduction of the Huisgen intermediate by DPDS even under ambient conditions. However, DPDS 
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did facilitate the first additive-free ambient catalytic-in-phosphine Wittig reaction, and the first 
overall ambient catalytic-in-phosphine Appel and Staudinger reactions. 
Next, we assessed the reductive potential of DPDS against acyclic phosphines for use in 
phosphine synthesis. Alone, it facilitated the fastest reduction of TPPO at 110 °C to date with 
only 1.25 equivalents of the reducing agent, far below the state-of-the-art conditions requiring 4 
equivalents of diethoxymethylsilane and 15 mol% BNPA. Additionally, these reactions were 
extremely simple to set up, requiring the exclusion of neither air nor water. Mono- and bis-
phosphines, both electron-deficient and electron-rich, were furnished from the corresponding 
oxides in 75-99% yield. We also developed a room temperature variant of this process where we 
used BNPA in combination with DPDS to reduce multiple acyclic phosphines in 82-99% yield. 
The potency of DPDS can thus either be used to render reduction additive-free or heat-free. 
We anticipate that DPDS will become the reagent of choice for both in situ phosphine 
recycling and phosphine synthesis due to its excellent chemoselectivity and impressive potency. 
The development of multiple methods for the chemoselective room-temperature reduction of 
phosphine oxides should also enable the synthesis of functionally diverse phosphines from their 
corresponding oxides. Finally, and perhaps most importantly, we have dispelled many incorrect 
assumptions about the overall process. Scientists that attempt to improve the phosphine oxide 
reduction process now understand the requirements for reduction, an extremely key step to future 
development by either our group or any of the others that are working towards the same goals 
1.13 Materials and Methods 
All commercially available reagents were used without further purification. 1PPO and 
TMPPO were synthesized as previously described. All synthesized phosphines were stored at -20 
°C wrapped in foil to exclude light and all synthesized silanes were stored at ambient temperature 
in a desiccator with colored walls to exclude UV light. Molecular sieves were activated by 
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heating at 200 °C under reduced pressure. Tetrahydrofuran (THF), toluene, and dichloromethane 
(DCM) were dispensed from an Inert® solvent dispensing system. Deuterated THF was 
purchased from Sigma-Aldrich in dry 1 gram ampules and used without further drying. 
Deuterated chloroform, DCM, and toluene were purchased from Cambridge Isotopes and used 
without further drying from 10 gram bottles stored in a desiccator. Lithium chloride was stored in 
a desiccator and dried with a Bunsen burner immediately before use. Anhydrous magnesium 
chloride was dried and stored in a dessicator prior to use. Zinc chloride was purified in its molten 
form to remove water and hydrogen chloride from the salt immediately before use. Anhydrous 
sodium sulfate was purchased and used without further purification. Piperidine was distilled over 
calcium hydride under reduced pressure immediately before use. 1H, 13C, 19F, and 31P NMR 
spectra were recorded on a Varian 400 MHz spectrometer, Bruker Avance 500 MHz 
spectrometer, or Varian INOVA 600 MHz spectrometer with broadband probes. High resolution 
mass spectra were collected on a Bruker BioTOF II mass spectrometer using PEG or PPG 
internal standards. Silica gel column chromatography was performed with silica gel (Dynamic 
Absorbents, 60A) or using a Teledyne-Isco RF-200 Combi-Flash system. Kugelrohr distillations 
were performed with a Buchi glass oven B-585 instrument. Enantiomeric ratios (ERs) were 
determined using a Chiralcel OJ column on a Waters 2695 HPLC system with a Waters 2996 
PDA for detection. 
  
rac-1-n-butyl-2,2,3-Trimethylphosphetane-1-oxide (TMBPO). To a flame-dried two-neck round 
bottom flask equipped with a stir bar was added dried magnesium(0) powder (50 mesh, 0.43 g, 18 
mmol), THF (2 mL), and one crystal of iodine. Stirring was initiated and a solution of 
bromobutane (1.6 mL, 15 mmol) in THF (13 mL) was added dropwise. When addition of the 
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bromide was complete, the reaction was refluxed for 2 h. The reaction was then cooled to 0 °C 
and a solution of S1 (1.992 g, 12 mmol) in THF (10 mL) was added dropwise to the stirring 
solution of S2. The reaction was allowed to warm to 23 °C and stirred for 16 h. After 16 h, the 
reaction was quenched by the addition of H2O (25 mL). The layers were separated and the 
aqueous layer was washed with DCM (3  25 mL). The organics were combined and dried 
(MgSO4). The reaction was concentrated in vacuo to a yellow oil and loaded onto silica gel. 
Purification by flash column chromatography on silica gel (40 g SiO2, 0–10% MeOH:DCM 
eluent, linear gradient) afforded the title compound (1.30 g, 57%) as off-white needles: Rf = 0.62 
(5:95 MeOH:DCM) stained with iodine. 1H NMR (500 MHz, CDCl3) δ 2.46-2.40 (m, 1H), 2.10-
2.04 (m, 1H), 1.86-1.82 (m, 1H), 1.73-1.70 (app. m, 2H), 1.68-1.65 (m, 2H), 1.49-1.45 (m, 2H), 
1.26-1.16 (app. dd, 6H), 1.03-1.02 (d, 3H), 0.97-0.94 (t, 3H); 13C NMR (125 MHz) δ 49.0, 37.3, 
30.2, 25.9, 24.2, 23.7, 22.5, 1, 6.1, 14.4, 13.7; 31P {1H} NMR (202 MHz, CDCl3) δ 49.68. HRMS 
for C10H21NaOP [M + Na+] calculated 211.122; found 211.1225. 
Additional purification: Preparatory TLC (5:95 MeOH:DCM) was used to purify small amounts 
of TMBPO for some syntheses of this molecule. In order to visualize this molecule with iodine, 
heat iodine crystals and then drop into the TLC chamber. Top spot (stains yellow with iodine) is 
desired product.  
  
rac-2,2,3-Trimethyl-1-pyrrolidinylphosphetane-1-oxide (TMPyrPO). To a flame-dried round 
bottom flask equipped with a stir bar was added S1 (2.16 g, 13 mmol), toluene (13 mL), 
trimethylamine (2.2 mL, 16 mmol), and pyrrolidine (1.2 mL, 14.6 mmol) sequentially. The 
reaction was sealed, purged with argon, and heated to 60 °C for 24 hours. After 24 hours, the 
reaction was cooled to 23 °C and filtered. The cake was washed with EtOAc (10 mL). The filtrate 
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was combined with the EtOAc wash, which were subsequently washed with 5% aqueous sodium 
bicarbonate (20 mL), dried (MgSO4) and concentrated in vacuo to afford the title compound (1.96 
g, 75%) as an orange oil and mixture of diastreomers: 1H NMR (500 MHz, CDCl3, Mixture of 
diastereomers) δ 3.33-3.23 (m, 4H), 2.65-2.60 (m, 1H), 2.14-2.06 (m, 1H), 1.91-1.88 (m, 4H), 
1.58-1.53 (app. M, 1H), 1.23-1.17 (app. dd, 6H), 1.03-1.02 (d, 3H); 13C NMR (125 MHz) δ 52.9, 
52.3, 46.6,37.8, 37.3, 26.6, 23.2, 17.5, 14.5; 31P {1H} NMR (202 MHz, CDCl3, Mixture of 
diastereomers) δ 48.83, 47.73. HRMS for C10H20NNaOP [M + Na+] calculated 224.1175; found 
224.1199.  
 
rac-1-cyclopropyl-2,2,3-Trimethylphosphetane-1-oxide (TMCypPO). To a flame-dried two-neck 
round bottom flask equipped with a stir bar was added dried magnesium(0) powder (50 mesh, 
0.43 g, 18 mmol), THF (2 mL), and one crystal of iodine. Stirring was initiated and a solution of 
bromocyclopropane (1.3 mL, 15 mmol) in THF (13 mL) was added dropwise. When addition of 
the bromide was complete, the reaction was refluxed for 2 h. The reaction was then cooled to 0 
°C and a solution of S1 (2.0 g, 12 mmol) in THF (10 mL) was added dropwise to the stirring 
solution of S3. The reaction was allowed to warm to room temperature and was stirred for 16 h. 
After 16 h, the reaction was quenched by the addition of deionized water (25 mL). The layers 
were separated and the aqueous layer was washed with DCM (3  25 mL). The organic layers 
were combined and dried with MgSO4, concentrated in vacuo to a yellow oil, and loaded onto 
silica gel. Purification by flash column chromatography on silica gel (40 g SiO2, 0–10% 
MeOH:DCM eluent, linear gradient) afforded the title compound (730 mg, 32%) as a yellow oil 
and mixture of diastereomers: Rf = 0.60 (5:95 MeOH:DCM) stained with iodine. 1H NMR (500 
MHz, CDCl3, Major diastereomer) δ 2.4-2.38 (m, 1H), 2.12-2.04 (m, 1H), 1.96-1.92 (m, 1H), 
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1.21-1.16 (app. dd, 6H), 0.99-0.98 (d, 3H), 0.87-0.74 (m, 4H); 13C NMR (125 MHz, CDCl3, 
Mixture of diasteromers) δ 49.0, 48.6, 46.6, 37.3, 36.9, 30.2, 25.9, 25.5, 24.3, 23.7, 22.6, 16.6, 
16.1, 14.4, 14.2, 13.7, 12.1, 11.7; 31P {1H} NMR (202 MHz, CDCl3, Mixture of Diastereomers) δ 
48.08 (major), 55.97 (minor). HRMS for C9H18OP [M + H+] calculated 173.1090; found 
173.1086. 
 
1,3-Diphenyl-disiloxane (DPDS).  
Initial method from the chlorosilane – To a separatory funnel charged with 10 g of 
partially melted ice was added a solution of chlorophenylsilane (2 g, 14 mmol, 2.14 mL) 
in diethyl ether (8 mL). The reaction was allowed to warm and was swirled by hand 
every ten minutes for an hour. Then, more diethyl ether (15 mL) was added to the 
reaction and the aqueous layer was drained. The ether was washed with water (10 mL) 
and then dried with MgSO4. The reaction was filtered and the solvent was evacuated in-
vacuo. The crude mixture was purified by Kugelrohr distillation to give 1.64 g (82%) of a 
colorless and clear oil. bp = 155 °C at 0.8 mmHg. NMR spectra and other physical data 
matched that of previous reports.122 
 
1,1,3,3-Tetraphenyl-disiloxane (TPDS). To a separatory funnel charged with 10 g of 
partially melted ice was added a solution of chlorodiphenylsilane (2.09 g, 9.6 mmol, 2.0 
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mL) in diethyl ether (8 mL). The reaction was allowed to warm and was swirled by hand 
every ten minutes for an hour. Then, more diethyl ether (15 mL) was added to the 
reaction and the aqueous layer was drained. The ether was washed with water (10 mL) 
and then dried with MgSO4. The reaction was filtered and the solvent was evacuated in-
vacuo. The crude mixture was purified by Kugelrohr distillation to give 1.65 g (90%) of a 
colorless solid (at 23 °C). bp = 290 °C at 0.6 mmHg. NMR spectra and other physical 
data matched that of previous reports.123 
 
1,3-Dimethyl-1,3-diphenyl-disiloxane (DMDPDS). To a separatory funnel charged with 
10 g of partially melted ice was added a solution of chloro(methyl)phenylsilane (2.19 g, 
13.9 mmol, 2.1 mL) in diethyl ether (8 mL). The reaction was allowed to warm and was 
swirled by hand every ten minutes for an hour. Then, more diethyl ether (15 mL) was 
added to the reaction and the aqueous layer was drained. The ether was washed with 
water (10 mL) and then dried with MgSO4. The reaction was filtered and the solvent was 
evacuated in-vacuo. The crude mixture was purified by Kugelrohr distillation to give 1.46 
g (81%) of a colorless and clear oil. bp = 150 °C at 0.8 mmHg. NMR spectra and other 
physical data matched that of previous reports.124 
 
Tetra-n-butyl ammonium-p-nitrobenzoate. To a round bottom flask equipped a stir bar 
was added p-nitrobenzoic acid (500 mg, 3.0 mmol), tetrabutylammonium bromide (1.0 g, 
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3.0 mmol), and THF (10 mL). The reaction was fitted with a reflux condenser and heated 
to 80 °C for 28 h. The reaction was cooled to 23 °C and concentrated in vacuo. The 
residue was taken up in cold toluene (15 mL), filtered, and concentrated in vacuo to 
afford the title compound (1.00 g, 82%) as a yellow solid: NMR spectra and other 
physical data matched that of previous reports.125 
Procedure for Phosphine Screen in the Catalytic Mitsunobu Reaction. 
To a 2-dram vial equipped with a stir bar was added p-nitrobenzoic acid (125 mg, 1.5 
equiv, 0.75 mmol) and 1PPO, TMPPO, TMBPO, or TMPyrPO (0.1 equiv, 0.05 mmol). 
THF (2 mL) was added followed by benzyl alcohol (57 L, 1.00 equiv, 0.50 mmol), 
DIAD (108 L, 1.10 equiv, 0.55 mmol), and then phenylsilane (1.1 equiv, 0.55 mmol). 
Reactions were sealed with a PTFE septum in the screw cap and heated to 80 °C. After 
18 hours, the reaction was cooled and concentrated directly onto silica gel. Benzyl 4-
nitrobenzoate was purified with all spectra matching previously published spectra. 
Procedure for Silane Screen in the Catalytic Mitsunobu Reaction. 
To a 2-dram vial equipped with a stir bar was added p-nitrobenzoic acid (125 mg, 1.5 
equiv, 0.75 mmol) and 1PPO, TMPPO, or TMBPO (0.1 equiv, 0.05 mmol). THF (2 
mL) was added followed by benzyl alcohol (57 L, 1.00 equiv, 0.50 mmol), DIAD (108 
L, 1.10 equiv, 0.55 mmol), and then silane (1.1 equiv, 0.55 mmol). Reactions were 
sealed with a PTFE septum in the screw cap and heated to 80 °C. After 18 hours, the 
reaction was cooled and concentrated directly onto silica gel. Benzyl 4-nitrobenzoate was 
purified with all spectra matching previously published spectra. 
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Procedure for Reduction of Phosphine Precatalysts with Phenylsilane at Room 
Temperature. 
To an NMR tube was added a phosphine oxide precatalyst (0.02 mmol, 0.04 M), d8-
toluene or d8-THF (final volume of 500 L), and phenylsilane (24.6 L, 10 equiv., 0.2 
mmol, 0.4 M). The tube was inverted three times to ensure proper mixing of the reagents 
and the interface between the tube and the cap was sealed with multiple layers of paraffin 
wax (parafilm®) to ensure no leaks. The reaction was heated to 25 C and monitored by 
31P NMR. 
Procedure for the Reduction of TPPO by DPDS for Figure 1.17. 
To an NMR tube was added d8-toluene (440 µL), DPDS (58 mg, 0.25 mmol, 0.5 M), and 
TPPO (5.6 mg, 0.02 mmol, 0.04 M). The tube was inverted three times to ensure proper 
mixing of the reagents and the interface between the tube and the cap was sealed with 
multiple layers of paraffin wax (parafilm®) to ensure no leaks. The reaction was heated 
to 110 °C and monitored with 31P NMR. 
Procedure for the reduction of 1PPO by TMDSA 
To an NMR tube was added 1PPO (3.7 mg, 1.0 equiv., 0.02 mmol, 0.04 M), d2-DCM 
(458 L), and TMDSA (42.0 L, 15.0 equiv., 0.3 mmol, 0.6 M). The tube was inverted 
three times to ensure proper mixing of the reagents and the interface between the tube 
and the cap was sealed with multiple layers of paraffin wax (parafilm®) to ensure no 
leaks. The reaction was heated to 80 °C and monitored with 31P NMR. 
Procedure for the Reduction of 1PPO by TMDSO with Protic Acids. 
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To an NMR tube was added 1PPO (3.7 mg, 1.0 equiv., 0.02 mmol, 0.04 M), d8-THF 
(440 L), TMDSO (53.0 L, 15.0 equiv., 0.3 mmol, 0.6 M), and either TFA (7.6 L, 5.0 
equiv., 0.1 mmol, 0.2 M) or AcOH (6.0 L, 5.0 equiv, 0.1 mmol, 0.2 M). The tube was 
inverted three times to ensure proper mixing of the reagents and the interface between the 
tube and the cap was sealed with multiple layers of paraffin wax (parafilm®) to ensure no 
leaks. The reaction was heated to 80 °C and monitored by 31P NMR. 
Procedure for the Reduction of 1PPO by TMDSO with Lewis Acids. 
To an NMR tube was added 1PPO (3.6 mg, 0.02 mmol, 0.04 M), d8-THF (447 µL), 
TMDSO (53 µL, 0.3 mmol, 0.6 M), and LiCl, MgCl2, or ZnCl2 (0.1 mmol, 0.2 M). The 
tube was inverted three times to ensure proper mixing of the reagents and the interface 
between the tube and the cap was sealed with multiple layers of paraffin wax (parafilm®) 
to ensure no leaks. The reaction was heated to 80 °C and monitored by 31P NMR for 7 h. 
Procedure for the Reduction of 1PPO by PhSiH3 with Lewis Acids. 
To three separate NMR tubes was added 1PPO (0.02 mmol, 0.04 M), d8-THF (475 L), 
and then PhSiH3 (25 L, 0.2 mmol, 0.4 M). To one of the tubes was added LiCl (4 mg, 
0.1 mmol, 0.2 M) and to another was added ZnCl2 (6.8 mg, 0.05 mmol, 0.1 M). All three 
tubes were inverted three times to ensure proper mixing of the reagents and the interface 
between the tubes and their respective caps were sealed with multiple layers of paraffin 
wax (parafilm®) to ensure no leaks. The reactions were heated to 80 C and monitored 
by 31P NMR. 
General Procedure of Catalytic Staudinger Ligations (Ashfeld).  
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To a 2-dram vial equipped with a stir bar was added 4-nitrobenzoic acid (50a mg 0.3 
mmol, 1.0 equiv.), TPP (13 mg, 0.05 mmol, 0.17 equiv.) or TPPO (13.8 mg, 0.05 mmol, 
phenylsilane (36 µL, 0.3 mmol, 1.0 equiv.). The reaction was sealed and stirred at various 
temperatures. After 18 h, the reaction was diluted with acetone (5 mL) and loaded 
directly onto silica gel (200 mg). Purification by flash column chromatography (0–50% 
EtOAc:hexanes eluent, step-wise gradient, 10% EtOAc incremental increase every 6 
column volumes) afforded the product. 
General Procedure of Stoichiometric Staudinger Ligations (Ashfeld). 
To a 2-dram vial equipped with a stir bar was added 4-nitrobenzoic acid (50.1 mg, 0.3 
mmol, 1.0 equiv.), TPP (88mg, 0.33 mmol, 1.1 equiv.) toluene (1 mL), and then benzyl 
azide (45 µL, 0.36 mmol, 1.2 equiv.). The reaction was sealed and stirred at various 
temperatures. After 18 h, the reaction was diluted with acetone (5 mL) and loaded 
directly onto silica gel (200 mg). Purification by flash column chromatography (0–50% 
EtOAc:hexanes eluent, step-wise gradient, 10% EtOAc incremental increase every 6 
column volumes) afforded the product. 
Procedure for Analysis of the Reaction of TMCypPO with DPDS. 
To an NMR tube was added TMCypPO (3.6 mg, 0.02 mmol, 0.04 M), d8-toluene (450 
µL), and DPDS (53 mg, 7.5 equiv., 0.15 mmol, 0.3 M). The tube was inverted three times 
to ensure proper mixing of the reagents and the interface between the tube and the cap 
was sealed with multiple layers of paraffin wax (parafilm®) to ensure no leaks. The 
reaction was heated to 25 °C and monitored by 31P NMR and 1H NMR. After 4 h, the 
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crude reaction mixture was poured from the NMR tube into a 1 dram vial. Aqueous 
hydrogen peroxide (30 %, 200 µL) was then added to the reaction mixture and the 
reaction was shaken on an orbital shaker for 10 minutes at 25 °C in which a color change 
to bright yellow was observed. The crude mixture was then diluted with DCM (3 mL) 
and samples were diluted another 1000-fold with acetonitrile. Samples were analyzed 
with an LC-MS using a C-18 column (Section 7.2.4) and an electrospray ionization 
source in positive mode. The ions corresponding to m/z = 173 and 175 were extracted 
from the total ion source to monitor the presence of the cyclopropyl and n-propyl 
compounds, respectively.  
Procedure for Analysis of the Reaction of TMCypPO with TMDSO and Ti(iOPr)4. 
To an NMR tube was added TMCypPO (3.6 mg, 0.02 mmol, 0.04 M), d8-toluene (481.7 
µL), TMDSO (17.7 µL, 5.0 equiv., 0.10 mmol, 0.2 M), and then Ti(iOPr)4 (0.6 µL, 0.1 
equiv., 0.002 mmol, 0.004 M). The tube was inverted three times to ensure proper mixing 
of the reagents and the interface between the tube and the cap was sealed with multiple 
layers of paraffin wax (parafilm®) to ensure no leaks. The reaction was heated to 80 °C 
and monitored by 31P NMR. After 4 h, the crude reaction mixture was poured from the 
added to the reaction mixture and the reaction was shaken on an orbital shaker for 10 
minutes at 25 °C in which a color change to bright yellow was observed. The crude 
mixture was then diluted as in section 7.1 and monitored by LC-MS using a C-18 column 
(Section 7.2.4) and an electrospray ionization source in positive mode. The ions 
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corresponding to m/z = 173 and 175 were extracted from the total ion source to monitor 
the presence of the cyclopropyl and n-propyl compounds, respectively. 
Procedure for Reduction of TMPPO by DMDPDS. 
To an NMR tube was added a phosphine oxide precatalyst (0.02 mmol, 0.04 M), d8-
toluene, or d8-THF (475 L), and then silane (10 equiv., 0.15 mmol, 0.3 M). The tube 
was inverted three times to ensure proper mixing of the reagents and the interface 
between the tube and the cap was sealed with multiple layers of paraffin wax (parafilm®) 
to ensure no leaks. The reaction was heated to 80 °C and monitored with 31P NMR. 
Procedure for the Reduction of 1PPO by DHDS. 
To an NMR tube was added 1PPO (0.02 mmol, 0.04 M), d8-THF (460 L), and then 
DHDS (37 mg, 7.5 equiv., 0.15 mmol, 0.3 M). The tube was inverted three times to 
ensure proper mixing of the reagents and the interface between the tube and the cap was 
sealed with multiple layers of paraffin wax (parafilm®) to ensure no leaks. The reaction 
was monitored with a variable temperature 31P NMR experiment at 80 C. 
Procedure for Testing the Reactivity of DPDS with Carboxylic Acids 
To an NMR tube was added 3-(trifluoromethyl)-benzoic acid (19 mg, 0.1 mmol), d8-THF 
or d8-Toluene (0.5 mL), and then DPDS (53 mg, 0.22 mmol). The tube was sealed with a 
cap and inverted three times to ensure proper mixing of the reagents and the interface 
between the tube and the cap was sealed with multiple layers of paraffin wax (parafilm®) 
to ensure no leaks. The reaction was heated to 80 C and monitored by 19F NMR. 
Procedure for Testing the Reactivity of DPDS with Alcohols 
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To an NMR tube was added d8-THF (0.5 mL), 4-(trifluoromethyl)-benzyl alcohol (13.7 
L, 1.0 equiv, 0.10 mmol), hexafluorobenzene (11.5 L, 1.0 equiv, 0.1 mmol) and DPDS 
(53 mg, 2.2 equiv, 0.22 mmol). The tube was inverted three times to ensure proper 
mixing of the reagents and the interface between the tube and the cap was sealed with 
multiple layers of paraffin wax (parafilm®) to ensure no leaks. The reactions were either 
heated to 80 C or kept at 23 °C and monitored by 19F NMR.  
Procedure for Testing the Reactivity of DPDS with Alcohols in the Presence of 
Benzoic Acids 
To an NMR tube was added 3-(trifluoromethyl)-benzoic acid (19 mg, 1.0 equiv, 0.10 
mmol) or p-nitrobenzoic acid (16 mg, 1.0 equiv., 0.10 mmol), d8-THF (0.5 mL), 4-
(trifluoromethyl)-benzyl alcohol (13.7 L, 1.0 equiv, 0.10 mmol), hexafluorobenzene 
(11.5 L, 1.0 equiv, 0.1 mmol) and DPDS (53 mg, 2.2 equiv, 0.22 mmol). The tube was 
inverted three times to ensure proper mixing of the reagents and the interface between the 
tube and the cap was sealed with multiple layers of paraffin wax (parafilm®) to ensure no 
leaks. The reactions were either heated to 80 C or kept at 23 °C and monitored with 19F 
NMR.  
Procedure for Testing the Reactivity of DPDS with Aldehydes 
To an NMR tube was added 4-cyanobenzaldehyde (13.1 mg, 1.0 equiv, 0.10 mmol), d8-
THF (0.5 mL), and DPDS (53 mg, 2.2 equiv, 0.22 mmol). The tube was inverted three 
times to ensure proper mixing of the reagents and the interface between the tube and the 
cap was sealed with multiple layers of paraffin wax (parafilm®) to ensure no leaks. The 
reaction was heated to 80 C and monitored with 1H NMR. 
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Procedure for Testing the Reactivity of DPDS with DIAD 
To an NMR tube was added DIAD (4.9 µL, 1.0 equiv, 0.025 mmol), d8-THF (0.5 mL), 3-
(trifluoromethyl)-benzoic acid (4.7 mg, 1.0 equiv, 0.025 mmol), and DPDS (13 mg, 2.3 
equiv, 0.056 mmol). The tube was inverted three times to ensure proper mixing of the 
reagents and the interface between the tube and the cap was sealed with multiple layers of 
paraffin wax (parafilm®) to ensure no leaks. The reaction was heated to 80 C and 
monitored by 1H NMR through observation of a shift in ppm of the methine protons. 
After 2.5 h, the NMR tube was cooled to 23 C, opened, and TMPPO (1 mg, 0.2 equiv, 
0.005 mmol) was added.  The tube was resealed, mixed, heated to 80 C, and monitored 
by 1H NMR. 
 
1.14 Proof that a Phosphine Concentration Dependence Demonstrates Reduction 
does not Proceed by a Multi-Step Process 
We first will represent the kinetic mechanism where reduction goes through a semi-stable 
intermediate and involves two steps through the figure below: 
 
 It is important to note that this is the kinetic mechanism being discussed. The real 
mechanism that would go through this kinetic mechanism includes phenylsilane, 
phenylsilanol, phenylsilanediol, and phenylsilanetriol. However, if, as was assumed prior 
to this paper, phenylsilane reduced phosphine oxides at a similar or greater rate than 
phenylsilanol and phenylsilanediol, then through reduction monitoring only k1 and k2 for 
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phenylsilane will be able to be extracted from the data, not whatever k values would exist 
for the same mechanism with phenylsilanol or phenylsilanediol. This is, again, due to the 
pseudo-first order nature of the experiment, so we can assume that the concentration of 
phenylsilane does not change throughout the course of the reaction. If a small amount of 
phenylsilanol is formed and it reduces at the same speed or slower, then its effect on the 
overall reduction progress will be negligible because of the >10x amount of phenylsilane 
present. 
 With that established, and remembering that we are making the assumption that 
phenylsilane is an equal or better reductant than phenylsilanol or phenylsilanediol, we 
can write the rate of formation of the intermediate species and phosphine formation: 
 
 
We are using pseudo-first order conditions, so [SiH] is constant, and we can let K1 = 
k1[SiH]: 
 
 
Using this combination of equations, we can solve for [P] and [PO-Si] as a function of 
time, k1, k2, and the initial concentration of [PO] (written as [PO]0). 
 
 
If we take [P] and divide it by the initial concentration of PO, we obtain: 
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Therefore, the left side of the equation is equal to an expression that does not have [PO]0 
in it, an expression that is only dependent on the rate constants and the time. When we 
drew the graphs with %PO remaining on the y-axis, what we were basically doing is 
dividing the concentration of phosphine oxide present by [PO]0. This quantity, then, 
should not change regardless of the value of [PO]0. Since changing [PO]0 does have an 
effect on the rate, the proposed multi-step mechanism with a semi-stable intermediate 
cannot be correct.  It is also noteworthy that this data strongly supports the notion that 
phosphine oxide catalyzes the formation of phenylsilanol, as this provides a reason for 
the rate to increase when [PO]0 increases. 
1.15 LC-MS Traces for “Radical Clock” Experiment 
TMCypPO Reduction with TMDSO & 10 mol% Ti(iPrO)4 (Lemaire’s Conditions) 
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TMCypPO Reduction with DPDS (Standard Conditions) 
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1.X16 1H, 31P, and 13C NMR Spectra 
TMBPO: 
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TMPyrPO: 
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TMCypPO: 
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DPDS: 
 
TPDS: 
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DMDPDS:  
 
Ethyl (E)-cinnamate: 
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(E)-1,3-Diphenyl-propen-3-one:  
 
Ethyl (E)-p-methoxycinnamate:  
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Ethyl (E)-p-cyanocinnamate:  
 
Methyl (E)-3-(p-cyanophenyl)-2-methylpropenoate:  
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Benzylamine:  
 
m-Nitrobenzylamine:  
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p-Methoxybenzylamine:  
 
(2S)-1-Amino-3-chloro-2-propanol: 
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1-Bromobutane: 
 
1-Bromo-2-phenylethane: 
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1-Bromo-1-phenylethane: 
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Chapter 2 
 
The Development of Mechanism-Based Inhibitors of Tubercular BioA 
 
Adapted with Permission from: 
 
Eiden, C. G.; Maize, K. M.; Finzel, B. C.; Lipscomb, J. D.; Aldrich, C. C. Rational 
Optimization of Mechanism-Based Inhibitors through Determination of the Microscopic 
Rate Constants of Inactivation. J. Am. Chem. Soc. 2017, unknown, PP 
 
and 
 
Eiden, C. G.; Aldrich, C. C. Synthesis of a 3-Amino-2,3-dihydropyrid-4-one and Related 
Heterocyclic Analogs as Mechanism-Based Inhibitors of BioA, a Pyridoxal-Phosphate 
(PLP) Dependent Enzyme. J. Org. Chem. 2017, unknown, PP 
 
This work was done in collaboration with Dr. John Lipscomb, Dr. Melanie Rogers, Dr. 
Brent Rivard, and Dr. Kimberly Maize. Dr. Maize obtained the crystal structure of 
inactivated BioA. Dr. Rogers and Dr. Rivard trained and assisted with the operation of 
the stopped-flow spectrophotometer and subsequent data processing. Dr. Lipscomb 
assisted with numerous aspects of the project, including the design of stopped-flow 
experiments, data presentation, and general guidance. 
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2.1 Introduction 
Tuberculosis (TB) has plagued mankind for millennia and is currently the leading cause of 
infectious disease mortality and morbidity worldwide, being responsible for over 1.8 million 
deaths in 2015.126 It is primarily caused by Mycobacterium tuberculosis (Mtb), an extremely 
slow-growing bacillus that requires extended periods of treatment and is impervious to most 
conventional anti-bacterials.127 The introduction of antibiotics combined with public practices 
specifically aimed to prevent the transmission of TB led to a near-eradication of the disease from 
industrialized nations in the 20th century.128 However, the last approved first-line drug for TB 
chemotherapy, Rifampin, was introduced in 1968. Combined with the necessary treatment time, 
the dearth of new antibiotics has led to the development of multiple drug-resistant TB strains.129 
In fact, reports over the last half century confirm the development of resistance to all first- and 
second-line antitubercular agents. It is thus imperative to develop new classes of anti-TB agents 
that are effective against drug-resistant TB and possess novel modes of action. 
Cofactor biosynthesis is an excellent source of potential therapeutic targets as many of the 
pathways are essential and lack a corresponding mammalian counterpart.130 Biotin (vitamin H) is 
the cofactor responsible for the activation of carbon dioxide in fatty acid biosynthesis and 
gluconeogenesis through attachment to acyl-CoA carboxylases (ACCs) and pyruvate coenzyme A 
carboxylase (PCC).131,132 Mycobacterium tuberculosis is particularly sensitive to biotin 
deprivation, as though ACCs are required in numerous organisms, Mtb uniquely relies on three 
non-redundant ACCs to synthesize the unparagoned lipids found in the extraordinarily complex 
mycobacterial cell wall.133134135 Additionally, gluconeogenesis is a vital process in Mtb to 
synthesize sugars needed for nucleotide and cell wall biosynthesis.136 
Amiclenomycin (ACM, Figure 2.1A) is an antibiotic that was isolated in 1974 from a 
Streptomyces lavendulae strain.137 It possesses selective antimicrobial activity against Mtb and 
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the fast-growing Mycobacterium smegmatis (Msmeg), and has been shown to exert its activity 
through inhibition of mycobacterial biotin biosynthesis.138139 The aforementioned dependence of 
Mtb on several biotin-containing enzymes may explain the distinct vulnerability of mycobacteria 
to ACM.140 The mechanism of action of ACM was elucidated by classic complementation studies 
employing biotin pathway intermediates.141 In Mtb and Msmeg, biotin biosynthesis begins by 
hijacking of the fatty acid biosynthesis pathway to generate pimeloyl-ACP,142 which is then 
elaborated to biotin over four enzymatic steps (Figure 2.1B).143144145146147148 The first step is 
carried out by BioF, yielding 7-keto-8-aminopelargonic acid (KAPA) from the decarboxylative 
condensation of pimeloyl-ACP and L-alanine. BioA then effects the reductive amination of 
KAPA into 7,8-diaminopelargonic acid (DAPA), which is followed by the BioD-catalyzed 
carboxylation of DAPA to form dethiobiotin (DTB). The pathway concludes with insertion of the 
sulfur atom by the iron-sulfur cluster enzyme BioB, affording biotin. The addition of exogenous 
DAPA, DTB, or biotin to whole-cell Msmeg antagonized the activity of ACM, whereas KAPA 
did not.149 Moreover, treatment of Msmeg with ACM led to an accumulation of KAPA.150 Taken 
together, these data pinpointed the antepenultimate step performed by BioA as the likely target of 
ACM.  
BioA is a pyridoxal-5-phosphate (PLP) dependent aminotransferase that uses S-
adenosylmethionine (SAM) as an amino donor when catalyzing the conversion of KAPA to 
DAPA.151152 Through a combination of elegant kinetic and structural studies, the amino-1,4-
cyclohexadienyl group on ACM was shown to bind the PLP of BioA.153154 The resulting external 
aldimine then undergoes redox isomerization via a quinonoid intermediate to a ketimine (Figure 
2.1C). However, rather than completing hydrolysis to generate the pyridoxamine-5-phosphate 
(PMP) form of the cofactor, the ketimine intermediate tautomerizes to a stable aromatic adduct 
that covalently inactivates BioA. 
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Figure 2.1. Biotin Biosynthesis, ACM, 1, and the Inactivation of BioA by 1. (A) Natural 
product ACM was the inspiration for 1. (B) Biotin biosynthesis proceeds in four steps 
from pimeloyl-ACP. (C) Inactivation of BioA by 1 occurs via a 4-step process resulting in 
a stable, aromatized adduct bound to the PLP cofactor. 
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The discovery of the mechanism of inactivation explains both the reason for and the function 
of the rare 1,4-cyclohexadiene moiety in ACM. However, while the 1,4-cyclohexadiene is 
absolutely critical for ACM’s activity, it is simultaneously the primary liability of ACM, as this 
moiety is chemically unstable and spontaneously aromatizes to an inactive benzene nucleus. Shi 
and Aldrich designed a series of chemically robust allylamine inhibitors (Table 2.1) with both 
acyclic (2) and cyclic warheads (3A-C) to replace the 1,4-cyclohexadiene of ACM.155 
Regrettably, the most effective of these compounds had minimal activity that was not time-
dependent, and they were unable to draw any clear conclusions other than suggesting that an ideal 
warhead likely includes a flat ring. More fruitfully, Aldrich and coworkers have described the 
design of a simplified analogue 1 (Figure 2.1A) wherein the 1,3-cyclohexadiene warhead of 
ACM was replaced with a more stable 3,6-dihydropyrid-2-one moiety,156 whose increased 
stability is derived from reduced aromatic stabilization energy of the corresponding 2-pyridone.  
Compound 1 was shown to inhibit BioA in a similar manner to ACM (Figure 2.1D), but further 
optimization of this scaffold has been hampered by the complex nature of the inactivation 
mechanism. 
Table 2.1. Allylamine Inhibitors: Structures and Activity Against BioA. 
Compound Structure IC50 (µM) 
2 
 
>100 
3A 
 
57.0 ± 1.9 
3B 
 
>100 
3C 
 
>100 
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Both 1 and ACM are mechanism-based inhibitors (MBIs) since they require transformation 
by the inhibited enzyme’s machinery to form active inhibitory species. Unlike conventional 
rapidly reversible inhibitors, MBIs display time-dependent inhibition and cannot be characterized 
by IC50 or KI values.157 Rather, the rate constant of inactivation (kobs) is typically measured as a 
function of inhibitor concentration to furnish the global kinetic parameters kinact and KI. kinact and 
KI are semi-analogous to Michaelis-Menten parameters and describe, respectively, the maximum 
possible value of kobs at infinite inhibitor concentration and the concentration of inhibitor that 
produces a kobs that is equal to one half of kinact.158 
In this study, we first designed direct analogues of 1, changing the nature of the tail based on 
information from a fragment-based screen with BioA. The synthesis of the alternative tail 
structures proved exceptionally difficult to accomplish in combination with the already complex 
methods necessary for warhead construction, so we abandoned this approach. Seeking to change 
the compound scaffold, we thoroughly investigated MBI optimization techniques, and found both 
kinact and KI are complex conglomerates of the individual microscopic rate constants of 
inactivation, with neither of the parameters definitively assessing binding affinity nor the identity 
of the rate limiting step. The only certain way to optimize an MBI was through complete 
characterization, so we performed stopped-flow studies and elucidated each of the microscopic 
rate constants of inactivation. This revealed the identity of the rate determining step, and we 
designed alternative dihydropyrid-4-one, dihydropyran-4-one, and dihydrothiopyran-4-one 
scaffolds to increase the rate of inactivation while simultaneously improving compound 
accessibility. These compounds were constructed and tested for their inhibitory activity against 
BioA, and we found that the dihydropyrid-4-one scaffold had an increased kinact, validating our 
design strategy. These findings substantially furthered the preclinical development of MBIs of 
BioA towards a novel anti-TB therapeutic  
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2.2 Adding an Electron Deficient Heterocycle 
To improve Compound 1, Finzel and coworkers investigated the structure of the binding 
pocket of BioA by co-crystallization with various fragments.159 They sought to identify 
alternative tail structures to replace the hydroxypropyl tail, which was known to make few 
favorable contacts with the enzyme.160 Unfortunately, they found that most fragments bound in 
the area occupied by the main pyridone ring of the PLP-adduct formed by 1, but two fragments 
were determined to have 5-membered rings that rested several angstroms away. Each of these 
rings were highly electron deficient, and likely had moderate π-stacking interactions with a 
nearby phenylalanine residue. The 1,2,3-triazole ring can be formed efficiently and 
regioselectively using Cu(I)-catalyzed click chemistry, and we were unsure whether one or two 
methylene groups would allow for the triazole to occupy the correct space, so we designed 
compounds 4 and 5 (Figure 2.2) to capitalize on potential energetically favorable interactions 
with BioA. 
 
Figure 2.2. Dihydropyrid-2-one Analogues of 1 
The synthesis of 4 began with L-Boc-Serine 6 (Scheme 2.1), which was transformed into 
Weinreb Amide 7 utilizing EDC and NMM in CH2Cl2.161 Performing this reaction in CH2Cl2 with 
NMM as the base was found to be superior to the more common aqueous system162 in both yield 
and reproducibility. Isopropylidene protection followed by reduction with LiAlH4 furnished 
Garner’s Aldehyde 9 in excellent yield.163,164 Wittig conditions afforded mono-substituted alkene 
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10 in a lower-than-desired yield, and the ensuing selective isopropylidene deprotection provided 
Boc-vinyl glycinol 11.165 
 
Scheme 2.1. Synthesis of Boc-Vinyl Glycinol 11. 
11 was utilized as the precursor to both the bottom and top halves of 4 (Scheme 2.2). In one 
path mesylation followed by azide displacement furnished 12 in reasonable yield, and subsequent 
Boc-deprotection using HCl in dioxane afforded amino-butene derivative 13. 11 was also 
subjected to Jones’ oxidation conditions to form Boc-vinyl glycine 14.166 The pKa of the α-proton 
of 14 is quite low by amino acid standards, so we used DEPBT, a coupling reagent developed 
specifically to avoid α-racemization,167,168 to catalyze the amide coupling with 13. Azido amide 
15 was produced in good yield with no observed racemization of either stereocenter. 
 
Scheme 2.2. Synthesis of Dihydropyrid-2-one Precursor Azido-amide 15  
At this point, the only steps that remained to synthesize 4 were the ring-closing metathesis 
(RCM) to form the dihydropyrid-2-one ring, a click reaction to construct the triazole, and removal 
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of the protecting group(s). To easily obtain analogues of 4 for further testing against BioA, it 
would be preferable to perform the click reaction as late in the synthetic scheme as possible. 
Therefore, we attempted an RCM reaction to form 16 using either the Grubbs II169 or Hoveyda-
Grubbs II170,171 catalysts (Scheme 2.3), but neither provided anything besides starting material 
upon workup. Due to the lack of metathesis reactions performed on compounds containing 
azides, we suspect that the complete lack of reactivity is likely due to reduction of the ruthenium 
center of the catalysts. We then switched our focus to triazole formation. Using TMS-acetylene as 
a liquid substitute for acetylene, we attempted the click reaction using both Cu(I) iodide directly 
as well as in situ generation of Cu(I) by adding sodium ascorbate to Cu(II) sulfate.172,173 Both 
reactions only provided 27% of desired TMS-triazole 17, but isolation of the by-products 
revealed that the Cu(I) iodide system was causing homocoupling of the TMS-Acetylene,174 while 
the Cu(II) conditions resulted in 51% of desilylated product 19, resulting in a quite acceptable 
78% overall yield. However, this reaction was extremely sluggish, completing only after a full 
week while requiring more than 20 equiv of TMS acetylene and nearly stoichiometric amounts of 
copper and ascorbate. Cu(I)-catalyzed click reactions are generally relatively rapid,175 so we 
propose that steric hindrance substantially slows this reaction, as only a single methylene group 
separates the azide from a methine group with substituents of considerable size. 
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Scheme 2.3. Synthesis of Dihydropyrid-2-one Triazole 4. 
Deprotection of the TMS group of 17 to consolidate the click reaction products proceeded in 
reasonable yield. However, the RCM reaction proved quite difficult. We have previously 
discovered that the dihydropyrid-2-one core of 4 aromatizes when heated to 80 °C, so we 
maintained a temperature of 50 °C by refluxing CH2Cl2. Reacting 19 with 20 mol% of the 
Hoveyda-Grubbs II catalyst for two days under the exclusion of light provided the desired 
dihydropyrid-2-one, though it could not be separated from some of the catalyst decomposition 
products. Subsequent Boc deprotection and purification by trituration furnished amino-
dihydropyrid-2-one 4 in poor yield from 19. 
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4 was assayed for its activity against BioA and subjected to multiple co-crystallization 
conditions with the enzyme to attempt to observe an aromatized adduct. Unfortunately, 4 
displayed no time-dependent inhibition of BioA, and failed to co-crystallize with BioA. 
Therefore, we began the synthesis of 5, rationalizing the failure of 4 to the close proximity of the 
pyridone preventing the triazole from freely rotating to a configuration that would allow for the 
desired π-stacking interaction. 
We wanted to structure the synthesis of 5 in such a way that would alleviate the difficulties 
we had with the RCM reaction and to form the triazoles at an even later stage for rapid 
derivatization. The original synthesis of 1 included a relatively high-yielding RCM reaction of a 
dihydropyrid-2-one precursor containing a TBS-protected hydroxypropyl tail.176 Envisioning that 
alcohol 21 would be able to undergo the RCM far more readily than 15 or 19, and could 
subsequently be modified to introduce an azide, we set out to synthesize amino-alcohol 20. 
The synthesis of 20 began with the conversion of D-methionine 22 to D-homoserine lactone 
hydrobromide 23 in good yield.177 Boc protection then afforded D-Boc-homoserine lactone 24 in 
excellent yield. We then envisioned a two-step process of DIBAL reduction preceding a Wittig 
reaction on the resulting lactol would furnish 26. DIBAL reduction proceeded smoothly, though 
25 degraded upon purification with a silica gel column, so we instead directly took the product 
onto the Wittig reaction. This exact reaction has been reported once previously,178 though with a 
curious procedure where following in situ generation of the phosphonium ylide, the product is 
added and refluxed in a mixture of CH2Cl2 and toluene. We tried this procedure several times, 
and were unable to obtain any product. In fact, the ylide appeared to degrade under such 
conditions, as we obtained considerable amounts of triphenylphosphine upon purification. Wittig 
reactions on 5-membered lactols with substituents at the α-position are known,179 so we attempted 
standard Wittig conditions as well as a Horner-Wadsworth-Emmons reaction in attempts to 
produce 26. These all failed. 
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Scheme 2.4. Design of Amine Coupling Partner towards Dihydropyrid-2-one 5 and Initial 
Failed Route 
Convinced that we would not be able to obtain 26 from 25, both due to personal experience 
and by observing reported strategies aimed at bypassing that conversion, we changed our 
synthetic scheme. First, we endeavored to synthesize the bis-Boc protected version of 25, as 
removing the acidic N-H proton could eliminate charge-charge interactions between the 
deprotonated amine and the ylide. Bis-Boc protection to construct 27 proceeded smoothly, but the 
increased reactivity and steric bulk of bis-Boc protection meant that bicyclo compound 28180 was 
the only product of the subsequent DIBAL reduction. We then chose to change our target 
molecule from mono-substituted alkene 20 to di-substituted alkene 30, as the latter would allow 
for a Wittig reaction with a stabilized ylide that would not deprotonate the amine. The ethyl ester 
of 30 should be irrelevant as an RCM reaction to form the dihydropyrid-2-one would remove it. 
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Scheme 2.5. Synthesis of Alternative Amine Coupling Partner 30 and Challenges to 
Obtain Dihydropyrid-2-one 33 
This plan initially tasted success, as addition of Ph3PCHCO2Et to 25 provided α,β-unsaturated 
ester 29 in quite good yield.181 Subsequent deprotection of 29 afforded 30182, which was coupled 
with R-vinyl glycine 14 to form amide 31. Unfortunately, this reaction worked very poorly when 
compared with the synthesis of 15. The fact that we were starting with an ammonium salt as 
opposed to a free amine could have been the reason, though an alternative possibility was that the 
free alcohol was interfering in the reaction. The seminal publication on DEPBT suggests that 
alcohols do not require protection, but this was not extensively tested.183 Regardless, we then 
attempted an RCM reaction using multiple conditions, but were unsuccessful in obtaining 
product. The alcohol of 31 was then protected with a TBS group in order to mirror the successful 
synthesis of 1.184 Unfortunately, subjecting 32 to RCM conditions resulted in an extremely 
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sluggish reaction. Utilizing upwards of 50 mol% of a RCM catalyst produced about 10% of 
product in 3-5 days, while the addition of ethylene gas, known to enhance the metathesis rate,185 
furnished about 10% product overnight. Neither set of conditions would result in a successful 
synthetic route to 5 and its analogues, as the yields were consistently too low, and at least four 
steps were required beyond this point. Therefore, we decided to take a step back and design an 
alternate route to 5 where both alkenes are mono-substituted and thus better disposed to take part 
in metathesis. 
To avoid any potential side reactions during amide coupling with an unprotected alcohol and 
to potentially enhance the rate through using an amine and not an ammonium salt, we designed 
amine 34 and set it as our objective. The synthesis of 34 began with 4-penten-1-ol 36, which was 
THP protected using standard methods. We then sought to add the amino group using conditions 
reported by Bao and Tambar for the stereoselective allylic amination of terminal olefins.186 
Addition of bis-benzenesulfonyl sulfurdiimide to 37 at 4 °C formed stable ene adduct 38 that can 
be purified by filtration. The rearrangement was then performed under Bao and Tambar’s Pd-
catalyzed conditions at low temperature, affording 39 in moderate yield and enantioselectivity, as 
ether-containing alkenes are reported to react less favorably. Aqueous base furnished mono-
benzenesulfonyl 40 in excellent yield,187 after which TBSOTf and dimethyl sulfide188 were used 
to switch to a more desirable protecting group. Benzenesulfonylamines are extremely stable, and 
as such we had to resort to Birch conditions to obtain the desired deprotected amine 34. 
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Scheme 2.6. Synthesis of Amine Precursor 34 via Enantioselective Allylic Amination and 
Challenges Towards the Dihydro-2-Pyridone Ring 
34 was coupled with 14 to furnish amide 35, which was then subjected to RCM conditions 
using either the Grubbs II or Hoyveda-Grubbs II catalyst. Unfortunately, the best yield that we 
obtained was 9% over both steps, and it was clear that the RCM was still not performing nearly to 
the degree that we desired. We were quite disappointed by this, and though there were certainly 
other methods that we could have attempted to synthesize 5, we felt that the difficulty and length 
of the syntheses to this point rendered extensive derivatization improbable. Instead, we wanted to 
change scaffolds to facilitate more efficient syntheses. Rather than just pick a new scaffold that 
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made sense from an ease of synthesis standpoint, we decided to attempt the first fully-informed 
rational optimization of an MBI. 
2.3 Optimization of MBIs 
The failure of compound 4 compounded with the length of the synthesis of new 
dihydropyrid-2-one analogues prompted a re-evaluation of the goals of this project. If every 
dihydropyrid-2-one MBI worked wonderfully, then perhaps it would be worth the time and effort 
involved in designing and executing a personalized synthesis for each inhibitor. Since this was 
not the case, we sought to redesign the warhead of 1 to enable a more efficient synthetic route 
that included late-stage derivatization capabilities.  
As previously discussed, early stage development of MBIs commonly revolves around 
improving the kinact/KI value of each inhibitor against the specified target. Usually, the warhead is 
left untouched, with optimization focused on gaining additional binding affinity through 
modification of the tail(s) of the MBI. The lack of direct optimization and development on MBI 
warheads means that few to no methods exist for rationalizing such processes. One can simply 
attempt to make molecules that can undergo the proposed mechanism of the MBI, but this level 
of rational design is far below what would be desired. In our case, this would involve following 
the suggestion of Shi and Aldrich that a flat ring is necessary, and then design flat rings that could 
form a stable adduct with the PLP of BioA. However, there are numerous compounds that fulfill 
those conditions, leaving us with far too many options. 
In an attempt to develop a rational method that guides MBI warhead development, we 
undertook a detailed investigation into prior MBI optimization strategies, attempting to tease out 
clues as to what our next steps should be. As expected, we found a large number of reports that 
used KI and kinact to optimize their MBIs, with increasing the kinact/KI value as the ultimate 
goal.189,190,191,192 The closest thing we observed to warhead optimization was a report that 
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synthesized a substantial number of warheads and then determined the kinact/KI values for each 
against the enzyme to establish which was optimal.193 Notably, in almost all reports, KI was being 
treated as the equilibrium constant of the initial binding event, and kinact assumed to be the rate of 
the key activation step of the MBI. Copeland has previously discussed that for MBIs with a three-
step mechanism of inactivation, the only time the KI is equivalent to the KD of the binding 
equilibrium is when the step immediately following binding is entirely rate limiting. As our 
presumed mechanism includes four steps (Figure 2.1), we decided to analyze generalized three 
and four-step kinetic mechanisms for MBI inactivation of an enzyme, specifically looking at the 
how KI and kinact change based on the individual microscopic rate constants of inactivation. 
To begin, we derived the KI and kinact values for several potential MBI mechanisms in terms 
of the individual rate constants (Table 2.2). For our analysis, the kinact of a MBI is defined as the 
maximum kobs possible arising from infinite concentration of inhibitor, where kobs is determined 
by fitting curves describing time-dependent formation of the final, inactivated complex, to 
exponentials of the type e^(-kobs*t). The KI is the concentration of inhibitor that produces a kobs 
equal to half of kinact. The values in Table 2.2 are derived assuming both a quasi-steady state for 
each intermediate Enzyme-Inhibitor complex and that the total enzyme concentration is constant. 
A sample derivation of the KI and kinact values of Mechanism 4 is included in the Methods section, 
showing the approach taken in deriving the values in Table 2.2. 
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Table 2.2. KI and kinact values for several mechanisms of MBIs as conglomerates of rate 
constants 
# Mechanism: KI (M) kinact (s-1) 
1 
 
  
2 
 
  
3 
 
  
4 
   
5 
 
  
6 
 
  
7 
 
  
8 
   
9 
 
  
 
The addition of more steps or reversibility causes KI and kinact to become significantly more 
complex congregates of the microscopic rate constants. Though Table 2.2 provides a wealth of 
valuable information, we wanted to explore exactly how the KI and kinact values depend on the 
individual rate constants in greater detail.  KI and kinact were thus calculated from a wide range of 
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values for each of the individual rate constants for a few mechanisms. These results are shown in 
Table 2.3. 
As mentioned previously, it is often naively assumed that a KI value obtained experimentally 
for an MBI will estimate the KD of the initial binding step with a high degree of fidelity. This is 
unequivocally shown to be untrue, as the KI only accurately estimates the KD of the initial binding 
event for both three- and four-step mechanisms when the step following binding is both 
irreversible and rate limiting. In every other case, the KI underestimates the KD, and often by a 
substantial margin (light blue, purple, green, and gray entries in Table 2.3). Since a significant 
number of MBIs will certainly inactivate enzymes through mechanisms where the second step is 
either reversible or non-rate limiting, it is unwise to assume without further information that KI 
estimates KD. The distinction between KI and KD is important because the KD, not the KI, 
determines how well an inhibitor will compete with the substrate for binding to the enzyme active 
site. 
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Table 2.3. The Effect of Changing the Rate Constants on KI, kinact, and KD. 
Mech# 
k1  
(M-1s-1) 
k-1  
(s-1) 
k2  
(s-1) 
k-2  
(s-1) 
k3  
(s-1) 
k4  
(s-1) 
k5  
(s-1) 
KD  
(M) 
KI  
(M) 
kinact  
(s-1) 
kinact/KI  
(M-1s-1) 
2 5 50 5 N/A 0.2 0.05 N/A 10 0.52 0.19 0.37 
2 5 50 5 N/A 2 0.05 N/A 10 3.20 1.42 0.44 
2 80 80 5 N/A 0.2 0.05 N/A 1 0.05 0.19 3.8 
2 20 100 1 N/A 1 1 N/A 5 3.37 0.33 0.097 
2 20 100 1 N/A 10 1 N/A 5 4.63 0.83 0.18 
2 20 100 10 N/A 1 1 N/A 5 0.92 0.83 0.90 
2 20 100 1 N/A 1 0.1 N/A 5 2.65 0.95 0.36 
2 80 40 1 N/A 1 1 N/A 1 0.34 0.33 0.97 
2 5 50 0.03 N/A 1 0.2 N/A 10 9.76 0.024 0.0025 
2 5 50 0.3 N/A 1 0.2 N/A 10 8.04 0.20 0.024 
2 30 30 0.03 N/A 1 0.2 N/A 1 0.98 0.024 0.024 
2 100 500 10 N/A 0.05 0.01 N/A 5 0.030 0.050 1.7 
2 100 500 10 N/A 0.5 0.01 N/A 5 0.25 0.48 1.9 
2 100 500 10 N/A 0.05 0.001 N/A 5 0.026 0.050 1.9 
3 5 50 5 0.5 0.05 N/A N/A 10, 0.91 1.00 0.045 0.045 
3 5 50 5 0.5 0.5 N/A N/A 10, 0.91 1.75 0.42 0.24 
3 80 80 5 0.5 0.05 N/A N/A 1, 0.091 0.10 0.045 0.45 
3 20 100 0.03 3 0.5 N/A N/A 5, 4.95 4.96 0.0042 0.00085 
3 20 100 0.3 3 0.5 N/A N/A 5, 4.5 4.61 0.039 0.0085 
3 20 100 0.3 0.3 5 N/A N/A 5, 2.5 4.75 0.27 0.057 
3 20 100 3 3 0.5 N/A N/A 5, 2.5 2.70 0.23 0.085 
3 20 100 30 3 0.5 N/A N/A 5, 0.45 0.54 0.45 0.83 
5 5 50 1 N/A 1 0.3 1 10 4.01 0.30 0.075 
5 5 50 10 N/A 1 0.3 1 10 0.73 0.88 1.2 
5 5 50 1 N/A 10 0.3 1 10 4.93 0.88 0.18 
5 5 50 1 N/A 1 3 1 10 6.80 0.17 0.025 
5 5 50 1 N/A 1 0.3 10 10 4.01 0.30 0.075 
5 5 50 1 N/A 1 0.3 0.02 10 0.25 0.019 0.076 
5 5 50 1 N/A 1 0.3 0.2 10 1.82 0.14 0.077 
The numbers in italics for results obtained for mechanism 3 arise from applying the rapid equilibrium 
assumption to the second step as well as the first step and obtaining a KD that is more consistent with how 
the inhibitor would compete with substrate. This number is a fair estimate for the green entries, and the top 
and bottom dark blue ones. 
 
The distinction between the two is further demonstrated by the observation that if the second 
step is irreversible and non-rate limiting, an increase in the speed of the rate limiting step will 
cause an increase in both the KI and the kinact values (light blue and purple entries in Table 2.3). 
Clearly, improving the rate of a step subsequent to an irreversible second step does not affect the 
KD of the initial binding event whatsoever, but it does cause significant changes in the KI value. 
This point calls into question kinact/KI as a consistently accurate measure of inactivation efficiency. 
An MBI with the rate constants in the second purple entry of Table 2.3 is clearly a better inhibitor 
than an MBI with the rate constants in the first purple entry.  It would compete with substrate 
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substantially better, but its kinact/KI value is only about 10% improved. This point is not to say that 
kinact/KI is a useless constant (it is certainly not), but rather to illustrate that it has pitfalls if treated 
as a complete descriptor of inactivation efficiency. 
A final point that is demonstrated from the results in Table 2.3 is that, if the second step is 
reversible, improving the equilibrium of this step increases the kinact and lowers the KI at the same 
time. This is not unexpected, as the extended reversibility would affect the apparent KD of 
binding, if not the KD of the initial binding event itself. Still, this result is one of the reasons that 
extensive kinetic analysis of an MBI could prove valuable; it reveals which steps are 
reversible/irreversible and even which steps are kinetically important.  If the second step is 
reversible, a 5-fold improvement of its equilibrium results in around a 25-fold improvement in 
inhibitory potency (Note: this does assume a rapid equilibrium for the second step). 
All of this analysis clearly demonstrates that kinact/KI is not an accurate global measure of 
enzymatic activity unless additional information is known about the system. Instead, it suggested 
that complete characterization of the mechanism of inactivation of a MBI would be necessary to 
allow for rational optimization. This would accurately describe the KD of binding and reveal the 
identity of the rate determining step for optimization of the kinact. Researchers would then be 
able to direct their efforts to effect the desired improvements. 
Complete characterization of the mechanism of inactivation requires obtaining each of the 
microscopic rate constants of this process. This likely requires some sort of detectable 
spectroscopic change to occur in the enzyme during the process of inactivation. Fortunately, most 
of the classes of enzymes that MBIs are commonly used to target contain such spectroscopic 
changes, including flavin-containing enzymes,194 heme-dependent oxidases,195,196 quinone-
dependent oxidases,197 and PLP-dependent enzymes such as BioA. There are also cases where the 
inhibitor itself undergoes detectable changes in a spectroscopic property.198 With so many 
systems containing such spectroscopic signatures, we propose that complete characterization of 
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MBIs is a widely applicable method. We also choose to optimize MBIs of BioA using this 
method, beginning with complete characterization of the process of inactivation of BioA by 1.  
2.4 Stopped Flow Evaluation of Inhibitor 1 Against BioA 
PLP-dependent enzymes undergo a series of states with distinguishable absorbance 
signatures, ideal for study with stopped-flow spectrophotometry. Incubation of 1 with BioA under 
stopped-flow conditions utilizing a diode-array detector showed three distinct absorbance regions 
with large, time-dependent changes (Figure 2.3B). An absorbance peak with a λmax of 410 nm 
decreases over time, while a corresponding increase is observed at 318 nm (Figure 2.4). These 
changes are likely caused by disappearance of the external aldimine and subsequent formation of 
the final, aromatized adduct (Figure 2.3).  Finding a peak with a λmax of 540 nm, which increases 
and then decreases in magnitude (Figure 2.5), can be surmised to be due to the presence of a 
quinonoid.199 Previous examination of quinonoid intermediates in PLP-dependent mechanisms 
generally place the λmax between 490 and 520 nm, though observation of such species is quite 
rare.200,201,202 We propose that the additional double bond on 1 that is in resonance with the 
quinonoid (Figure 2.3A) causes the observed red shift of the peak. 
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Figure 2.3. BioA Mechanism and Observed Inactivation by 1. (A) Postulated mechanism 
of inactivation of BioA by compound 1 with observed absorbance maxima. (B) 
Absorbance traces from incubation of 12.5 µM BioA with 250 µM 1 in BICINE pH 8.6 at 
23 °C 
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Fitting the reaction time course observed at 540, 410, or 318 nm to summed exponential 
expressions revealed two fast and one slow reciprocal relaxation times (RRTs) (Figure 2.4, 2.5). 
The slow RRT had a value significantly less that the kinact, indicating that it arises a minor side 
reaction. Therefore, kinetic evidence for only two of the four postulated steps was initially 
obtained. However, close inspection of the earliest time points in the 540 nm time course showed 
a very short (<2 s) burst in absorbance that was previously unaccounted for (Figure 2.5B).  
Refitting the 540 nm time course to include another exponential with a very fast RRT allowed the 
early time domain to be accurately modeled. The observation of three kinetically competent 
RRTs shows that the reaction must have at least 3 steps. 
 
Figure 2.4. Traces Obtained from Spectrophotometrically Monitoring the Incubation of 
BioA with 1. All traces use 12.5 µM BioA with 200 µM 1 in BICINE pH 8.6 at 23 °C. (A) 
Trace obtained from monitoring at 410 nm for 1000 s with fitting. (B) Trace obtained from 
monitoring at 320 nm for 1000 s with fitting. (C) Residuals from fitting of part (A). (D) 
Residuals from fitting of part (B). 
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Figure 2.5. Traces from Spectrophotometric Monitoring of the Incubation of BioA with 1 
at 540 nm. All traces use 12.5 µM BioA with 200 µM 1 in BICINE pH 8.6 at 23 °C. (A) 
1000 s trace with fitting. (B) 10 s trace with fitting using one (blue) or two (orange) 
exponentials. (C) Residuals from fitting of part (A). (D) Residuals from single exponential 
fitting of part (B).  (E) Residuals from double exponential fitting of part (B). 
An examination of the concentration dependence on 1 for each of the kinetically competent 
RRTs reveals distinctive patterns. The fastest RRT displays a linear correlation with the 
concentration of 1, while the second fastest RRT shows no dependence and the slowest RRT has a 
hyperbolic dependence (Figure 2.6). The magnitudes of the RRTs are separated by ~30-fold, 
facilitating the data analysis. The linear relationship for the fastest RRT means that it reflects 
primarily binding of 1, probably through rapid formation of the external aldimine. The very slight 
absorbance increase at 540 nm is unexpected for the aldimine, but feasible.203,204 The intercept 
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and slope of the plot give the reverse and forward rate constants for binding, respectively, while 
the ratio gives the binding KD.  Because the reaction is reversible and the RRT is large, it is likely 
that this binding reaction reaches near equilibrium prior to the downstream reactions. If this is the 
case, then one would expect the plot of at least one of the other RRTs to exhibit a hyperbolic 
concentration dependence on 1, as seen for the slowest RRT (Figure 2.6C).  The forward and 
reverse rate constants for the step following initial complex formation, as well as the KD for the 
immediately preceding binding reaction can be computed from the hyperbolic curve.  
Accordingly, the KD computed in this way is in good agreement with the KD computed from the 
plot in Figure 2.6A (180 vs 240 µM). The intercept at zero of the hyperbolic curve means that the 
remaining RRT should not exhibit a concentration dependence on 1 and gives information about 
only the rate constants for downstream steps. Thus, the lack of concentration dependence on 1 of 
the second fastest RRT (Figure 2.6B) indicates that it correlates with the rate constant(s) for a 
step or steps that follow the irreversible second step of the sequence. This analysis suggests that 
the slowest step in the sequence is the formation of the quinonoid, and the second fastest step 
corresponds to its disappearance. 
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Figure 2.6. Dependence of the Reciprocal Relaxation Times on the Concentration of 1 
and the Final Rate Constants Determined. (A-C) Dependence of the observed RRTs on 
the concentration of 1. (D) Rate constants determined from analysis of graphs A-C. First 
step forward rate constant is the slope in part (A); reverse rate constant is the intercept 
in part (A). Second step rate constant is the asymptote of the hyperbola in part (C) minus 
the y-intercept. Third step rate constant is the y-value in part (B). 
The microscopic rate constants of inactivation are displayed in Figure 2.6D. Using the 
formula from Table 2.2, entry 2, KI and kinact were calculated from the determined rate constants 
and are within 2-fold of the experimentally determined values under steady-state conditions. This 
assignment of rate constants to specific steps was also confirmed by multiple checks using 
simulation and estimation of the maximum amount of quinonoid formation. It is notable that the 
tautomerization step to form the aromatized adduct is not observed by this analysis, and thus must 
be significantly (>30) faster than ketimine formation, which is plausible as its rate would only 
be limited by the access of the bound inhibitor to proton donors and acceptors. 
The kinetic analysis reveals that there are no detectable reversible steps post-binding and that 
the second step is almost entirely rate-limiting, which means KI approximates the KD of the 
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Michaelis complex [BioA•1] and kinact approximates the rate of formation of the quinonoid. This 
provides all the information necessary for rational optimization of the scaffold of 1. We now 
know that only the first step is reversible, so improving the initial binding equilibrium provides a 
corresponding increase to the overall KD. However, the key discovery is that kinact equals the rate 
of quinonoid formation. This is essential for the scaffold-hopping that we are going to attempt to 
do. Ideally, the new scaffold would be much easier to synthesize, have similar structural features 
to the dihydropyrid-2-one of 1, and facilitate more rapid quinonoid formation. 
2.5 Design, Synthesis, and Evaluation of Modified Warheads 
Since the quinonoid is formed following the deprotonation of the α-proton on 1 by Lys283 of 
BioA (Figure 2.3A), we hypothesized lowering the pKa of this proton would enhance kinact. 2,3-
Dihydro-4-pyranone (42) and 2,3-dihydro-4-pyridone (43) scaffolds (Figure 2.7) were initially 
designed based on the computationally predicted pKa values of their α-protons: 15.1 for 42 and 
14.3 for 43, which are nearly six pKa units less than the predicted value for 1 (pKa ~ 21.1). The 
greater acidity is due to conversion of the amide in 1 to a more electron withdrawing vinylogous 
ester and amide in 42 and 43, respectively. We were also attracted to the scaffolds of 42 and 43 
because they remove the second stereocenter (at C6 in 1) by shifting the position of the olefin, a 
change that we expected would simplify analogue synthesis. Synthesizing 42 and 43 would allow 
for direct comparison of the dihydropyrid-2-one ring of 1 to its dihydropyran-4-one and 
dihydropyrid-4-one counterparts.  
 
Figure 2.7. Dihydropyran-4-one and Dihydropyrid-4-one Scaffolds for MBI Development 
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Both ring systems have previously been reported, with 2,3-dihydro-4-pyranones commonly 
synthesized through hetero-Diels-Alder (HDA) reactions between Danishefsky’s diene and 
aldehydes.205  Unfortunately, the HDA method is generally limited to variation at C2 and C6, and 
modification of Danishefsky’s diene to introduce an amino group appeared quite challenging.  
Georg and co-workers recently reported a versatile synthesis of 2,3-dihydro-4-pyridones through 
6-endo-dig cyclization of an ynone derived from β-amino acids; however, the introduction of 
amino substituents at C3 was not disclosed.206207208 Modifying this strategy, we envisioned that 
using ynones derived from either serine or 1,2-diaminopropionic acid could be cyclized to 
efficiently construct the desired ring systems with an amino group at C3 (Scheme 2.7). The 
ynones could be synthesized from the addition of an alkynyllithium reagent to an amino acid 
derived Weinreb amide.    
First Generation Syntheses of 42 and 43. To begin the synthesis of 42, commercially 
available Boc-serine was again transformed into Weinreb amide 7 by employing EDC and NMM 
in CH2Cl2 (Scheme 2.7).209 Addition of three equivalents of alkynyllithium 44 to 7 furnished α-
amino ynone 45 upon quench.210 Unfortunately, all of the standard conditions (AgOTf211, 
AuCl212, Pd(MeCN)4(BF4)2213) that promote 6-endo-dig cyclizations of alcohols into ynones 
instead provided the 5-endo-dig product.  It was difficult to confirm this cyclization, as 5-
membered cyclic enaminones and 2,3-dihydro-4-pyranones have very similar 1D NMR 
resonances,214215 and the isolated product was unstable and polymerized readily.  Thankfully, an 
HMBC correlation between the α-proton and the fully substituted olefinic carbon combined with 
a lack of correlation between the protons on the hydroxymethyl chain and that same carbon 
confirmed the identity of the cyclic enaminone.  It is worth noting that this synthesis was also 
attempted unsuccessfully with a trityl group replacing the Boc, imagining that significant 
increases in steric hindrance towards cyclization could be helpful. While these results were 
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disappointing, we remained undismayed towards pursuing an analogous synthesis of 43, since we 
surmised the enhanced nucleophilicity of the β-amino group of 47 over the β-hydroxy group in 45 
would override the unproductive competitive cyclization of the α-Boc-amine.  
 
Scheme 2.7. Retrosynthetic Analysis & First Generation Syntheses Towards 42 and 43 
A congruent route for the synthesis of 43 necessitates the conversion of the alcohol in 7 to an 
amine. To begin, 46 was synthesized through mesylation of 7 followed by azide displacement.  
Notably, the yield of the azide displacement increased by 20% when a longer reaction time was 
used concomitant with reduced heat (from 60 °C to 40 °C). Using MeOH as the solvent for the 
subsequent hydrogenation gave widely variable yields,216 but switching to EtOH afforded 47, the 
desired diaminopropionic acid derivative, in excellent yield. However, addition of lithium 
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acetylide 48 to 47 only furnished the product in trace quantities, instead producing many 
uncharacterizable highly polar products in addition to a low yield (<10%) of the enynone that 
would result from addition of the alkyne and elimination of the β-amino.217  
As the synthesis of 45 from 7 and 44 was quite facile, further investigation seemed warranted 
to understand the failure of 48 to add into 47.  An obvious difference in reactivity between 7 and 
47 is that the alcohol of 7 gets deprotonated by alkynyllithium species, whereas the unprotected 
amino group of 47 does not.  7 and 47 also have highly contrasting solubility in THF: 7 is highly 
soluble (>0.5 M), whereas the maximum solubility of 47 is ~0.02 M.  The lack of solubility of 47 
appeared more likely to be causing the undesired reactivity, so we hypothesized that 47, 
following mono- or di-lithiation (di-lithiation through reaction of the acetylide with the Weinreb 
amide of 47), was forming insoluble aggregates that had perplexing reactivity.218 Polar additives, 
both organic (HMPA, DMPU, TMEDA, LiHMDS), and inorganic (LiCl) were added to the 
reaction to break up the potential aggregates,219 with none producing a desired effect. The use of 
alkynylmagensium reagents was also unproductive. Having no remaining alternatives, we chose 
to protect the β-amino group of 47 to enhance solubility.  Common amino protecting groups 
orthogonal to Boc, such as Fmoc or Cbz, could not be used for this synthesis, so bis-PMB and 
trityl protecting groups were chosen (Scheme 2.8). Compounds 49 and 50 were synthesized using 
standard conditions in moderate yield.  When 49 and 50 were subjugated to the problematic 
ynone-formation reaction, isolation of the products revealed large (>40%) yields of tritylamine 
and bis-PMB-amine indicating competitive β-elimination was a major side-reaction. Given the 
extremely poor nature of these leaving groups, this is unexpected, but must be facilitated by 
lithium coordination.  These results also shed light on the failure of combining β-amino 47 and 
lithium acetylide 48, suggesting a similar elimination mechanism occurs with ejection of lithium 
amide, formally an endergonic process. Notably, elimination was not observed with 7 since the 
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β-hydroxy group is deprotonated under the reaction conditions and elimination would formally 
lead to release of the dianion lithium oxide, an even more endergonic process. 
 
Scheme 2.8. Amine Protection Reveals 48 causes Beta-Elimination of 47. 
Design and Synthesis of Dihydrothiopyranone 51. Having now uncovered the reasons for 
the failure of the original syntheses of both 42 and 43, a shrewd solution came to bear.  We 
hypothesized replacing the ethereal oxygen in 42 with a sulfur atom, thus changing the 
heterocyclic core, should solve the problems with the originally designed synthesis while 
maintaining the molecule’s ability to inactivate BioA. Thiols are more acidic than alcohols and 
should therefore remain deprotonated during the key Weinreb amide coupling reaction with an 
alkynyllithium, preventing β-elimination. Thiols are also substantially more nucleophilic; 
consequently, the resulting ynone should favor the desired 6-endo-dig cyclization pathway over 
the undesired 5-endo-dig pathway observed with 7.220 We thus began the synthesis of 51, the 2,3-
dihydro-4-thiopyranone analogue of 42 and 43 (Scheme 2.9). 
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Scheme 2.9. Synthesis of Dihydrothiopyran-4-one 51 from Cysteine Precursors 
Compound 15 was synthesized from (±)-14 using our optimized conditions for Weinreb 
amide formation in excellent yield.  S-Trityl deprotection proceeded smoothly with the addition 
of Et3SiH and a drop of TFA to afford 16.221 Addition of 10 to 16 while maintaining a 
temperature of -78 °C provided the desired 2,3-dihydro-4-thiopyranone ring through spontaneous 
cyclization of the intermediate ynone, validating our synthetic plan. The TBS group was 
deprotected to produce 18, after which Boc-deprotection was attempted.  The use of TFA in 
CH2Cl2 furnished a mixture of desired product 13 and its TFA ester,222 a virtually unprecedented 
esterification under these conditions.  However, switching to HCl in dioxane provided 13 in a 
convenient, 5-step synthesis from commercially available N-Boc-S-trityl cysteine 14. 
Second Generation Syntheses of 2 and 3. Bolstered by the successful synthesis of 
dihydrothiopyranone 51, we envisioned two alternate approaches to tackle the synthesis of 42 and 
43. In the first of these, we recognized that bis-protection of the α-amino group of 45 would be 
necessary for the synthesis of 42 to prevent competitive 5-endo-dig cyclization while for target 43 
protection of the β-amino group of 47 with a suitable protecting group would be required to 
prevent undesired β-elimination. Both of these strategies appeared challenging.  For example, bis-
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Boc-α-amino protection would certainly react with the adjacent alkoxide generated in situ from 
the addition of a lithium acetylide,223 while the protecting group requirements for the β-amino 
group are overly restrictive due the necessity for orthogonality with the α-amino Boc and 
compatibility under the strongly basic reaction conditions of the alkynyllithium addition. The 
second approach, that we ultimately elected to perform, involved installation of the troublesome 
α-amino group post-cyclization, which would considerably simplify the synthesis and avoid both 
of the aforementioned challenges. The feasibility of the new synthetic plan was supported by a 
report by Collet and coworkers,224 who demonstrated the reagent N-Boc-3-(4-
cyanophenyl)oxaziridine could electrophilically transfer a –NHBoc group to the carbon of an 
enolate. Moreover, a report by Gouault and coworkers confirmed that the required enolate could 
be regioselectively generated in an analogous C6-substituted N-Boc protected 2,3-dihydro-4-
pyridone derivative and react successfully in an aldol-type reaction.225  
As stated above, the retrosynthetic plan calls for cyclization of an ynone followed by 
electrophilic amination at the C3 carbon. (Scheme 2.10) The second-generation synthesis of 42 
begins with the mono-PMB-protection of 1,3-propanediol 57 to form 58.226  Subsequent Jones 
oxidation and Weinreb amide formation227 afforded ynone precursor 59.  Addition of 
alkynyllithium 60 furnished 61 in excellent yield, which was then deprotected with DDQ to 
provide β-hydroxy ynone 62.  The ensuing cyclization using AgOTf afforded dihydro-4-pyranone 
63 without incident, ready for the electrophilic amination.  To our surprise, addition of LiHMDS 
to a solution of 63 resulted in a rearrangement of the heterocycle to form 64, which was 
rigorously characterized. The simplest route to formation of 64 is α-enolate formation leading to 
β-elimination of the endocyclic ether oxygen, rupturing the dihydropyranone core and forming an 
alkoxy-dienone, furnishing 64 upon quench, similar to the mechanism previously been 
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postulated by Boring and Sindelar.228 The facility of this base-catalyzed degradation pathway 
completely nullified this synthetic route.  
 
Scheme 2.10. Synthesis of 2-Amino-Dihydropyran-4-ones by Electrophilic Amination 
Leads to Ring Cleavage via Beta-Elimination 
As mentioned previously, Gouault and coworkers had demonstrated that replacing the 
ethereal oxygen with a Boc-protected amino, as an analogous second generation synthesis of 43 
would necessitate, would result in stable and nucleophilic enolates for the desired electrophilic 
amination,229 so we chose to proceed with this synthesis.  Boc-β-alanine 65 was first transformed 
into Weinreb amide 66 using standard conditions (Scheme 2.11).  Subsequent addition of 48 
furnished Boc-protected β-amino ynone 67, primed for cyclization.  Ynone 67 was added to 
PPh3AuOTf generated in situ from the combination of AgOTf and PPh3AuCl, producing 
dihydropyridone 68.230 Enolate formation employing LiHMDS followed by addition of N-Boc-3-
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(4-cyanophenyl)oxaziridine afforded the desired electrophilic amination product 69.  In this 
reaction, the byproduct p-cyanobenzaldehyde undergoes rapid aldol addition with the enolate, 
limiting the theoretical yield to approximately 50%.34 Deprotection of the TBS group using 
HF·pyridine proceeded smoothly; however, the final bis-Boc deprotection of 70 proved 
unconquerable.  Boc groups on the N1 position of dihydro-4-pyridones are much more 
challenging to remove than standard alkyl-amino Boc groups, requiring up to 24 hours using TFA 
in CH2Cl2.231 Several conditions were attempted (TFA in CH2Cl2, HCl in dioxane/EtOAc, phenol 
and TMSCl in CH2Cl2)232 that provided only trace amounts of product.  The Boc-amino group on 
C3 was cleanly deprotected within an hour applying any of these conditions, but longer reaction 
times to remove the second Boc group resulted in extensive decomposition. We speculate that 
dimerization of the resulting α-aminoketones to a tricyclic pyrazine derivative is occurring based 
on the well-known propensity of α-aminoketones to furnish dihydropyrazines, which can 
spontaneously oxidize.233 
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Scheme 2.11. Synthesis of 43 by Electrophilic Amination Fails During the Final 
Deprotection 
Third Generation Syntheses of 42 and 43. Frustrated by the repeated failures, it was 
decided to return to the original retrosynthetic plans and modify them to accommodate necessary 
changes.  As mentioned above, in the synthesis of 43, the β-amino group on 47 needs to be 
protected with either an amide or carbamate group so that the addition of the lithium acetylide 
removes the amino proton.  Most conventional amide and carbamate protecting groups are either 
not stable to lithiates or appeared impossible to remove without side-reactivity.  One that 
appeared adequate for our purposes is (2-Trimethylsilyl)ethoxycarbonyl (Teoc), which is quite 
robust to lithiation and can be removed in the presence of a Boc group with TBAF.234 
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Scheme 2.12. Synthesis of 43 using Teoc Protection of the Beta-Amino Group 
The synthesis of 43 using this revised route began with (±)-Boc-asparagine 71 (Scheme 2.12).  
A modified Hoffman rearrangement provided mono-Boc protected 72 with only a filtration 
necessary for purification.235 Subsequent addition of 4-nitrophenyl 2-(trimethylsilyl)ethyl 
carbonate, in a modified procedure from the one developed by Rosowski and Wright,236 afforded 
differentially protected diaminopropionic acid derivative 73 following purification by simple 
aqueous extraction.  The only previous synthesis of 73, published by Boger and coworkers in 
2000, required four steps from N-Boc-serine methyl ester.237 Formation of the Weinreb amide 
furnished 74, which reacted with alkynyllithium 48 to provide ynone 75.  Compared to the 
previous conversion of 66 to 67, formation of 75 was quite sluggish, likely due to increased steric 
hindrance from the Teoc group.  The most challenging point of the synthesis proved the next step, 
concomitant removal of the Teoc and TBS groups.   
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Attempted deprotection of 75 using TBAF rapidly consumed the starting material, yet only 
yielded 76 in a 12% yield with numerous highly polar side-products. We hypothesized this was 
due to the strong basicity of TBAF.  AcOH and water are known to attenuate both the basicity 
and reactivity of TBAF,238 and as such they were each added to TBAF deprotections of 75, 
attempting to remove the Teoc and TBS groups while leaving the rest of the molecule intact. To 
our dismay their inclusion either abolished activity (AcOH, >10 equiv H2O) or slowed the 
reaction without improvement of the yield (<10 equiv H2O). Careful monitoring by TLC showed 
a faint intermediate spot with an Rf value slightly below the staring material that rapidly appeared 
following the addition of TBAF and slowly disappeared during the course of the reaction.  
Isolation of this spot revealed that the TBS group had been removed and liberated alcohol 
cyclized into the ynone, forming a substituted tetrahydrofuran (Scheme 2.12).  This was the sole 
product when >10 equivalents of H2O was added to the TBAF reaction, though it appeared to 
degrade during chromatography, as we were never able to isolate it in yields above 50%.  
Realizing that the formation of the vinylogous ester in the tetrahydrofuran intermediate would 
tame the acidity of the α or γ protons as compared to 75, which were believed to be the source of 
the low yield, a two-step process was developed for this dual deprotection.  First, TBAF and 
water (60 equiv) were stirred with 75 for 16 h, after which it had been entirely converted to the 
tetrahydrofuran intermediate.  Then 4 Å molecular sieves were added, sequestering much of the 
water and causing deprotection of the Teoc group within 5 minutes.  This procedure more than 
tripled the yield to 39%, a feasible yield for continuing.  The speed of the second Teoc 
deprotection surprised us, but commercially available 1 M TBAF in THF contains 5% (w/w) H2O 
significantly dampening its activity.239 Very little water remains -following addition of the sieves, 
so the TBAF is extremely reactive and can remove even a robust group like Teoc in under 5 min.  
We also tried replacing the TBS group in 76 with several common protecting groups (Bn, THP, 
MOM) to test whether mono-Teoc deprotection could improve the cyclization yield. 
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Unfortunately, in all attempted cyclizations lacking the TBS group, the yield never approached 
20%, further demonstrating the importance of the vinylogous ester intermediate. Finally, 
deprotection of 76 employing 4 M HCl in dioxane completed the synthesis of dihydropyridone 
43. 
Turning our attention towards the synthesis of 42, N,N-diprotection of the serine-derived 
Weinreb amide was deemed essential prior to ynone formation.  The most common ways to 
protect both protons of an amine group are using either phthalimide or bis-Boc, both of which 
were eliminated from consideration for this system. Phthalimide deprotection requires relatively 
harsh conditions that would be incompatible with the remaining heterocycle, while the bis-Boc 
derivative is extremely bulky and would be highly susceptible to intramolecular cyclization with 
the β-alkoxy generated from alkynyllithium addition to form a stable oxazolidinone.  Instead, we 
decided to adopt the approach reported by Devlin & Du Bois240 which utilized dual Boc and 
MOM protecting groups to protect an amine. This appeared ideal for our system, as MOM and 
Boc share similar stability profiles as well as deprotection conditions, and a MOM group is both 
less electron withdrawing and smaller than a Boc group, making intramolecular cyclization to 
form an oxazolidinone much slower. 
Beginning with 7, standard TBS protection conditions afforded 77 in excellent yield. MOM 
protection using KHMDS as the base furnished the desired tri-protected serine derivative,241 
whose Rf was coincident with 77. This intermediate was not isolated, but directly deprotected 
with HF·Pyridine to furnish Weinreb amide 78.  Surprisingly, when 78 was left in CDCl3 
overnight for 13C NMR characterization, the molecule cyclized to 1,3-oxazolidine due to residual 
acid (Scheme 2.13), an undesirable reaction that foreshadowed complications with the future 
Lewis acid catalyzed 6-endo-dig cyclization.  The use of non-acidic solvents such as acetone or 
CH2Cl2 was necessary for successful characterization.  Addition of 44 to 78 at -78 °C furnished 
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the desired dual Boc-MOM protected ynone 79 in satisfactory yield. Maintaining a temperature of 
-78 °C proved essential to prevent the aforementioned intramolecular cyclization of the β-
alkoxide into the Boc group. 
 
Scheme 2.13. Synthesis of Dual Boc-MOM Protected Amino Ynone 79 and Side 
Reactivity from the Beta-Hydroxyl 
To our consternation, the cyclization of 79 to dihydropyranone 80 proved problematic, as 
standard conditions (AgOTf, AuCl) rapidly produced 80 along with a bevy of side-products 
(Table 2.4, entries 1-2).  The reactivity of the MOM group in the presence of Ag(I) salts has been 
previously exploited in several synthetic transformations,242 so the observed side-reactivity was 
not surprising.   The rapidity of these reactions suggested that dampening the activity of the 
Lewis acid would be necessary to improve the reaction.  Lowering the temperature, while 
successful in completely stopping the reaction (Table 2.4, entry 3), did not alleviate the undesired 
reactivity at temperatures where the reaction proceeded (Table 2.4, entry 4).  Pursuing alternative 
alkynophillic Lewis acids lead to the discovery that PPh3AuCl did not promote any reaction 
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(Table 2.4, entry 5), in contrast to AuCl. Surmising that the substantially increased electron 
density from the phosphine ligand dampened the reactivity of the gold catalyst, we attempted to 
see if a “sweet spot” in electron density on the gold could be attained, where cyclization would 
occur without the undesired side-reactivity. A well-known way to modify the properties of gold 
catalysts is to induce ion exchange through the addition of silver salts.243 Switching to 
bistriflimide (Table 2.4, entry 6) provided a very similar product profile to the original conditions, 
but the substitution of hexafluoroantimonate (Table 2.4, entry 7) afforded 80 in substantially 
increased yield, validating this approach. The use of triflate (Table 2.4, entry 8) proved the most 
successful, producing the highest yield with a modest reaction time of 3 h. The undesired side 
products were still present with this modification, but in greatly lessened amounts.  
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Table 2.4. Metal-Catalyzed Cyclization of Hydroxy-Ynone 79 to Dihydropyran-4-one 80 
 
TBDPS deprotection of 80 using HF·Pyridine swiftly afforded penultimate intermediate 81 
(Scheme 2.14).  However, standard Boc deprotection conditions were unsuccessful in forming the 
final product 42, instead leading to degradation.  Fearing that aprotic conditions were leading to 
attack of the ketone onto the MOM group as seen previously (Table 2.4), both aqueous acid and a 
switch of the solvent to MeOH were attempted, with neither providing more than trace amounts 
of product.  Employing a Lewis acid in anhydrous conditions was also fruitless, as SnCl4244 failed 
to produce 42.  A report by Hu and coworkers245 using BiCl3 as a Lewis acid in a partially 
 
Entry Conditions Yield 
1 AgOTf (1.0 equiv), 5 min, 23 °C 15% 
2 AuCl (0.1 equiv), 5 min, 23 °C 10% 
3 AgOTf (1.0 equiv), 3 h, -40 °C N.R. 
4 AgOTf (1.0 equiv), 20 min, -15 °C ~10% 
5 PPh3AuCl (0.1 equiv), 3 h, 23 °C N.R. 
6 
PPh3AuCl (0.1 equiv), 
AgNTf2 (0.05 equiv), 10 min, -78 to 0 °C 
7% 
7 
PPh3AuCl (0.1 equiv), 
AgSbF6 (0.07 equiv), 16 h, -78 to 0 °C 
43% 
8 
PPh3AuCl (0.2 equiv), 
AgOTf (0.1 equiv), 3 h, -78 to 0 °C 
52% 
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aqueous environment appeared perfect for our system.  Indeed, slight modifications to their 
procedure furnished 42, completing the trio of desired scaffolds. 
 
Scheme 2.14. Final Deprotections to Furnish Dihydropyran-4-one 42. 
Biochemical Results. Compounds 42, 43, and 51 were then evaluated for their ability to 
irreversibly inhibit BioA. We developed a LC-MS/MS method for the detection of dethiobiotin 
with biotin as an internal standard and used it with the conditions previously established by 
Aldrich and coworkers for assaying BioA by coupling it with tubercular BioD.246 0.5 µM BioA 
was preincubated with 0.05-1 mM of inhibitor in the absence of substrates, and aliquots were 
removed at times between 2 and 40 minutes. Each of these aliquots were assayed for their 
remaining enzymatic activity by measuring the production of DTB following the addition of 
substrates and BioD. Neither dihydro-4-pyranone 42 nor dihydro-4-thiopyranone 51 had any 
inhibitory activity; however, dihydro-4-pyridone 43 displayed time-dependent inhibition of BioA, 
consistent with what one would expect from a MBI. The lack of activity of 42 and 51 was found 
to due to their instability in the basic aqueous conditions of the assay. The kobs values were 
obtained through plotting the observed rates of DTB formation versus preincubation time at each 
inhibitor concentration. Next, the kobs values were plotted against the concentration of inhibitor, 
and fitting this data to a hyperbola produced the KI and kinact values displayed in Table 2.5 (See 
experimental section). Dihydropyrid-4-one 43 possesses a nearly 3-fold increase in kinact relative 
to 1, and the rate limiting step cannot be slower than the kinact, so we successfully increased the 
rate of quinonoid formation by at least 3-fold. This validates our hypothesis that lowering the pKa 
of the α-proton would lead to more rapid deprotonation by BioA, though this improvement was 
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less than we anticipated based on the predicted difference in pKa between 43 and 1. 
Unfortunately, this did come with a concomitant increase in the KI value when compared to 1, 
likely due to a loss of binding affinity in the initial equilibrium.  
Table 2.5. KI and kinact Values for the Inhibition of BioA by 1, 42, 43, and 51 
Compound Structure kinact (min-1) KI (mM) 
1 
 
0.18 ± 0.01 0.52 ± 0.07 
42 
 
<0.01 >5 
43 
 
0.48 ± 0.12 3.9 ± 1.2 
51 
 
<0.01 >5 
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Based on the crystal structures available, the higher KI could not have been predicted, so we 
consider it an unfortunate happenstance. The increased kinact value means that the dihydro-4-
pyridone scaffold has greater potential for development, as it has a higher theoretical limit for 
mechanism-based inhibition for BioA. It is also extremely likely that binding affinity could be 
regained through replacement of the 3-hydroxypropyl chain, and the fact 43 can be constructed in 
7 steps from commercially available starting materials would greatly expedite such syntheses. 
However, based on the stringent requirements for Teoc deprotection and the reactions sequence 
required for moderate yield formation of 75, all analogues of 43 would have to be synthesized 
directly from 76. This certainly makes a reasonable number of analogues feasible, but it does 
limit the available pool without development of another synthetic route that could integrate 
alternative tail structures. 
On the other hand, the increased kinact of 43 provides strong support for our method of MBI 
optimization. Rational optimization of an MBI’s rate limiting step, to our knowledge, has not 
been previously performed. Our stopped-flow analyses directed us to improving the rate of 
quinonoid formation, which we successfully accomplished through the synthesis of 43, an 
inhibitor with a decreased pKa value of the α-proton. When viewed through the lens of being the 
first attempt rational optimization of an MBI and providing a roadmap for others to do the same, 
this work is a resounding triumph. 
2.6 Conclusion. 
This work highlights the continued preclinical development of MBIs of BioA, including 
switching scaffolds and the development of a novel approach to MBI optimization. We initially 
attempted to develop analogues of 1 through replacement of its hydroxypropyl tail by either a 
methylene or di-methylene linkage to electron-deficient triazoles. We successfully synthesized 
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compound 4, but it had no activity against BioA and the difficulty of analogue development 
convinced us that an alternative scaffold was necessary. An extensive investigation into KI and 
kinact for various mechanisms by which mechanism-based inhibition can occur revealed that these 
parameters are commonly interpreted incorrectly. It also demonstrated that complete knowledge 
of the microscopic rate constants of inhibition is necessary for rational optimization of MBIs. To 
advance the development of MBIs of BioA while also providing an example of the novel 
approach of complete MBI characterization, we analyzed the inhibition of BioA by 1 using 
stopped-flow spectrophotometry. This revealed that 1 inactivated BioA by a rapid reversible 
binding step followed by two irreversible steps that were significantly slower. The rate of 
quinonoid formation was found to be the kinetic bottleneck, which was vital information towards 
the design of new scaffolds for BioA inhibition. We designed dihydropyran-4-one 42, 
dihydropyrid-4-one 43, and dihydrothiopyran-4-one 51 as potential inhibitors of BioA with 
reduced pKa values of the α-proton. Envisioning congruent synthetic pathways of cyclization 
following generation of an α-amino ynone intermediate, we easily constructed 51 but were forced 
to amend our strategies for 42 and 43, as competitive 5-exo-dig cyclization, β-elimination of the 
ynone, and dimerization of the resultant α-amino carbonyls all complicated the syntheses of the 
scaffolds. We were able to overcome these challenges utilizing specialized protecting groups, 
including Teoc protection of the β-amino group in the assembly of 43 and Boc-MOM protection 
of the α-amino group in the synthesis of 42. Dihydropyran-4-one 42 and dihydrothiopyran-4-one 
51 were found to be unstable in the assay conditions, but dihydropyrid-4-one 43 possessed an 
improved kinact against BioA, validating our pKa-based design strategy. The synthesis of 43 
facilitates construction of many analogues, but an alternative synthetic route would be necessary 
for compounds that contain a shorter carbon chain for the tail of the MBI. The increased kinact also 
demonstrates the value of our rational approach to optimization, and this work should provide a 
clear blueprint for its usage in future rational MBI development. 
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2.7 Experimental Procedures. 
General Methods. All reactions were performed under an inert atmosphere of dry Ar in 
oven-dried (150 °C) or flame-dried glassware. 1H and 13C NMR spectra were recorded on a 400, 
500, or 600 MHz spectrometer. Proton chemical shifts are reported in ppm from an internal 
standard of residual chloroform (7.26), methanol (3.31), or acetone (2.05), and carbon chemical 
shifts are reported in ppm from an internal standard of residual chloroform (77.16), methanol 
(49.00), or acetone (29.84). Proton chemical data are reported as follows: chemical shift, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, pent = pentet, m = multiplet, br = 
broad), coupling constant(s), integration. High resolution mass spectra were obtained on a TOF II 
TOF/MS instrument equipped with an ESI interface. TLC analysis were performed on TLC silica 
gel plates and were visualized with UV light, ninhydrin, 10% PMA, or KMnO4 solution. 
Purifications were performed by flash chromatography on silica gel or with a medium-pressure 
flash chromatography system equipped with flash column silica cartridges.   
Materials. An anhydrous solvent dispensing system using two packed columns of neutral 
alumina was used for drying THF and CH2Cl2, while two packed columns of molecular sieves 
were used to dry DMF, and the solvents were dispensed under Argon. 7247, 8-10248, 11249, 12-13250, 
14251, 23252, 24-25253, 27254, 37255, 44256, 48257, 58258, and 60259 were prepared as previously 
described. 
Enzymatic Assay to Determine the Global Kinetic Parameters of of BioA.    
A. Assay Procedure. 50 DMSO solutions of inhibitor (final concentrations 0, 200 µM, 400 
µM, 700 µM, and 1 mM) were added to 1 buffer solutions of 100 mM Bicine, 50 mM NaHCO3, 
1 mM MgCl2, 5 mM ATP, pH 8.6. BioA (0.5 µM) was then added to each to well (total volume 
50 µL) to initiate BioA inactivation.  
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In order to measure residual BioA activity, a coupled assay with BioD was used, which 
together with BioA converts 7-keto-8-aminopelargonic acid (KAPA) to dethiobiotin.  This was 
accomplished by removing 5 µL aliquot of the initial solution at various incubation time points 
(2.5, 5, 10, 20, and 40 min) and adding to 95 µL of a reaction solution, containing saturating 
concentrations of all substrates and diluting the initial inhibitor 20-fold, ensuring no further 
inhibition.  The final concentrations present in the reaction solution are 100 mM Bicine (pH 8.6), 
50 mM NaHCO3, 1 mM MgCl2, 5 mM ATP, 5 mM SAM, 25 nM BioA, 2 µM BioD, 1 mM 
TCEP, and 25 µM KAPA.57  The reaction solutions were run for 60 min (which remained under 
initial velocity conditions), then quenched with a solution of 500 nM biotin in 10% trichloroacetic 
acid.  The dethiobiotin concentration was quantified by LC-MS/MS analysis with a gradient from 
0-100% MeCN–H2O containing 0.1% Formic Acid. Biotin was monitored through the m/z 
243200 transition and dethiobiotin was monitored through the m/z 213170 transition. Assays 
were run in duplicate on multiple days. The negative control contained no inhibitor (DMSO 
only), and the positive control contained no BioA. 
B. Data Analysis. The LC-MS/MS traces were analyzed by MultiQuant 2.0.2 to obtain the 
area under the curve (AUC) for both dethiobiotin (analyte) and biotin (internal standard). Then, 
the dethiobiotin AUC was divided by the biotin AUC, and this number was converted into a 
concentration using the standard curve. A plot was generated of preincubation time vs. percentage 
of BioA activity remaining, and curves for each concentration of inhibitor were fit to equation 3 
with Graphpad Prism to obtain values for kobs at each inhibitor concentration: 
                                                                              (1) 
In equation 1, y is the concentration of dethiobiotin, and A is the activity observed with no 
inhibitor.  The concentration of inhibitor was then plotted against the generated kobs values, and 
this was fit to equation 2 with Graphpad Prism to determine the KI and kinact values. 
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           (2) 
 Sample Derivation of the KI and kiaact Values for Mechanism 4 in Table 2.2 
This is written for the following mechanism: 
 
The labels for the intermediate and final complexes are changed to allow for simple writing with 
Word’s equation editor. KI and kinact are defined as they are in Table S1, and the assumptions 
necessary are the quasi-steady state assumption for each intermediate Enzyme-Inhibitor complex 
and that the total enzyme concentration stays constant. 
 
 
 
 
 
We express [EI] in terms of the other variables: 
 
 
 
Letting KM = (k2 + k-1)/k1: 
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Solving for [EA]: 
 
 
 
 
 
 
Now, we solve for [EB]: 
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Now, solving for [EP]: 
 
 
Let us define X: 
 
 
 
 
 
With D as the constant that arises from evaluation of an indefinite integral: 
 
 
 
 
 
Since D is just a random, unknown constant, let us set e^D = F: 
 
Now, we know that at time t= 0, [EP] = 0: 
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This means that when evaluating an inactivation time course and fitting it to an exponential, the 
kobs is equal to X. 
 
 
 
kinact is the left fraction in the equation directly above, as at infinite concentration of I, the right 
fraction will become 1, and kobs will be equal to the left fraction. KI is equal to the bottom right of 
the right fraction, as when the concentration of inhibitor equals this constant, the kobs will be half 
of the kinact. 
Stopped-Flow Analysis of the Inhibition of BioA by 1.  
A. Experimental Notes. Water used in all experiments was purified with a Millipore Super-Q 
system. Stopped flow experiments were performed using an Applied Photophysics stopped-flow 
instrument (model SX.18MV with the SX Pro-Data upgrade) at 25 °C. One syringe was filled 
with the stated concentration of BioA in 100 mM BICINE pH 8.6. The other syringe was filled 
with a solution derived from diluting a 20 mM solution of 1 in DMSO with 100 mM BICINE pH 
8.6 to the specified concentration of 1. All buffers were degassed prior to use. BioA was 
expressed as previously described260 and 1 was synthesized as previously described.261 
Experiments were either monitored with a diode-array or a single wavelength detector. The 
concentration of BioA was kept below one-fifth of the concentration of 1, establishing pseudo-
first order conditions. The kinetic data was analyzed to extract reciprocal relaxation times with 
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Applied Photophysics Pro-Data Viewer through fitting reaction time courses to summed 
exponential expressions.  Simulations of the system with the obtained rate constants were 
performed with Tenua. 
B. Data Analysis. The reaction time course for a series of first order or pseudo first order 
reactions can be fit by a sum of exponential expressions where the number of exponential terms is 
equal to the number of steps.262,263  The time course is fit using nonlinear regression analysis to 
yield reciprocal relaxation times (RRTs) and amplitudes of the exponential terms. The RRT 
values are only equal to rate constants for individual steps in the reaction series if each step is 
irreversible.  The order of magnitude of the RRTs in this case do not necessarily correlate with 
the order of steps in the reaction series.  The presence of an irreversible step in the reaction series 
uncouples RRTs so that some of the RRTs may correlate with the rate constants for specific steps 
in the reaction series that occur after the irreversible step. For the reaction considered in this 
study, the second step is functionally irreversible, so one of the RRTs directly gives the rate 
constant for the final step in the reaction series. The presence of an irreversible step can often be 
detected by the lack of substrate concentration dependence on some of the RRT values. This is 
true because reversible steps couple RRT values such that a given RRT reflects more than one 
rate constant. In the general case, it is necessary to extract the rate constants from experimental 
RRT values using expressions derived by integrating the series of differential rate equations that 
pertain to the proposed reaction steps.  This leads to complex equations relating RRTs and rate 
constants.  For example, for a two-step reversible binding reaction, the two RRTs are equal to the 
plus and minus roots of a quadratic equation containing all of the forward and reverse rate 
constants for the steps.  Thus, neither of the RRTs correlates directly to one step of the series, but 
both will contain the second order rate constant for substrate binding and exhibit substrate 
concentration dependence.  A useful simplification is possible if the substrate (or inhibitor) 
binding reaction initiates the reaction series and is fast compared with downstream reactions.264,265  
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This allows it to reach an approximate equilibrium before the succeeding reactions occur. The 
specific criterion is that the reverse rate constant for binding reaction exceed the forward rate 
constant for the following reaction by >3 fold.  If this is the case, then a plot of the fast RRT vs 
substrate concentration will be linear (which is what we observe) with the slope and intercept 
equal to the forward and reverse binding rate constants, respectively (equation 3). The plot of the 
slower RRT vs substrate concentration will be hyperbolic with the y-intercept equal to the reverse 
rate constant of the step following binding.  The extrapolated maximum value of the hyperbola 
will be the sum of the forward and reverse rate constants for this reaction and the apparent KD for 
the curve will be the KD of the preceding binding reaction (equation 4, where A is the substrate or 
inhibitor). 
                                            (3) 
                                             (4) 
If the KD values determined from the two plots agree, then it suggests that the criteria for 
utilization of this simplification have been met and that one reaction directly follows the other.  
For the data analyzed in this study, the fastest and slowest RRTs give linear and hyperbolic plots 
vs 1, respectively, and these plots yield similar values for the binding KD (240 µM from equation 
3, 180 µM from equation 4). The concentration dependencies of all three observed RRTs allowed 
the reactions to be put in the correct sequence and the rate constants and KD values to be 
extracted. 
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(S)-2-[(tert-Butoxycarbonyl)amino]-N-((S)-1-azidobut-3-en-2-yl)but-3-enamide (15). To a 
solution of 14 (280 mg, 1.4 mmol, 1.0 equiv) in THF (15 mL) at 0 °C was added 13 (180 mg, 1.6 
mmol, 1.2 equiv), NaHCO3 (590 mg, 7.0 mmol, 5.0 equiv) and DEPBT (1.5 g, 4.9 mmol, 3.5 
equiv). The reaction was stirred for 1 h, then allowed to warm up to 23 °C. After 48 h, the 
reaction mixture was partitioned between EtOAc (75 mL) and saturated aqueous NH4Cl (50 mL). 
The layers were separated and the aqueous layer was extracted with EtOAc (3  20 mL). The 
organic layers were then combined and washed with water (1  30 mL) and brine (1  30 mL), 
dried (MgSO4), and concentrated. Purification by flash chromatography (5% EtOAc–hexane to 
25% EtOAc–hexane, linear gradient) afforded the title compound (302 mg, 73%) as a white 
powder: Rf = 0.15 (20% EtOAc–hexane); 1H NMR (600 MHz, CDCl3) δ 6.46 (br. s., 1H), 5.93 
(ddd, J = 6.5, 10.6, 17.0 Hz, 1H), 5.81 (ddd, J = 5.3, 10.4, 17.2 Hz, 1H), 5.22–5.46 (m, 5H), 
4.61–4.77 (m, 2H), 3.41–3.54 (m, 2H), 1.45 (s, 9H); 13C NMR (150 MHz, CDCl3) δ 169.7, 155.4, 
134.3, 133.7, 118.4, 117.7, 80.3, 57.1, 54.3, 51.0, 28.3; 
 
(S)-2-[(tert-Butoxycarbonyl)amino]-N-((S)-1-(4-(trimethylsilyl)-1H-1,2,3-triazol-1-yl)but-3-
en-2-yl)but-3-enamide (17). To a solution of 15 (150 mg, .50 mmol, 1.0 equiv) and TMS 
acetylene (250 mg, 2.5 mmol, 5.0 equiv) in t-BuOH (2 mL) was added a solution of CuSO4*5 
H2O (13 mg, .05 mmol, 0.1 equiv) and sodium ascorbate (31 mg, .15 mmol, 0.3 equiv) in water (2 
mL). The reaction mixture was stirred vigorously. After 24 h, 0.1 equiv of CuSO4*5 H2O, 0.3 
equiv of sodium ascorbate, and 3.0 equiv of TMS acetylene were added. After an additional 48 h, 
0.1 equiv of CuSO4*5 H2O, 0.3 equiv of sodium ascorbate, 3.0 equiv of TMS acetylene, and 
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water (0.2 mmol) were added. Following another 48 h, 0.3 equiv of sodium ascorbate and 3.0 
equiv of TMS acetylene were added. 48 h after the final addition of reagents, the reaction was 
partitioned between EtOAc (80 mL) and 1 M NH4OH (40 mL). The layers were separated and the 
organic layer was washed with 1 M NH4OH (1  40 mL). The combined aqueous layers were 
extracted with EtOAc (2  30 mL). The combined organic extracts were washed with brine (1  
30 mL), dried (MgSO4), and concentrated. Purification by flash chromatography (20% EtOAc–
hexane to 80% EtOAc–hexane, linear gradient) afforded both the title compound (54 mg, 27%) 
and its desilylated analog 19 (82 mg, 51%), both as white powders: Rf = 0.2 (50% EtOAc–
hexane); 1H NMR (600 MHz, CDCl3) δ 7.53 (s, 1H), 6.72 (d, J = 7.6 Hz, 2H), 5.71–5.89 (m, 3H), 
5.15–5.42 (m, 5H), 4.84–4.96 (m, 1H), 4.45–4.70 (m, 3H), 1.44 (s, 9H), 0.32 (s, 9H); 13C NMR 
(150 MHz, CDCl3) δ 169.8, 155.1, 146.6, 133.6, 133.3, 130.1, 118.30, 118.27, 80.1, 57.1, 52.1, 
52.0, 28.3, -1.2; MS (ESI+) calcd for C18H32N5O3Si [M + H]+ 394.2269, found 394.2. 
 
(S)-N-((S)-1-(1H-1,2,3-Triazol-1-yl)but-3-en-2-yl)-2-[(tert-Butoxycarbonyl)amino]-but-3-
enamide (19). To a solution of 17 (54 mg, .14 mmol, 1.0 equiv) in anhydrous THF (2 mL) at 0 
°C was added HF·Pyridine (1 mL) dropwise. After 2 h the reaction was partitioned between 
EtOAc (60 mL) and saturated NaHCO3 (20 mL). The layers were separated and the aqueous layer 
was extracted with EtOAc (2 x 20 mL). The combined organic layers were dried (MgSO4) and 
concentrated. Purification by flash chromatography (30% EtOAc–hexane to 80% EtOAc–hexane, 
linear gradient) afforded the title compound (28 mg, 64%) as a white powder: Rf = 0.2 (80% 
EtOAc–hexane); 1H NMR (600 MHz, CDCl3) δ 7.68 (s, 1H), 7.60 (s, 1H), 6.79–6.96 (m, 1H), 
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5.76–5.88 (m, 2H), 5.21–5.36 (m, 5H), 4.90 (pen, J = 6.2 Hz, 1H), 4.54–4.70 (m, 3H), 1.44 (s, 
9H); 13C NMR (150 MHz, CDCl3) δ 170.0, 155.3, 133.7, 133.4, 133.1, 124.6, 118.5, 118.4, 80.3, 
57.2, 52.6, 51.8, 28.3; 
 
(3S,6S)-6-((1H-1,2,3-Triazol-1-yl)methyl)-3-amino-3,6-dihydropyridin-2(1H)-one 
Hydrochloride Salt (4). To a solution of 19 (60 mg, .19 mmol, 1.0 equiv) in CH2Cl2 (20 mL) 
was added Hoveyda-Grubbs II Catalyst (12 mg, .019 mmol, 0.1 equiv). The reaction was refluxed 
under the exclusion of light for 24 h followed by the addition of Hoveyda-Grubbs II Catalyst (12 
mg). After a total of 48 h at reflux, the reaction mixture was concentrated. Purification by flash 
chromatography (0% MeOH–CH2Cl2 to 10% MeOH–CH2Cl2, linear gradient) afforded the Boc-
protected analog of the title compound (11 mg, Rf = 0.40 (10% CH2Cl2–hexane)) and 19 (23 mg). 
This analog (11 mg, 0.38 mmol, 1.0 equiv) was then dissolved in 4 M HCl in dioxane (2 mL). 
After 1 h, the reaction mixture was concentrated. Purification by trituration (dissolve in MeOH, 
crash out with Et2O) afforded the title compound (6.4 mg, 15%) as a white solid: 1H NMR (600 
MHz, CD3OD) δ 7.99 (s, 1H), 7.75 (s, 1H), 6.16–6.22 (m, 1H), 5.90–5.96 (m, 1H), 4.59–4.75 (m, 
3H), 4.40–4.46 (m, 1H). 
 
Ethyl (R,E)-4-[(tert-butoxycarbonyl)amino]-6-hydroxyhex-2-enoate (29). To a solution of 25 
(202 mg, 1.0 mmol, 1.0 equiv) in toluene (25 mL) at 23 °C was added Ph3PCHCO2Et (523 mg, 
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1.5 mmol, 1.5 equiv). After 6 h, the reaction was partitioned between EtOAc (120 mL) and water 
(50 mL). The layers were separated and the organic layer was washed with brine (1  50 mL), 
dried (MgSO4), and concentrated. Purification by flash chromatography (300 mL 10% EtOAc–
hexane, 800 mL 40% EtOAc–hexane), afforded the title compound (221 mg, 81%) as a clear oil: 
Rf = 0.35 (50% EtOAc–hexane); 1H NMR, 13C NMR, and MS data matched reported values.266 
 
Ethyl (R,E)-4-((S)-2-[(tert-butoxycarbonyl)amino]but-3-enamido)-6-hydroxyhex-2-enoate 
(31). To a solution of 29 (273 mg, 1.0 mmol, 1.0 equiv) in CH2Cl2 (5 mL) at 0 °C was added 4 M 
HCl in dioxane (2.5 mL) After 15 min, the ice bath was removed and the reaction was allowed to 
warm to 23 °C, and after 1 h the reaction mixture was concentrated to give a white solid. This 
was added to a solution of 14 (200 mg, 1.0 mmol, 1.0 equiv) in THF (15 mL) at 0 °C, followed 
by NaHCO3 (420 mg, 5.0 mmol, 5.0 equiv) and DEPBT (1.05 g, 3.5 mmol, 3.5 equiv). The 
reaction was stirred for 1 h, then allowed to warm up to 23 °C. After 48 h, the reaction mixture 
was partitioned between EtOAc (100 mL) and saturated aqueous NH4Cl (10 mL). Water (70 mL) 
was added and the layers were separated. The aqueous layer was extracted with EtOAc (2  100 
mL). The organic layers were then combined and washed with water (1  30 mL) and brine (1  
30 mL), dried (MgSO4), and concentrated. Purification by flash chromatography (25% EtOAc–
hexane to 70% EtOAc–hexane, linear gradient) afforded the title compound (75 mg, 21%) as a 
pale yellow powder: Rf = 0.35 (50% EtOAc–hexane); 1H NMR (400 MHz, CDCl3) δ 6.90 (dd, J = 
5.1, 15.7 Hz, 1H), 6.84 (br. s., 1H), 5.84–6.02 (m, 2H), 5.40 (d, J = 16.8 Hz, 1H), 5.25–5.36 (m, 
2H), 4.86 (br. s, 1H), 4.66 (br. s., 1H), 4.20 (q, J = 7.0 Hz, 2H), 3.58–3.81 (m, 2H), 2.68 (br. s, 
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1H), 1.93–2.08 (m, 1H), 1.58–1.69 (m, 1H), 1.46 (s, 9H), 1.29 (t, J = 7.2 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 170.4, 166.1, 155.4, 146.6, 133.6, 121.6, 118.5, 80.5, 60.6, 58.8, 57.3, 48.1, 36.2, 
28.3, 14.2; 
 
Ethyl (R,E)-4-((S)-2-[(tert-butoxycarbonyl)amino]but-3-enamido)-6-((tert-
butyldimethylsilyl)oxy)hex-2-enoate (32). To a solution of 31 (128 mg, 0.27 mmol, 1.0 equiv) 
in CH2Cl2 (20 mL) at 0 °C was added imidazole (53 mg, 0.81 mmol, 3.0 equiv) and TBSCl (45 
mg, 0.32 mmol, 1.2 equiv). The reaction mixture was allowed to warm to 23 °C after an hour, and 
after 16 h it was partitioned between CH2Cl2 (60 mL) and water (20 mL). The layers were 
separated and the organic layer was washed with saturated aqueous NH4Cl (1  20 mL) and brine 
(1  20 mL), dried (MgSO4), and concentrated. Purification by flash chromatography (10% 
EtOAc–hexane to 30% EtOAc–hexane, linear gradient) afforded the title compound (91 mg, 
71%) as a pale yellow oil: Rf = 0.25 (20% EtOAc–hexane); 1H NMR (400 MHz, CDCl3) δ 6.92 
(d, J = 7.8 Hz, 1H), 6.86 (dd, J = 5.1, 15.7 Hz, 1H), 5.79–5.96 (m, 2H), 5.46 (br. s, 1H), 5.35 (d, J 
= 17.2 Hz, 1H), 5.25 (d, J = 10.2 Hz, 1H), 4.72–4.82 (m, 1H), 4.61 (br. s, 1H), 4.15 (q, J = 7.0 
Hz, 2H), 3.68 (dd, J = 4.3, 6.7 Hz, 2H), 1.86–1.97 (m, 1H), 1.70–1.80 (m, 1H), 1.43 (s, 9H), 1.25 
(t, J = 7.2 Hz, 3H), 0.88 (s, 9H), 0.04 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 169.3, 166.1, 155.1, 
146.8, 133.9, 121.3, 118.0, 80.0, 60.3, 59.9, 57.1, 48.8, 35.6, 28.2, 25.9, 18.2, 14.1, -5.5; 
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4-Bromo-N-(((4-bromophenyl)sulfonamido)thio)-N-((3R)-5-((tetrahydro-2H-pyran-2-
yl)oxy)pent-1-en-3-yl)benzenesulfonamide (39). To a solution of bis-benzenesulfonylsulfur 
diimide (2.0 g, 5.8 mmol, 1.0 equiv) in Et2O at 3 °C was added 37 (4.34 g, 25.4 mmol, 4.3 equiv). 
After 24 h, the reaction mixture was filtered, and cold Et2O (80 mL) was used to wash the cake. 
Collecting the precipitate afforded the titular compound (2.73 g, 92%: Rf = 0.25 (10% MeOH–
CH2Cl2)), which spontaneously undergoes an ene-type reaction at 23 °C, so were unable to 
characterize this product by NMR (1H NMR was always a mixture of 38 and rac-39). 
To a solution of 38 (3.33 g, 6.5 mmol, 1.0 equiv) in MeOH (20 mL) at -78 °C was added a pre-
mixed solution of Pd(TFA)2 (216 mg, 0.65 mmol, 0.1 equiv) and the bis-oxazoline chiral ligand 
(260 mg, 0.78 mmol, 0.12 equiv) in 36 mL MeOH dropwise. The reaction mixture was 
maintained at -78 °C for the duration of the addition, then stirred at -15 °C. After 7 days, the 
reaction mixture was concentrated down and purified by flash chromatography (10% EtOAc–
hexane to 30% EtOAc–hexane, linear gradient) to afford the title compound (2.05 g, 62%, >90% 
ee): Rf = 0.65 (50% EtOAc–hexane); Proper characterization of 39 by 1H NMR was extremely 
difficult due to the presence of multiple stereocenters in addition to rotamers from the 
benzenesulfonyl groups. Therefore, after verifying that the product was at least quite similar to 
the desired product, we carried it forward to the synthesis of 40, where we were able to obtain 
accurate characterization. 
 
4-Bromo-N-((3R)-5-((tetrahydro-2H-pyran-2-yl)oxy)pent-1-en-3-yl)benzenesulfonamide 
(40). To a solution of 39 (2.05 g, 4.0 mmol, 1.0 equiv) in MeOH (40 mL) and THF (10 mL) was 
added 1 N NaOH (10 mL). After 48 h, the organic solvent was removed by rotary evaporation. 
Water (40 mL) was added and the aqueous layer was extracted with EtOAc (3  100 mL). The 
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combined organic layers were dried (MgSO4) and concentrated.  Purification by flash 
chromatography (10% EtOAc–hexane to 30% EtOAc–hexane, linear gradient) afforded the title 
compound (1.19 g, 90%) as a clear oil: Rf = 0.65 (50% EtOAc–hexane); 1H NMR (400 MHz, 
CDCl3) δ 7.88 (dd, J = 3.7, 6.8 Hz, 2H), 7.44–7.60 (m, 3H), 5.56–5.72 (m, 1.5H), 5.44 (br. s., 
0.5H), 5.10–5.23 (m, 1H), 5.05 (t, J = 9.2 Hz, 1H), 4.50 (d, J = 17.6 Hz, 1H), 3.94–4.08 (m, 1H), 
3.72–3.93 (m, 2H), 3.41–3.58 (m, 1.5H), 3.30–3.41 (m, 0.5H), 1.68–1.87 (m, 4H), 1.57 (br. s., 
4H); 
 
(R)-4-bromo-N-(5-((tert-butyldimethylsilyl)oxy)pent-1-en-3-yl)benzenesulfonamide (41). To 
a solution of 40 (1.19 g, 3.6 mmol, 1.0 equiv) in CH2Cl2 (20 mL) at -50 °C was added TBSOTf 
(1.24 g, 4.7 mmol, 1.3 equiv). After 50 min, Me2S (670 mg, 10.8 mmol, 3.0 equiv) was also 
added to the reaction mixture. After 2 h of stirring, the reaction was quenched with the addition of 
1:1 Et3N/MeOH (10 mL). CH2Cl2 (100 mL) was then added and the reaction mixture was washed 
with saturated aqueous NaHCO3 (1  25 mL) and brine (1  25 mL). The organic layer was then 
dried (MgSO4) and concentrated.  Purification by flash chromatography (5% EtOAc–hexane to 
20% EtOAc–hexane, linear gradient) afforded the title compound (1.04 g, 82%) as a lear oil: Rf = 
0.8 (50% EtOAc–hexane); 1H NMR (400 MHz, CDCl3) δ 7.83–7.91 (m, 2H), 7.52–7.58 (m, 1H), 
7.45–7.52 (m, 2H), 5.79 (d, J = 6.3 Hz, 1H), 5.65 (ddd, J = 6.1, 10.5, 16.9 Hz, 1H), 5.17 (td, J = 
1.3, 17.1 Hz, 1H), 5.06 (td, J = 1.1, 10.4 Hz, 1H), 4.00 (dq, J = 5.0, 6.3 Hz, 1H), 3.73 (ddd, J = 
4.0, 8.1, 10.5 Hz, 1H), 3.59 (ddd, J = 4.3, 6.0, 10.4 Hz, 1H), 1.54–1.76 (m, 2H), 0.92 (s, 9H), 0.06 
(s, 6H); 13C NMR (100 MHz, CDCl3) δ 141.1, 137.3, 132.3, 128.8, 127.2, 116.2, 60.3, 55.3, 36.4, 
25.8, 18.1, -5.6; 
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(R)-5-((tert-butyldimethylsilyl)oxy)pent-1-en-3-amine (34). A 3-necked flask was charged with 
a coldfinger (attached to a bubbler) in the middle, an ammonia source on one side, and a septum 
on the other. The flask was cooled to -78 °C and ammonia flowed through the apparatus until 10-
15 mL had liquefied. Excess sodium metal was then added. To this ammonia/sodium solution was 
added a solution of 41 (209 mg, 0.59 mmol, 1.0 equiv) in dry THF (10 mL) dropwise. After 1 h, 
the reaction was quenched with the addition of EtOH, and the mixture was allowed to warm to 23 
°C. The reaction mixture was then partitioned between EtOAc (50 mL) and 10% aqueous Na2CO3 
(20 mL). The organic layer was then dried (MgSO4) and concentrated. Purification by flash 
chromatography (5% MeOH–CH2Cl2to 30% MeOH–CH2Cl2, linear gradient) afforded the title 
compound (97 mg, 76%) as a white powder: Rf = 0.35 (50% MeOH–CH2Cl2); 1H NMR (400 
MHz, CDCl3) δ 5.76 (ddd, J = 6.7, 10.3, 17.1 Hz, 1H), 5.07 (d, J = 17.2 Hz, 1H), 4.96 (d, J = 10.6 
Hz, 1H), 3.58–3.73 (m, 2H), 3.43 (q, J = 6.7 Hz, 1H), 1.55–1.66 (m, 2H), 1.52 (br. s., 2H), 0.84 
(s, 9H), 0.00 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 143.1, 113.2, 60.4, 51.7, 40.0, 25.8, 18.1, -
5.5; 
 
(3S,6R)-3-[(tert-butoxycarbonyl)amino]-6-(2-((tert-butyldimethylsilyl)oxy)ethyl)-3,6-
dihydropyridin-2(1H)-one (33). To a solution of 14 (600 mg, 3.0 mmol, 1.8 equiv) in dry THF 
(40 mL) at 0 °C was added NaHCO3 (1.12 g, 13.3 mmol, 7.8 equiv) and DEPBT (2.39 g, 8.0 
mmol, 4.7 equiv) sequentially. After 1 h, a solution of 34 (368 mg, 1.7 mmol, 1.0 equiv) in dry 
THF (15 mL) was added dropwise. After 3 d, the reaction was quenched with the addition of 
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saturated aqueous NH4Cl (5 mL) and subsequent water (50 mL). The reaction mixture was 
extracted with EtOAc (2  100 mL). The combined organic layers were washed with brine (1  
30 mL), dried (MgSO4), and concentrated. Purification by flash chromatography (5% MeOH–
CH2Cl2 to 30% MeOH–CH2Cl2, linear gradient) afforded 35 in modest purity. 
To the resulting solution of 35 in dry DCM was added Hoveyda-Grubbs II catalyst (29 mg, 0.46 
mmol). The reaction mixture was heated to reflux for 2 d, then cooled and concentrated. 
Purification by flash chromatography (5% EtOAc–hexane to 25% EtOAc–hexane, linear 
gradient) afforded the title compound (28 mg, 9%) as a pale yellow oil: Rf = 0.2 (20% EtOAc–
hexane); 1H NMR 400 MHz, CDCl3) δ 7.03 (br. s., 1H), 5.94 (d, J = 9.8 Hz, 1H), 5.71 (d, J = 
10.2 Hz, 1H), 5.26–5.43 (m, 1H), 4.56 (br. s., 1H), 4.12–4.25 (m, 1H), 3.69–3.91 (m, 2H), 1.75–
1.83 (m, 1H), 1.45 (s, 9H), 0.92 (s, 9H), 0.09 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 166.0, 
155.9, 127.2, 127.0, 79.8, 61.7, 60.0, 53.1, 37.8, 28.3, 25.8, 18.1, -5.6; 
 
3-Amino-6-(3-hydroxypropyl)-2,3-dihydro-4H-pyran-4-one (42). To a solution of 81 (9.0 
mg, 0.029 mmol, 1.0 equiv) in MeCN (0.5 mL) was added BiCl3 (17 mg, 0.054 mmol, 1.9 equiv).  
The reaction was then sealed and heated at 55 °C for 2 h.  MeOH (5 mL) was then added and the 
reaction mixture was filtered, then concentrated to 3 mL.  H2O (10 mL) was added and the 
mixture was filtered again. Removal of the solvent afforded the title compound (2.9 mg, 49%) as 
a white solid: 1H NMR (400 MHz, CD3OD) δ 5.49 (s, 1H), 4.75 (dd, J = 10.0, 5.0 Hz, 1H), 4.18–-
4.32 (m, 2H), 3.56 (t, J = 6.1 Hz, 2H), 2.41 (t, J = 7.6 Hz, 2H), 1.77 (pent, J = 7.0 Hz, 2H); 13C 
NMR (100 MHz, CD3OD) δ 187.9, 181.9, 103.1, 69.2, 61.9, 50.8, 32.4, 30.4; HRMS (ESI+) 
calcd for C8H14NO3 [M + H]+ 172.0968, found 172.0967 (error 0.4 ppm). 
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(±)-3-Amino-6-(3-hydroxypropyl)-2,3-dihydro-1H-pyridin-4-one hydrochloride (43). To 
a pre-chilled flask containing 76 (12 mg, 0.044 mmol, 1.0 equiv) was added cold 4 M HCl in 
dioxane (2 mL).  After 45 min at 0 °C, the reaction mixture was concentrated.  The residue was 
taken up in a minimal amount of methanol and precipitated with ether to afford the title 
compound (7.5 mg, 82%) as a white powder in equilibrium with a dimer (4:1 monomer:dimer): 
1H NMR (400 MHz, CD3OD) δ 4.52 (t, J = 6.9 Hz, 1H dimer), 4.18 (dd, J = 16.2, 7.2 Hz, 1H 
dimer), 3.98-4.08 (m, 1H dimer, 1H monomer), 3.88 (dd, J = 12.9, 6.7 Hz, 1H monomer), 3.66 (t, 
J = 5.7 Hz, 2H, dimer), 3.58 (t, J = 6.2 Hz, 2H monomer), 3.51 (t, J = 13.7 Hz, 1H monomer), 
2.84 (t, J = 7.2 Hz, 2H, dimer), 2.41 (td, J = 7.6, 2.5 Hz, 2H monomer), 1.97 (pent, J = 6.6 Hz, 
2H, dimer), 1.79 (pent, J = 7.0 Hz, 2H monomer); 13C NMR (100 MHz, DMSO-d6) δ 183.9, 
169.0, 93.6, 59.8, 49.4, 42.8, 30.63, 30.61; HRMS (ESI+) calcd for C8H15N2O2 [M + H]+ 
171.1128, found: 171.1133 (error 2.9 ppm).  
 
2-[(tert-Butoxycarbonyl)amino]-8-(tert-butyldiphenylsilyloxy)-1-hydroxy-oct-4-yn-3-one 
(45). To a solution of 5-(tert-butyldiphenylsilyloxy)-1-pentyne267 (11.2 g, 34.9 mmol, 3.4 equiv) 
in THF (110 mL) at -78 °C was added n-BuLi (15.7 mL of a 2.5 M solution in hexanes, 39.1 
mmol 3.8 equiv).  The reaction was stirred for 2 h, then a solution of 7 (2.56 g, 10.3 mmol, 1.0 
equiv) in THF (50 mL) was added slowly.  The reaction was allowed to warm to 23 °C over 2 h. 
After 16 h, the reaction was quenched by the dropwise addition of glacial AcOH (20 mL).  The 
reaction mixture was partitioned between saturated aqueous NaHCO3 (150 mL) and EtOAc (300 
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mL).  The layers were separated and the organic layer was washed with saturated aqueous 
NaHCO3 (1  150 mL) and saturated aqueous NaCl (1  100 mL), dried (MgSO4), and 
concentrated. Purification by flash chromatography (500 mL 10% EtOAc–hexane, 1 L 15% 
EtOAc–hexane, 500 mL 20% EtOAc–hexane, 1.5 L 25% EtOAc–hexane), afforded the title 
compound (3.37 g, 64%) as a yellow oil: Rf = 0.1 (20% EtOAc–hexane); 1H NMR (400 MHz, 
CDCl3) δ 7.67 (d, J = 7.0 Hz, 4H), 7.33–7.50 (m, 6H), 5.67 (d, J = 7.0 Hz, 1H), 4.41 (br s, 1H), 
3.94–4.15 (m, 2H), 3.75 (t, J = 5.7 Hz, 2H), 2.59 (t, J = 7.0 Hz, 2H), 1.85 (pent, J = 6.3 Hz, 2H), 
1.47 (s, 9H), 1.08 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 184.3, 155.7, 135.4, 133.4, 129.6, 
127.6, 98.4, 80.2, 78.9, 63.4, 62.8, 61.9, 30.4, 28.2, 26.8, 19.1, 15.7;  HRMS (ESI+) calcd for 
C29H39NNaO5Si [M + Na]+ 532.2490, found 532.2498 (error 1.5 ppm). 
 
(S)-3-Azido-2-[(tert-butoxycarbonyl)amino]-N-methoxy-N-methylpropanamide (46). To 
a solution of 7 (9.5 g, 38.2 mmol, 1.0 equiv), Et3N (6.4 ml, 45.8 mmol, 1.2 equiv) in CH2Cl2 (150 
mL) at 0 °C was added MeSO2Cl (3.2 mL, 42.0 mmol, 1.1 equiv) dropwise. The mixture was 
stirred for 1 h at 0 °C, then the reaction mixture was washed with water (1  70 mL), saturated 
aqueous NaHCO3 (1  70 mL), 10% aqueous KHSO4 (1  70 mL), and saturated aqueous NaCl (1 
 70 mL). The organic layer was dried (MgSO4), concentrated, and placed under high vacuum for 
30 min.  It was then redissolved in DMF (175 mL), to which NaN3 (7.5 g, 115 mmol, 3.5 equiv) 
was added.  The reaction was heated at 40 °C for 18 h, then partitioned between ice (200 g) and 
EtOAc (250 mL).  Following melting of the ice, the layers were separated and the aqueous layer 
was extracted with EtOAc (2  250 mL).  The combined organic extracts were then dried 
(MgSO4) and concentrated. Purification by flash chromatography (5% EtOAc–hexane to 30% 
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EtOAc–hexane, linear gradient) afforded the title compound (8.10 g, 78%) as a clear oil: Rf = 
0.55 (50% EtOAc–hexane); 1H NMR, 13C NMR, and HRMS data matched reported values.268 
 
(S)-3-Amino-2-[(tert-butoxycarbonyl)amino]-N-methoxy-N-methylpropanamide (47). To 
a solution of 46 (219 mg, 0.80 mmol, 1.0 equiv) in EtOH (11 mL) was added 10% Pd/C (85 mg).  
The reaction vessel was then sealed and flushed 3 times with H2.  After 4 h, the reaction mixture 
was filtered over EtOH-wetted Celite and concentrated to afford the title compound (193 mg, 
98%) as a white solid: 1H NMR (400 MHz, CDCl3) δ 5.45 (d, J = 7.04 Hz, 1H), 4.70 (br s., 1H), 
3.78 (s, 3H), 3.23 (s, 3H), 3.01 (dd, J = 13.3, 4.7 Hz, 1H), 2.86 (dd, J = 13.3, 5.8 Hz, 1H), 1.45 (s, 
9H); 13C NMR (100 MHz, CDCl3) δ 171.3, 155.7, 79.7, 61.5, 52.8, 44.0, 32.0, 28.3; HRMS 
(ESI+) calcd for C10H22N3O4 [M + H]+ 246.1605, found 246.1615 (error 4.1 ppm). 
  
(S)-2-[(tert-Butoxycarbonyl)amino]-N-methoxy-N-methyl-3-(tritylamino)propanamide 
(49). To a solution of 47 (1.02 g, 4.10 mmol, 1.0 equiv) and Et3N (1.27 mL, 9.03 mmol, 2.2 
equiv) in CH2Cl2 (50 mL) at 23 °C was added trityl chloride (1.42 g, 4.93 mmol, 1.2 equiv).  
After 12 h, the reaction mixture was concentrated. Purification by flash chromatography (5% 
EtOAc–hexane to 30% EtOAc–hexane, linear gradient) afforded the title compound (1.15 g, 
74%) as a clear oil: Rf = 0.65 (50% EtOAc–hexane); 1H NMR (400 MHz, CDCl3) δ 7.44 (d, J = 
7.8 Hz, 6H), 7.21–7.32 (m, 6H), 7.10–7.21 (m, 3H), 5.40 (d, J = 8.6 Hz, 1H), 4.86 (br s, 1H), 3.67 
(s, 3H), 3.19 (s, 3H), 2.55 (dt, J = 10.8, 4.5 Hz, 1H), 2.27 (td, J = 11.6, 5.7 Hz, 1H), 1.96 (br s, 
1H), 1.45 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 172.2, 155.6, 145.7, 128.5, 127.8, 126.3, 79.7, 
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70.5, 61.5, 50.9, 45.6, 32.2, 28.4; HRMS (ESI+) calcd for C29H35N3NaO4 [M + Na]+ 512.2520, 
found 512.2503 (error 3.3 ppm). 
 
(S)-2-[(tert-Butoxycarbonyl)amino]-3-[bis(4-methoxybenzyl)amino]-N-methoxy-N-
methylpropanamide (50). To a solution of 47 (0.732 g, 2.96 mmol, 1.0 equiv) and DIPEA (1.56 
mL, 8.9 mmol, 3.0 equiv) in MeCN (11 mL) at 23 °C was added PMBCl (1.0 mL, 7.4 mmol, 2.5 
equiv).  After 24 h, Et3N (5 mL) was added and the reaction was partitioned between saturated 
aqueous NaCl (70 mL) and EtOAc (80 mL).  The layers were separated and the aqueous layer 
was extracted with EtOAc (2  80 mL).  The combined organic extracts were dried (MgSO4) and 
concentrated.  Purification by flash chromatography (5% EtOAc–hexane to 60% EtOAc–hexane, 
linear gradient) afforded the title compound (596 mg, 41%) as a clear oil: Rf = 0.45 (50% EtOAc–
hexane); 1H NMR (400 MHz, CDCl3) δ 7.25 (d, J = 8.6 Hz, 4H), 6.84 (d, J = 8.6 Hz, 4H), 5.01 
(d, J = 8.6 Hz, 1H), 4.90 (br s, 1H), 3.61–3.84 (m, 11H), 3.41 (d, J = 13.3 Hz, 2H), 3.17 (s, 3H), 
2.55–2.74 (m, 2H), 1.48 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 172.0, 158.6, 155.4, 131.1, 
130.1, 113.6, 79.3, 61.5, 57.5, 55.2, 54.9, 49.3, 32.0, 28.4;  HRMS (ESI+) calcd for C26H38N3O6 
[M + H]+ 488.2755, found 488.2769 (error 3.1 ppm). 
 
(±)-3-Amino-6-(3-hydroxypropyl)-2,3-dihydro-4H-thiopyran-4-one hydrochloride (51). 
To a pre-chilled flask containing 56 (51 mg, 0.177 mmol, 1.0 equiv) was added cold 4 M HCl in 
dioxane (10 mL). After 1 h at 0 °C, the reaction mixture was concentrated in vacuo. The residue 
was dissolved in a minimal amount of MeOH and precipitated with ether, which afforded the title 
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compound (21 mg, 53%) as a white solid: 1H NMR (400 MHz, CD3OD) δ 6.23 (s, 1H), 4.30 (dd, 
J = 14.9, 4.7 Hz, 1H), 3.60 (t, J = 6.1 Hz, 2H), 3.45 (dd, J = 14.6, 13.0 Hz, 1H), 3.34 (dd, J = 
12.7, 4.7 Hz, 1H), 2.56 (dt, J = 7.6, 2.4 Hz, 2H), 1.84 (pent, J = 7.0 Hz, 2H); 13C NMR (100 
MHz, CD3OD) δ 188.0, 167.5, 119.1, 60.1, 52.7, 34.1, 31.4, 28.7;  HRMS (ESI+) calcd for 
C8H14NO2S [M + H]+ 188.0740, found 188.0740 (error 0 ppm). 
  
(±)-N-(tert-Butoxycarbonyl)-S-trityl-cysteine N-methoxy-N-methylamide (53). To a 
solution of (±)-52 (2.5 g, 5.4 mmol, 1.0 equiv), N-methylmorpholine (0.66 ml, 5.9 mmol, 1.1 
equiv), and N,O-dimethylhydroxylamine·HCl (0.60 g, 5.9 mmol, 1.1 equiv) in CH2Cl2 (15 mL) at 
-15 °C was added EDC (1.13 g, 5.9 mmol, 1.1 equiv) in four equal portions over 15 min. The 
mixture was stirred for 16 h at -15 °C, then partitioned between 1 N aqueous HCl (25 mL) and 
CH2Cl2 (40 mL).  The organic layer was separated and washed with 1 N aqueous HCl (1  25 
mL), after which the aqueous layers were combined and extracted with CH2Cl2 (1  50 mL)  The 
combined organic extracts were washed with saturated aqueous NaHCO3 (2  30 mL), saturated 
aqueous NaCl (1  30 mL), dried (MgSO4), and concentrated to afford the title compound (2.62 
g, 96%) as a white solid: Rf = 0.45 (50% EtOAc–hexane); 1H NMR, 13C NMR, and HRMS data 
matched reported values.269 
 
(±)-N-(tert-Butoxycarbonyl)-cysteine N-methoxy-N-methylamide (54). To a solution of 
53 (2.60 g, 5.13 mmol, 1.0 equiv) and Et3SiH (0.98 mL, 6.16 mmol, 1.2 equiv) in CH2Cl2 (60 
mL) at 0 °C was added TFA (2.4 mL, 31.3 mmol, 6.1 equiv), causing the solution to turn bright 
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yellow due to the presence of the triphenylmethyl cation. The reaction was stirred for 1 h at 0 °C 
until the solution had again become clear, then quenched with saturated aqueous NaHCO3 (50 
mL).  The layers were separated and the aqueous layer was extracted with CH2Cl2 (3  50 mL).  
The combined organic extracts were dried (MgSO4) and concentrated under reduced pressure.  
Purification by flash chromatography (10% EtOAc–hexane to 40% EtOAc–hexane, linear 
gradient) afforded the title compound (1.19 g, 88%) as a clear oil: Rf = 0.45 (50% EtOAc–
hexane); 1H NMR (400 MHz, CDCl3) δ 5.44 (d, J = 6.7 Hz, 1H), 4.88 (br s, 1H), 3.78 (s, 3H), 
3.24 (s, 3H), 2.74–2.97 (m, 2H), 1.39–1.55 (m, 10H, C(CH3)3 and SH); 13C NMR (101 MHz, 
CDCl3) δ 170.6, 155.3, 80.0, 61.7, 51.9, 32.1, 28.3, 27.1;  HRMS (ESI+) calcd for 
C10H20N2NaO4S [M + Na]+ 287.1036, found 287.1023 (error 4.5 ppm). 
 
(±)-3-N-[(tert-Butoxycarbonyl)amino]-6-[3-(tert-butyldimethylsilyloxy)propyl]-2,3-
dihydro-4H-thiopyran-4-one (55). To a solution of 5-(tert-butyldimethylsilyloxy)-1-pentyne270 
(282 mg, 1.42 mmol, 3.2 equiv) in THF (10 mL) at -78 °C was added n-BuLi (0.58 mL of a 2.5 
M solution in hexanes, 1.45 mmol 3.3 equiv).  The reaction was stirred for 1 h, then a solution of 
54 (117 mg, .44 mmol, 1.0 equiv) in THF (5 mL) was added dropwise.  After 5 h at -78 °C, the 
reaction was quenched by the dropwise addition of saturated aqueous NH4Cl (5 mL).  The 
reaction mixture was allowed to warm to 23 °C and partitioned between saturated aqueous NH4Cl 
(20 mL) and EtOAc (50 mL).  The layers were separated and the aqueous layer was extracted 
with EtOAc (2  40 mL).  The combined organic extracts were dried (MgSO4) and concentrated. 
Purification by flash chromatography (0% EtOAc–hexane to 15% EtOAc–hexane, linear 
gradient) afforded the title compound (71 mg, 40%) as a pale yellow oil: Rf = 0.2 (10% EtOAc–
hexane); 1H NMR (400 MHz, CDCl3) δ 6.08 (s, 1H), 5.79 (br s, 1H), 4.34 (d, J = 14.1 Hz, 1H), 
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3.61 (t, J = 6.1 Hz, 2H), 3.50 (d, J = 9.4 Hz, 1H), 3.01 (t, J = 13.5 Hz, 1H), 2.45 (t, J = 7.6 Hz, 
2H), 1.71–1.83 (pent, J = 6.8 Hz, 2H), 1.44 (s, 9H), 0.87 (s, 9H), 0.03 (s, 6H); 13C NMR (101 
MHz, CDCl3) δ 191.1, 166.2, 155.5, 119.8, 80.1, 61.5, 54.5, 34.6, 31.73, 31.67, 28.3, 25.9, 18.2, -
5.4 (2C);  HRMS (ESI+) calcd for C19H35NNaO4SSi [M + Na]+ 424.1948, found 424.1960 (error 
2.8 ppm). 
 
(±)-3-N-[(tert-Butoxycarbonyl)amino]-6-(3-hydroxypropyl)-2,3-dihydro-4H-thiopyran-
4-one (56).  To a solution of 55 (70 mg, 0.174 mmol, 1.0 equiv) in THF (7 mL) at 0 °C was 
added HF·Pyridine (0.7 mL) dropwise over 30 min.  The reaction was stirred at 0 °C for 3 h, then 
quenched with saturated aqueous NaHCO3 (25 mL).  The aqueous layer was extracted with 
EtOAc (4  35 mL). The combined organic extracts were dried (MgSO4), concentrated, and 
purified by flash chromatography (15% EtOAc–hexane to 65% EtOAc–hexane, linear gradient) 
affording the title compound (40 mg, 80%) as a white powder: Rf = 0.45 (80% EtOAc–hexane); 
1H NMR (400 MHz, CDCl3) δ 6.12 (s, 1H), 5.81 (br s, 1H), 4.37–4.40 (m, 1H), 3.69 (t, J = 6.3 
Hz, 2H), 3.50–3.54 (m, 1H), 3.04 (t, J = 13.5 Hz, 1H), 2.51 (t, J = 7.8 Hz, 2H), 2.06 (br s, 1H, 
OH), 1.86 (pent, J = 7.0 Hz, 2H), 1.46 (s, 9H); 13C NMR (101 MHz, CDCl3) δ 191.1, 165.8, 
155.5, 119.8, 80.1, 61.3, 54.5, 34.4, 31.6, 31.4, 28.3; HRMS (ESI+) calcd for C13H21NNaO4S [M 
+ Na]+ 310.1083, found 310.1088 (error 1.6 ppm). 
 
3-(4-Methoxybenzyloxy)-N-methoxy-N-methylpropanamide (59). To a solution of 58 
(3.78 g, 19.3 mmol, 1.0 equiv) in acetone (11 mL) at 0 °C was added 2 M Jones’ Reagent (23.2 
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mL). The mixture immediately turned green and some precipitation was observed.  After 90 min, 
iPrOH was added until the reaction turned deep blue, signifying a complete quench.  The reaction 
mixture was filtered over Celite and concentrated to remove all of the acetone. The crude product 
was dissolved in water (30 mL) and extracted with EtOAc (3  100 mL). The combined organic 
extracts were dried (MgSO4), concentrated, then redissolved in CH2Cl2 (130 mL).  To this 
solution was sequentially added N,O-dimethylhydroxylamine hydrochloride (2.52 g, 25.1 mmol, 
1.3 equiv), EDC (4.8 g, 25.1 mmol, 1.3 equiv), Et3N (3.5 mL, 25.1 mmol, 1.3 equiv), and DMAP 
(3.1 g, 25.1 mmol, 1.3 equiv).  After 16 h at 23 °C, the reaction mixture was washed with 1 M 
aqueous HCl (1  50 mL), saturated aqueous NaCl (1  50 mL), saturated aqueous NaHCO3 (1  
50 mL), and saturated aqueous NaCl (1  50 mL).  The organic layer was then dried (MgSO4), 
and concentrated.  Purification by flash chromatography (20% EtOAc–hexane to 60% EtOAc–
hexane, linear gradient) afforded the title compound (2.34 g, 72%) as a clear viscous liquid: 1H 
NMR (400 MHz, CDCl3) δ 7.26 (d, J = 8.5 Hz, 2H), 6.87 (d, J = 8.6 Hz, 2H), 4.47 (s, 2H), 3.72–
3.85 (m, 5H), 3.67 (s, 3H), 3.18 (s, 3H), 2.74 (t, J = 6.5 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 
172.3, 159.2, 130.4, 129.3, 113.7, 72.9, 65.6, 61.3, 55.2, 32.5, 32.0; HRMS (ESI+) calcd for 
C13H19NNaO4 [M + Na]+ 276.1206, found 276.1206 (error 0 ppm). 
 
1-(4-Methoxybenzyloxy)-8-(triisopropylsilyloxy)oct-4-yn-3-one (61). To a solution of 5-
(triisopropylsilyloxy)-1-pentyne271 (2.9 g, 12.0 mmol, 1.3 equiv) in THF (40 mL) at -78 °C was 
added n-BuLi (4.4 mL of a 2.5 M solution in hexanes, 11.0 mmol 1.2 equiv).  The reaction was 
stirred for 1.5 h, then a solution of 59 (2.34 g, 12.0 mmol, 1.0 equiv) in THF (50 mL) was added 
dropwise.  The reaction was allowed to warm to 23 °C over 2 h, and after 16 h was quenched 
with AcOH (2 mL). EtOAc (300 mL) was then added and the reaction mixture was washed with 
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saturated aqueous NaHCO3 (2  100 mL) and saturated aqueous NaCl (1  50 mL), dried 
(MgSO4), and concentrated. Purification by flash chromatography (0% EtOAc–hexane to 15% 
EtOAc–hexane, linear gradient) afforded the title compound (3.51 g, 88%) as a pale yellow 
liquid: Rf = 0.7 (20% EtOAc–hexane); 1H NMR (400 MHz, CDCl3) δ 7.26 (d, J = 8.5 Hz, 2H), 
6.88 (d, J = 8.6 Hz, 2H), 4.46 (s, 2H), 3.81 (s, 3H), 3.72–3.80 (m, 4H), 2.82 (t, J = 6.3 Hz, 2H), 
2.50 (t, J = 7.2 Hz, 2H), 1.79 (pent, J = 6.5 Hz, 2H), 0.97–1.16 (m, 21H); 13C NMR (100 MHz, 
CDCl3) δ 185.8, 159.2, 130.1, 129.3, 113.8, 94.7, 80.8, 72.8, 64.6, 61.5, 55.3, 45.7, 31.0, 18.0, 
15.5, 11.9;  HRMS (ESI+) calcd for C25H40NaO4Si [M + Na]+ 455.2588, found 455.2594 (error 
1.1 ppm). 
 
1-Hydroxy-8-(triisopropylsilyloxy)oct-4-yn-3-one (62). To a solution of 61 (3.45 g, 7.97 
mmol, 1.0 equiv) in CH2Cl2 (60 mL) at 23 °C was added DDQ (2.17 g, 9.56 mmol 1.2 equiv) and 
H2O (6 mL).  After 1.5 h, the reaction mixture was partitioned between CH2Cl2 (50 mL) and 
saturated aqueous NaHCO3 (50 mL).  The layers were separated and the aqueous layer was 
extracted with CH2Cl2 (3  100 mL).  The combined organic extracts were dried (MgSO4) and 
concentrated. Purification by flash chromatography (5% EtOAc–hexane to 20% EtOAc–hexane, 
linear gradient) afforded the title compound (2.34 g, 94%) as a pale yellow liquid: Rf = 0.15 (20% 
EtOAc–hexane); 1H NMR (400 MHz, CDCl3) δ 3.91 (q, J = 5.6 Hz, 2H), 3.78 (t, J = 5.9 Hz, 2H), 
2.82 (t, J = 5.5 Hz, 2H), 2.53 (t, J = 7.0 Hz, 2H), 2.19 (t, J = 6.5 Hz, 1H, OH), 1.81 (pent, J = 6.5 
Hz, 2H), 1.00–1.16 (m, 21H); 13C NMR (101 MHz, CDCl3) δ 187.3, 95.4, 80.8, 61.4, 57.7, 47.6, 
30.9, 18.0, 15.5, 11.9; HRMS (ESI+) calcd for C17H32NaO3Si [M + Na]+ 335.2013, found 
335.2022 (error 2.7 ppm). 
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6-[3-((Triisopropylsilyl)oxy)propyl]-2,3-dihydro-4H-pyran-4-one (63). To a solution of 62 
(2.36 g, 7.55 mmol, 1.0 equiv) in CH2Cl2 (150 mL) was added AgOTf (1.94 g, 7.55 mmol, 1.0 
equiv).  After 2 h, the reaction mixture was filtered over Celite, concentrated, and purified by 
flash chromatography (5% EtOAc–hexane to 20% EtOAc–hexane, linear gradient) affording the 
title compound (1.46 g, 62%) as a clear oil: Rf = 0.15 (20% EtOAc–hexane); 1H NMR (400 MHz, 
CDCl3) δ 5.36 (s, 1H), 4.46 (t, J = 6.9 Hz, 2H), 3.72 (t, J = 6.1 Hz, 2H), 2.52 (t, J = 6.9 Hz, 2H), 
2.37 (t, J = 7.6 Hz, 2H), 1.79 (pent, J = 6.9 Hz, 2H), 1.02–1.13 (m, 21H); 13C NMR (100 MHz, 
CDCl3) δ 192.2, 177.9, 104.6, 67.9, 62.1, 35.7, 31.3, 29.6, 18.0, 11.9; HRMS (ESI+) calcd for 
C17H32NaO3Si [M + Na]+ 335.2013, found 335.2021 (error 2.4 ppm). 
 
6-Hydroxy-1-[(triisopropylsilyl)oxy]octa-5,7-dien-4-one (64). To a solution of 63 (1.39 g, 
4.0 mmol, 1.0 equiv) in THF (40 mL) at -78 °C was added LiHMDS (4.9 mL of a 1M solution in 
THF, 4.9 mmol, 1.1 equiv). After 30 min at -78 °C, N-Boc-cyanophenyl oxaziridine (0.60 g, 2.45 
mmol, 0.55 equiv) was added over 10 min as a solution in THF (10 mL).  After 50 min, saturated 
aqueous NH4Cl (5 mL) was added, and the reaction was warmed to 23 °C.  The reaction mixture 
was then partitioned between saturated aqueous NH4Cl (50 mL) and EtOAc (100 mL).  The 
layers were separated and the aqueous layer was extracted with EtOAc (2 x 100 mL). The 
combined organic extracts were dried (MgSO4) and concentrated.  Purification by flash 
chromatography (5% EtOAc–hexane  30% EtOAc–hexane, linear gradient) afforded the title 
compound (157 mg, 11%) as a clear liquid, along with several other products that were unable to 
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be fully characterized: Rf = 0.8 (20% EtOAc–hexane); 1H NMR (400 MHz, CDCl3) δ 6.26 (dd, J 
= 17.1, 1.5 Hz, 1H), 6.13 (dd, J = 17.1, 10.6 Hz, 1H), 5.67 (dd, J = 10.4, 1.4 Hz, 1H), 5.58 (s, 
1H), 3.73 (t, J = 6.1 Hz, 2H), 2.52 (t, J = 7.6 Hz, 2H), 1.87 (pent, J = 6.8 Hz, 2H), 0.99–1.15 (m, 
21H); 13C NMR (101 MHz, CDCl3) δ 202.1, 175.4, 132.4, 125.1, 100.3, 62.4, 37.0, 28.4, 18.0, 
12.0; HRMS (ESI+) calcd for C17H32NaO3Si [M + Na]+ 335.2013, found 335.2005 (error 2.4 
ppm). 
 
3-[(tert-Butoxycarbonyl)amino]-N-methoxy-N-methylpropanamide (66). To a solution of 
N-Boc-β-alanine (8.5 g, 45.0 mmol, 1.0 equiv), N-methylmorpholine (5.5 ml, 49.5 mmol, 1.1 
equiv), and N,O-dimethylhydroxylamine·HCl (4.98 g, 49.5 mmol, 1.1 equiv) in CH2Cl2 (100 mL) 
at -15 °C was added EDC (9.49 g, 49.5 mmol, 1.1 equiv) in four equal portions over 15 min. The 
mixture was stirred for 16 h at -15 °C, then washed with 1 N aqueous HCl (2  25 mL), saturated 
aqueous NaHCO3 (2  25 mL), and saturated aqueous NaCl (1  25 mL).  The organic layer was 
then dried (MgSO4), and concentrated to afford the title compound (9.69 g, 93%) as a white solid: 
Rf = 0.1 (50% EtOAc–hexane); 1H NMR, 13C NMR, and HRMS data matched reported values.272 
 
1-[(tert-Butoxycarbonyl)amino]-8-(tert-butyldimethylsilyloxy)oct-4-yn-3-one (67). To a 
solution of 5-(tert-butyldimethylsilyloxy)-1-pentyne273 (4.25 g, 21.4 mmol, 2.2 equiv) in THF (35 
mL) at -78 °C was added n-BuLi (8.6 mL of a 2.5 M solution in hexanes, 21.4 mmol 2.2 equiv).  
The reaction was stirred for 1.25 h, then a solution of 66 (2.25 g, 9.7 mmol, 1.0 equiv) in THF (15 
mL) was added dropwise.  The reaction was allowed to warm to 23 °C after 2 h.  After 16 h, the 
reaction was quenched by the dropwise addition of AcOH (5 mL), then partitioned between 
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saturated aqueous NaHCO3 (50 mL) and EtOAc (150 mL).  The layers were separated and the 
organic layer was washed with saturated aqueous NaHCO3 (1  50 mL) and saturated aqueous 
NaCl (1  50 mL), dried (MgSO4), and concentrated. Purification by flash chromatography (5% 
EtOAc–hexane to 25% EtOAc–hexane, linear gradient) afforded the title compound (2.13 g, 
59%) as a clear oil: Rf = 0.3 (20% EtOAc–hexane); 1H NMR (400 MHz, CDCl3) δ 4.94 (br s, 1H), 
3.69 (t, J = 5.7 Hz, 2H), 3.41 (q, J = 5.6 Hz, 2H), 2.78 (t, J = 5.5 Hz, 2H), 2.48 (t, J = 7.0 Hz, 
2H), 1.78 (pent, J = 6.5 Hz, 2H), 1.44 (s, 9H), 0.90 (s, 9H), 0.06 (s, 6H); 13C NMR (100 MHz, 
CDCl3) δ 186.7, 155.7, 95.0, 80.7, 79.3, 61.1, 45.5, 35.1, 30.7, 28.4, 25.9, 18.3, 15.5, -5.4; HRMS 
(ESI+) calcd for C19H35NNaO4Si [M + Na]+ 392.2228, found 392.2220 (error 2.0 ppm). 
 
1-tert-Butoxycarbonyl-6-[3-(tert-butyldimethylsilyloxy)propyl]-2,3-dihydro-4H-pyridin-
4-one (68). To a solution of 67 (2.127 g, 5.8 mmol, 1.0 equiv) and PPh3AuCl (143 mg, 0.29 
mmol, 0.05 equiv) in CH2Cl2 (35 mL) at 23 C was added AgOTf (200 mg, 0.58 mmol, 0.1 equiv). 
After 2 h, the reaction mixture was filtered over Celite and concentrated.  Purification by flash 
chromatography (0% EtOAc–hexane to 25% EtOAc–hexane, linear gradient) afforded the title 
compound (1.501 g, 71%) as a clear oil: Rf = 0.35 (20% EtOAc–hexane); 1H NMR (400 MHz, 
CDCl3) δ 5.41 (s, 1H), 4.01 (t, J = 6.7 Hz, 2H), 3.62 (t, J = 6.1 Hz, 2H), 2.76 (t, J = 7.6 Hz, 2H), 
2.48 (t, J = 6.7 Hz, 2H), 1.72 (pent, J = 6.9 Hz, 2H), 1.54 (s, 9H), 0.90 (s, 9H), 0.05 (s, 6H); 13C 
NMR (100 MHz, CDCl3) δ 194.7, 161.3, 152.0, 112.3, 83.0, 62.2, 46.6, 37.3, 32.3, 31.1, 28.1, 
25.9, 18.3, -5.3; HRMS (ESI+) calcd for C19H35NNaO4Si [M + Na]+ 392.2228, found 392.2222 
(error 1.5 ppm). 
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(±)-1-(tert-Butoxycarbonyl)-3-[(tert-butoxycarbonyl)amino]-6-[3-(tert-
butyldimethylsilyloxy)propyl]-2,3-dihydro-4H-pyridin-4-one (69). To a solution of 68 (1.48 g, 
4.0 mmol, 1.0 equiv) in THF (50 mL) at -78 °C was added LiHMDS (4.4 mL of a 1 M solution in 
THF, 4.4 mmol, 1.1 equiv). After 30 min at -78 °C, N-Boc-cyanophenyloxaziridine (0.54 g, 2.2 
mmol, 0.55 equiv) was added over 10 min as a solution in THF (10 mL).  After 50 min, saturated 
aqueous NH4Cl (5 mL) was added, and the reaction was warmed to 23 °C.  The reaction mixture 
was then partitioned between saturated aqueous NH4Cl (50 mL) and EtOAc (100 mL).  The 
layers were separated and the aqueous layer was extracted with EtOAc (2  100 mL). The 
combined organic extracts were dried (MgSO4) and concentrated.  Purification by flash 
chromatography (0% EtOAc–hexane to 25% EtOAc–hexane, linear gradient) afforded the title 
compound (744 mg, 38%) as a clear oil: Rf = 0.55 (20% EtOAc–hexane); 1H NMR (400 MHz, 
CDCl3) δ 5.37 (s, 1H), 5.31 (br s, 1H), 4.78 (dd, J = 12.3, 5.3 Hz, 1H), 4.22 (d, J = 12.5 Hz, 1H), 
3.62 (dt, J = 6.1, 3.1 Hz, 2H), 3.24 (t, J = 13.2 Hz, 1H), 2.99 (td, J = 14.7, 7.5 Hz, 1H), 2.58 (td, J 
= 15.0, 7.6 Hz, 1H), 1.72 (pent, J = 6.9 Hz, 2H), 1.52–1.64 (m, 9H), 1.46 (s, 9H), 0.90 (s, 9H), 
0.05 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 191.7, 162.9, 155.5, 151.8, 108.7, 83.6, 80.0, 62.0, 
53.7, 51.3, 32.1, 31.2, 28.3, 28.0, 25.9, 18.3, -5.3 (2C); HRMS (ESI+) calcd for C24H44N2NaO6Si 
[M + Na]+ 507.2861, found 507.2876 (error 3.0 ppm). 
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(±)-1-(tert-Butoxycarbonyl)-3-[(tert-butoxycarbonyl)amino]-6-(3-hydroxypropyl)-2,3-
dihydro-4H-pyridin-4-one (70). To a solution of 69 (734 mg, 1.51 mmol, 1.0 equiv) in THF (50 
mL) at 0 °C was added HF·Pyridine (5 mL) over a 30 min period.  After 4 h at 0 °C, the reaction 
mixture was partitioned between saturated aqueous NaHCO3 (50 mL) and EtOAc (100 mL).  The 
layers were separated and the aqueous layer was extracted with EtOAc (4  60 mL).  The 
combined organic extracts were dried (MgSO4) and concentrated.  Purification by flash 
chromatography (20% EtOAc–hexane to 70% EtOAc–hexane, linear gradient) afforded the title 
compound (478 mg, 85%) as a clear oil: Rf = 0.55 (80% EtOAc–hexane); 1H NMR (400 MHz, 
CDCl3) δ 5.38 (s, 1H), 5.29 (br s, 1H), 4.76 (dd, J = 12.5, 5.5 Hz, 1H), 4.21 (d, J = 12.1 Hz, 1H), 
3.67 (t, J = 6.0 Hz, 2H), 3.25 (t, J = 13.1 Hz, 1H), 3.01 (dt, J = 14.5, 7.2 Hz, 1H), 2.64 (dt, J = 
15.1, 7.7 Hz, 1H), 1.73–1.85 (m, 2H), 1.54 (s, 9H), 1.45 (s, 9H); 13C NMR (101 MHz, CDCl3) δ 
191.7, 162.7, 155.5, 151.8, 108.8, 83.8, 80.1, 61.7, 53.7, 51.2, 31.7, 31.1, 28.3, 28.0; HRMS 
(ESI+) calcd for C18H30N2NaO6 [M + Na]+ 393.1996, found 393.2012 (error 4.1 ppm). 
 
(±)-3-Amino-2-[(tert-butoxycarbonyl)amino]propionic acid (72).  To a slurry of (±)-N-
Boc-asparagine (10.0 g, 43.1 mmol, 1.0 equiv) in 2:2:1 EtOAc–MeCN–H2O (120 mL) at 10 °C 
was added iodosobenzene diacetate (16.6 g, 51.5 mmol, 1.2 equiv).  The reaction was allowed to 
warm to 23 °C over 2 h.  After 16 h, the reaction mixture was filtered, and the filter cake was 
washed with EtOAc (150 mL), then dried in vacuo to afford the title compound (6.06 g, 69%) as 
a white solid. 1H NMR, 13C NMR, and HRMS data matched reported values.274 
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(±)-2-(tert-Butoxycarbonyl)amino-3-[2-(trimethylsilyl)ethyloxycarbonyl]propionic acid 
(73). To a solution of 72 (0.41 g, 2.01 mmol, 1.0 equiv) in 1.5 M aqueous Na2CO3 (10 mL) at 23 
°C was added 4-nitrophenyl 2-(trimethylsilyl)ethyl carbonate (Teoc-ONp) (0.68 g, 2.41 mmol, 
1.2 equiv) in dioxane (5 mL) dropwise. The reaction was heated to 40 °C for 48 h, after which it 
was a bright yellow solution.  Na2S2O4 was then added to the reaction mixture until the solution 
turned white, which signifies when the p-nitrophenol has been reduced to the aniline.  H2O (30 
mL) was added and the reaction mixture was extracted with Et2O (1  20 mL).  The layers were 
separated and the organic layer was extracted with 1 N Na2CO3 (3  15 mL).  The combined 
aqueous extracts were acidified to a pH of 2 with 2 N HCl and extracted with CH2Cl2 (3  100 
mL). The combined organic extracts were dried (MgSO4) and concentrated to afford the title 
compound (0.593 g, 85%) as a clear oil: Rf = 0.1 (10% MeOH– CH2Cl2); 1H NMR, 13C NMR, and 
HRMS data matched reported values.275 
 
(±)-2-N-(tert-Butoxycarbonyl)-3-N-[2-(trimethylsilyl)ethyloxycarbonyl]-2,3-diamino-N-
methoxy-N-methylpropanamide (74). To a solution of 73 (0.58 g, 1.66 mmol, 1.0 equiv), N-
methylmorpholine (0.20 ml, 1.83 mmol, 1.1 equiv), and N,O-dimethylhydroxylamine·HCl (0.18 
g, 1.83 mmol, 1.1 equiv) in CH2Cl2 (13 mL) at -15 °C was added EDC (1.13 g, 5.9 mmol, 1.1 
equiv) in four equal portions over 15 min. The mixture was stirred for 2 h at -15 °C, then 
partitioned between saturated aqueous 1 N HCl (35 mL) and CH2Cl2 (35 mL). The layers were 
separated and the aqueous layer was extracted with CH2Cl2 (1  50 mL), after which the organic 
layers were combined and washed with saturated aqueous NaHCO3 (1  30 mL), dried (MgSO4), 
and concentrated, affording the title compound (0.62 g, 95%) as a white solid: Rf = 0.45 (50% 
EtOAc–hexane); 1H NMR (400 MHz, CDCl3) δ 5.54 (br s, 1H), 5.11 (br s, 1H), 4.75 (br s, 1H), 
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4.11 (t, J = 8.4 Hz, 2H), 3.76 (s, 3H), 3.48 (br s, 2H), 3.19 (s, 3H), 1.42 (s, 9H), 0.94 (t, J = 8.40 
Hz, 2H), 0.01 (s, 9H); 13C NMR (101 MHz, CDCl3) δ 170.6, 156.8, 155.5, 79.8, 63.1, 61.6, 50.9, 
42.7, 32.3, 28.2, 17.6, -1.6; HRMS (ESI+) calcd for C16H33N3NaO6Si [M + Na]+ 414.2031, found: 
414.2032 (error 0.2 ppm).  
 
(±)-2-[(tert-Butoxycarbonyl)amino]-8-(tert-butyldimethylsilyloxy)-1-[2-
(trimethylsilyl)ethoxycarbonyl]-oct-4-yn-3-one (75). To a solution of 5-(tert-
butyldimethylsilyloxy)-1-pentyne276 (0.96 g, 4.82 mmol, 3.2 equiv) in THF (15 mL) at -78 °C 
was added n-BuLi (1.99 mL of a 2.5 M solution in hexanes, 4.97 mmol 3.3 equiv). After 2 h, a 
solution of 74 (0.59 g, 1.51 mmol, 1.0 equiv) in THF (15 mL) was added dropwise.  After 16 h at 
-78 C, AcOH (3 mL) was added dropwise to quench. The reaction mixture was partitioned 
between EtOAc (80 mL) and saturated aqueous NaHCO3 (40 mL).  The aqueous layer was 
extracted with EtOAc (1  80 mL), and the combined organic extracts were dried (MgSO4) and 
concentrated. Purification by flash chromatography (5% EtOAc–hexane to 30% EtOAc–hexane, 
linear gradient) afforded the title compound (317 mg, 40%, 73% BRSM) as a pale yellow oil: Rf = 
0.3 (20% EtOAc–hexane); 1H NMR (400 MHz, CDCl3) δ 5.62 (br s, 1H), 5.08 (br s, 1H), 4.40 (br 
s, 1H), 4.12 (t, J = 8.4 Hz, 2H), 3.47–3.78 (m, 4H), 2.49 (t, J = 7.0 Hz, 2H), 1.78 (pent, J = 6.5 
Hz, 2H), 1.43 (s, 9H), 0.94 (t, J = 8.4 Hz, 2H), 0.87 (s, 9H), 0.04 (s, 6H), 0.01 (s, 9H); 13C NMR 
(101 MHz, CDCl3) δ 184.5, 157.0, 155.5, 98.9, 80.1, 78.9, 63.4, 61.7, 61.1, 42.0, 30.6, 28.2, 25.8, 
18.2, 17.6, 15.7, -1.6, -5.5; HRMS (ESI+) calcd for C25H48N2NaO6Si2 [M + Na]+ 551.2943, 
found: 551.2955 (error 2.2 ppm).  
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(±)-3-[(tert-Butoxycarbonyl)amino]-6-(3-hydroxypropyl)-2,3-dihydro-1H-pyridin-4-one 
(76). To a solution of 1 M TBAF in THF (2.72 mL, 2.72 mmol, 4.0 equiv) at 0 °C was added H2O 
(0.74 mL, 40.8 mmol, 60 equiv), THF (10 mL), and a solution of 75 (0.36 g, 0.68 mmol, 1.0 
equiv) in THF (10 mL), respectively.  The reaction was allowed to warm to 23 °C over 2 h. After 
16 h, 4 Å molecular sieves (6 g) were added, and 5 min after saturated aqueous NaHCO3 (30 mL) 
was added to quench.  The reaction mixture was filtered through a thin pad of Celite and 
extracted with EtOAc (3  25 mL). The combined organic extracts were dried (MgSO4) and 
concentrated. Purification by flash chromatography (0% MeOH–CH2Cl2 to 10% MeOH–CH2Cl2, 
linear gradient) afforded the title compound (72 mg, 39%) as a pale yellow oil: Rf = 0.3 (10% 
MeOH–CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 6.40 (br s, 1H), 5.63 (br s, 1H), 4.99 (s, 1H), 
3.93–4.18 (m, 2H), 3.68 (t, J = 5.9 Hz, 2H), 3.16 (t, J = 13.1 Hz, 1H), 2.37 (t, J = 7.0 Hz, 2H), 
1.81 (pent, J = 6.5 Hz, 2H), 1.44 (s, 9H); 13C NMR (101 MHz, CDCl3) δ 188.6, 167.7, 156.2, 
95.6, 79.9, 61.2, 52.0, 46.4, 31.5, 30.2, 28.3; HRMS (ESI+) calcd for C13H22N2NaO4 [M + Na]+ 
293.1472, found: 293.1469 (error 0.2 ppm).  
 
N-(tert-Butoxycarbonyl)-O-(tert-butoxydimethylsilyl)-serine-N-methoxy-N-
methylamide (77).  To a solution of 5 (3.0 g, 12.1 mmol, 1.0 equiv) in DMF (35 mL) at 23 °C 
was added imidazole (2.49 g, 36.2 mmol, 3.0 equiv) and tert-butyldimethylchlorosilane (2.25 g, 
14.5 mmol, 1.2 equiv) sequentially. After 16 h, the reaction was partitioned between 10% KHSO4 
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(60 mL) and EtOAc (250 mL). The layers were separated and the organic layer was washed with 
10% KHSO4 (1  60 mL) and saturated aqueous NaHCO3 (1  50 mL). The combined organic 
extracts were dried (MgSO4) and concentrated. Purification by flash chromatography (5% 
EtOAc–hexane to 25% EtOAc–hexane, linear gradient) afforded the title compound (4.16 g, 
95%) as a clear oil. 1H NMR, 13C NMR, and HRMS data matched reported values.277 
 
N-(tert-Butoxycarbonyl)(methoxymethyl)serine-N-methoxy-N-methylamide (78).  To a 
solution of 77 (12.6 g, 34.8 mmol, 1.0 equiv) in THF (100 mL) at -78 °C was added solid 
KHMDS (13.2 g, 66.2 mmol, 1.9 equiv).  After 1 h, MOMCl (8.0 g, 99.3 mmol, 2.9 equiv) was 
added dropwise, and the reaction was allowed to warm to 23 °C over 2 h.  After 16 h, the reaction 
mixture was partitioned between saturated aqueous NH4Cl (200 mL) and EtOAc (250 mL).  The 
layers were separated and the aqueous layer was extracted with EtOAc (1  250 mL).  The 
combined organic extracts were dried (MgSO4) and concentrated.  To a solution of the resulting 
mixture in THF (130 mL) at 0 °C was added HF·Pyridine (14 mL).  Saturated aqueous NaHCO3 
(400 mL) was added after 4.5 h to quench.  The product was extracted with EtOAc (2  300 mL), 
and the combined organic extracts were dried (MgSO4) and concentrated.  Purification by flash 
chromatography (25% EtOAc–hexane to 55% EtOAc–hexane, linear gradient) afforded the title 
compound (7.2 g, 71%) as a colorless oil: Rf = 0.15 (50% EtOAc–hexane); 1H NMR (400 MHz, 
acetone-d6) δ 5.12 (br s, 0.5H), 4.76–4.95 (m, 2.5H), 3.91 (br s, 1H), 3.77 (s, 3H), 3.67–3.75 (m, 
1H), 3.58–3.66 (m, 1H), 3.32 (br s, 3H), 3.14 (br s, 3H), 1.47 (s, 9H); 13C NMR (100 MHz, 
acetone-d6) δ 171.5, 156.0, 81.1, 77.5, 61.9, (61.2, 61.1), (59.3, 57.7), 56.0, 32.6, 28.5;  HRMS 
(ESI+) calcd for C12H24N2NaO6 [M + Na]+ 315.1527, found 315.1538 (error 3.5 ppm). 
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2-[(tert-Butoxycarbonyl)(methoxymethyl)amino]-8-(tert-butyldiphenylsilyloxy)-1-
hydroxy-oct-4-yn-3-one (79). To a solution of 5-(tert-butyldiphenylsilyloxy)-1-pentyne278 (0.507 
g, 1.57 mmol, 2.3 equiv) in THF (8 mL) at -78 °C was added n-BuLi (0.66 mL of a 2.5 M 
solution in hexanes, 1.64 mmol 2.4 equiv).  The reaction was stirred for 1.5 h, then a solution of 
78 (200 mg, 0.68 mmol, 1.0 equiv) in THF (10 mL) was added dropwise.  After 16 h at -78 °C, 
the reaction was quenched by the dropwise addition of AcOH (3 mL).  The reaction mixture was 
allowed to warm to 23 °C and partitioned between saturated aqueous NH4Cl (20 mL) and EtOAc 
(50 mL).  The layers were separated and the aqueous layer was extracted with EtOAc (2  40 
mL).  The combined organic extracts were dried (MgSO4) and concentrated. Purification by flash 
chromatography (5% EtOAc–hexane to 40% EtOAc–hexane, linear gradient), afforded the title 
compound (185 mg, 49%) as a pale yellow oil: Rf = 0.55 (50% EtOAc-hexane); 1H NMR (400 
MHz, acetone-d6, ratio of rotamers 1:1) δ 7.63–7.78 (m, 4H), 7.38–7.53 (m, 6H), 4.89 (dd, J = 
10.8, 6.0 Hz, 1H), 4.75 (dd, J = 10.8, 6.0 Hz, 1H), 4.07–4.30 (m, 1.5H), 3.75–4.00 (m, 3.5H), 
3.38 (s, 1.5 H), 3.36 (s, 1.5H), 2.57–2.67 (m, 2H), 1.80–1.91 (m, 2H), 1.48 (s, 4.5 H), 1.40 (s, 
4.5H), 1.05 (s, 9H); 13C NMR (100 MHz, acetone-d6) δ (185.2, 184.9), (155.6, 155.3), 136.1, 
134.4, 130.7, 128.8, (95.3, 94.9), (81.8, 81.5), (80.48, 80.41), (80.33, 80.14), (69.7, 69.4), 63.0, 
(61.4, 60.9), (56.4, 56.3), (31.58, 31.53), (28.6, 28.4), 27.3, 19.8, 16.0;  HRMS (ESI+) calcd for 
C31H43NNaO6Si [M + Na]+ 576.2752, found 576.2744 (error 1.4 ppm). 
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3-[(tert-Butoxycarbonyl)(methoxymethyl)amino]-6-[3-(tert-
butyldiphenylsilyloxy)propyl]-2,3-dihydro-4H-pyran-4-one (80). To a solution of 79 (23 mg, 
0.042 mmol, 1.0 equiv), and PPh3AuCl (2 mg, 0.004 mmol, 0.1 equiv) in CH2Cl2 (15 mL) at -78 
°C was added AgOTf (750 µg, 0.003 mmol, 0.075 equiv). The reaction was stirred for 40 min at -
78 °C, then placed in an ice bath to warm to 0 °C.  After 30 min, the reaction mixture was 
partitioned between saturated aqueous NaCl (5 mL) and CH2Cl2 (10 mL).  The layers were 
separated and the aqueous layer was extracted with CH2Cl2 (1  10 mL). The combined organic 
extracts were dried (MgSO4) and concentrated.  Purification by flash chromatography (100 mL 
hexane, 150 mL 10% EtOAc-hexane, 75 mL 15% EtOAc-hexane, 100 mL 20% EtOAc-hexane) 
afforded the title compound (12 mg, 52%) as a pale yellow oil: Rf = 0.3 (20% EtOAc–hexane); 1H 
NMR (400 MHz, acetone-d6, ~1.4:1 mixture of rotamers) δ 7.62–7.77 (m, 4H), 7.35–7.54 (m, 
6H), 5.30 (s, 1H), 4.39–4.82 (m, 4.3H), 4.21 (dd, J = 13.7, 6.3 Hz, 0.7H), 3.75 (t, J = 6.3 Hz, 2H), 
3.30 (s, 3H), 2.45 (t, J = 7.4 Hz, 2H), 1.87 (pent, J = 6.9 Hz, 3H), 1.47 (s, 3.7H), 1.37 (s, 5.3H), 
1.05 (s, 9H); 13C NMR (100 MHz, acetone-d6) δ (189.6, 189.5), (177.54, 177.47), (155.4, 155.1), 
136.4, 134.5, 130.7, 128.8, (104.4, 104.1), 81.5, (79.9, 79.7), (70.4, 70.3), 63.6, (58.9, 58.2), 
(55.7, 55.6), 31.5, 30.2, (28.4, 28.3), 27.3, 19.8; HRMS (ESI+) calcd for C31H43NNaO6Si [M + 
Na]+ 576.2752, found 576.2750 (error 0.3 ppm). 
 
3-[(tert-Butoxycarbonyl)(methoxymethyl)amino]-6-(3-hydroxypropyl)-2,3-dihydro-4H-
pyran-4-one (81). To a solution of 80 (0.48 g, 0.87 mmol, 1.0 equiv) in THF (45 mL) at 0 °C 
was added HF·Pyridine (4.5 mL) dropwise. The reaction was stirred for 16 h at 0 °C, then 
quenched with saturated aqueous NaHCO3 (100 mL) over 5 min. The aqueous layer was 
extracted with EtOAc (3  80 mL), and the combined organic extracts were dried (MgSO4) and 
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concentrated.  Purification by flash chromatography (15% EtOAc–hexane to 80% EtOAc–
hexane, linear gradient) afforded the title compound (0.189 g, 69%) as a pale yellow oil: Rf = 0.55 
(EtOAc); 1H NMR (CDCl3, 500 MHz, 1:1 mixture of rotamers) δ 5.40 (s, 0.5 H), 5.37 (s, 0.5H), 
4.80 (dd, J = 11.2, 5.9 Hz, 1H), 4.53–4.72 (m, 2.5H), 4.44–4.50 (m, 1H), 4.24 (dd, J = 13.9, 6.0 
Hz, 0.5H), 3.70 (br s, 2H), 3.36 (s, 1.5H), 3.32 (s, 1.5H), 2.29–2.44 (m, 2H), 1.76–1.89 (m, 2H), 
1.49 (s, 4.5H), 1.44 (s, 4.5H); 13C NMR (100 MHz, CDCl3) δ (189.7, 189.4), (177.2, 176.9), 
(154.6, 154.5), (103.9, 103.5), (81.8, 81.5), (79.3, 79.1), (69.7, 69.6), 61.7, (57.9, 57.2), (55.7, 
55.5), 31.0, 29.2, (28.2, 28.1); HRMS (ESI+) calcd for C15H25NNaO6 [M + Na]+ 338.1574, found 
338.1579 (error 1.5 ppm). 
 
Section 2.8. Spectra of Synthesized Compounds 
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